{"resourceType":"ValueSet","id":"nzpocs","meta":{"versionId":"1","lastUpdated":"2024-11-05T17:12:49.034+13:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>NZPOCS</h2><tt>https://nzhts.digital.health.nz/fhir/ValueSet/nzpocs</tt><p>A LOINC FHIR ValueSet of NZPOCS Observation Code Set</p></div>"},"url":"https://nzhts.digital.health.nz/fhir/ValueSet/nzpocs","version":"20241016","name":"NZPOCS","title":"NZPOCS","status":"active","experimental":false,"publisher":"HISO","description":"A LOINC FHIR ValueSet of NZPOCS Observation Code Set","compose":{"include":[{"system":"http://loinc.org","version":"2.78","concept":[{"code":"1003-3","display":"Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"AHG (indirect, complement)"}]},{"code":"100383-9","display":"Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Monkeypox DNA NAA+probe Ql (Specimen)"}]},{"code":"1004-1","display":"Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"AHG (direct, complement)"}]},{"code":"1005-8","display":"Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"AHG (indirect, IgG)"}]},{"code":"1007-4","display":"Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"AHG (direct, polyspecific)"}]},{"code":"100-8","display":"Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefoperazone suscep (MIC)"}]},{"code":"1008-2","display":"Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"AHG (indirect, polyspecific)"}]},{"code":"10331-7","display":"Rh [Type] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rh phenotype"}]},{"code":"10333-3","display":"Appearance of Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Appearance CSF"}]},{"code":"10334-1","display":"Cancer Ag 125 [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CA 125"}]},{"code":"104-0","display":"Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceforanide suscep (MIC)"}]},{"code":"10501-5","display":"Lutropin [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"LH"}]},{"code":"10574-2","display":"Fructose [Moles/?volume] in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fructose seminal fluid"}]},{"code":"10579-1","display":"Leukocytes [#/volume] in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Leucocytes semen"}]},{"code":"10580-9","display":"Liquefaction [Time] in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Liquefaction semen"}]},{"code":"10602-1","display":"Spermatozoa Abnormal Head/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Abnormal forms (head) semen"}]},{"code":"10603-9","display":"Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Abnormal forms (midpiece) semen"}]},{"code":"10604-7","display":"Spermatozoa Abnormal Tail/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Abnormal forms (tail) semen"}]},{"code":"10605-4","display":"Spermatozoa Agglutinated/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Agglutination semen"}]},{"code":"10611-2","display":"Spermatozoa Immotile/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Non-motile semen"}]},{"code":"10613-8","display":"Spermatozoa Viable/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vitality semen"}]},{"code":"10620-3","display":"Spermatozoa Nonprogressive/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Non-progressive semen"}]},{"code":"10622-9","display":"Spermatozoa Normal/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Normal forms semen"}]},{"code":"10624-5","display":"Spermatozoa Rapid/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rapid progressive semen"}]},{"code":"10626-0","display":"Spermatozoa Slow/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Slow progressive semen"}]},{"code":"10635-1","display":"Acanthamoeba sp identified in Eye by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amoebae culture"}]},{"code":"10653-4","display":"Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clotrimazole suscep (MIC)"}]},{"code":"10697-1","display":"Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nystatin suscep (MIC)"}]},{"code":"10715-1","display":"Schistosoma sp identified in Urine sediment by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Schistosoma urine"}]},{"code":"10718-5","display":"Strongyloides sp Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Strongyloides Ab"}]},{"code":"10720-1","display":"Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Terbinafine suscep (MIC)"}]},{"code":"10728-4","display":"Trichomonas sp identified in Genital specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trichomonas culture"}]},{"code":"10739-1","display":"Virus identified in Unspecified specimen by Electron microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Viruses (EM)"}]},{"code":"10753-2","display":"Fat.microscopic observation [Identifier] in Stool by Sudan IV stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fat faeces (stain)"}]},{"code":"108-1","display":"Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotaxime suscep (MIC)"}]},{"code":"10835-7","display":"Lipoprotein a [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lipoprotein (a) - mass/volume"}]},{"code":"10839-9","display":"Troponin I.cardiac [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Troponin I"}]},{"code":"10840-7","display":"Atropine [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Atropine "}]},{"code":"10860-5","display":"Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Varicella zoster (culture)"}]},{"code":"10886-0","display":"Prostate Specific Ag Free [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PSA (free)"}]},{"code":"10998-3","display":"Oxycodone [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxycodone, urine"}]},{"code":"11011-4","display":"Hepatitis C virus RNA [Units/?volume] (viral load) in Serum or Plasma by Probe and target amplification method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis C Viral Load (IU/mL)"}]},{"code":"11018-9","display":"Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Peroxidase stain"}]},{"code":"11060-1","display":"Reducing substances [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reducing substances faeces "}]},{"code":"11067-6","display":"Bleeding time","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bleeding time"}]},{"code":"11084-1","display":"Reagin Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reagin Ab (titre)"}]},{"code":"11085-8","display":"Schistosoma sp identified in Stool by Concentration","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Schistosome faeces"}]},{"code":"11135-1","display":"Appearance of Spun Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Supernatant CSF"}]},{"code":"11227-6","display":"Pyruvate kinase [Presence] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyruvate kinase (screen)"}]},{"code":"112-3","display":"Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotetan suscep (MIC)"}]},{"code":"11257-3","display":"Haemophilus influenzae B IgG Ab [Mass/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"H Influenza Type2 Ab"}]},{"code":"11266-4","display":"Streptococcus agalactiae Ag [Presence] in Unspecified specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Grp B Strep Ag"}]},{"code":"11483-5","display":"Varicella zoster virus DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Varicella zoster (NAAT)"}]},{"code":"11545-1","display":"Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microscopy (acid fast stain)"}]},{"code":"11546-9","display":"Microscopic observation [Identifier] in Unspecified specimen by Other stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microscopy (other stain)"}]},{"code":"11555-0","display":"Base excess in Blood by calculation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Base excess blood "}]},{"code":"11556-8","display":"Oxygen [Partial pressure] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PO2 blood "}]},{"code":"11557-6","display":"Carbon dioxide [Partial pressure] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PCO2 blood "}]},{"code":"11558-4","display":"pH of Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"pH blood "}]},{"code":"11572-5","display":"Rheumatoid factor [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rheumatoid factor"}]},{"code":"11573-3","display":"Rheumatoid factor IgM [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rheumatoid factor IgM"}]},{"code":"11579-0","display":"Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"TSH DL <= 0.05 mIU/L Qn"}]},{"code":"11580-8","display":"Thyrotropin [Units/?volume] in Serum or Plasma by Detection limit <= 0.005 mIU/?L","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"TSH -  by Detection limit <= 0.005 mIU/?L"}]},{"code":"116-4","display":"Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefoxitin suscep (MIC)"}]},{"code":"120-6","display":"Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefpodoxime suscep (MIC)"}]},{"code":"12176-4","display":"Amino acids [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amino Acids"}]},{"code":"12195-4","display":"Creatinine renal clearance/1.73 sq M in 24 hour","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Creat clearance (1.73 body SA)"}]},{"code":"12241-6","display":"Osmotic fragility of Red Blood Cells by Diluted RBC","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Osmotic fragility"}]},{"code":"12254-9","display":"Volume of Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Volume body fluid"}]},{"code":"12256-4","display":"Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Semen (post vasectomy)"}]},{"code":"12293-7","display":"Cotinine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cotinine urine"}]},{"code":"12308-3","display":"Hydrocodone [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hydrocodone, urine"}]},{"code":"12319-0","display":"Thioridazine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thioridazine"}]},{"code":"12327-3","display":"Ketamine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ketamine urine"}]},{"code":"12389-3","display":"Olanzapine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Olanzapine"}]},{"code":"12467-7","display":"Amino acids [Identifier] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amino Acids urine (ident)"}]},{"code":"124-8","display":"Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefprozil suscep (MIC)"}]},{"code":"12-5","display":"Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin suscep (MIC)"}]},{"code":"12708-4","display":"Tin [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tin urine"}]},{"code":"12841-3","display":"Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PSA (free/total)"}]},{"code":"12851-2","display":"Protein Fractions [interpretation] in Serum or Plasma by Electrophoresis","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein (electrophoresis)"}]},{"code":"128-9","display":"Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefsulodin suscep (MIC)"}]},{"code":"12916-3","display":"Porphobilinogen synthase [Enzymatic activity/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ala Dehydratase blood"}]},{"code":"12998-1","display":"Methylene chloride [Mass/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methylene chloride  blood"}]},{"code":"13000-5","display":"Mandelate [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mandelic acid urine"}]},{"code":"1304-5","display":"D Ab [Titer] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rh D Ab (titre)"}]},{"code":"13046-8","display":"Variant lLymphocytes/100 leukocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphocytes (atypical) (%)"}]},{"code":"13087-2","display":"Complement alternate pathway AH50 [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alternative pathway activity / AH50"}]},{"code":"13238-1","display":"Epstein Barr virus Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV Ab"}]},{"code":"13304-1","display":"HLA-DR [Type]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HLA-DR typing "}]},{"code":"13309-0","display":"Duffy group Ag [Type] on Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Duffy Phenotype"}]},{"code":"13310-8","display":"Kell group Ag [Type] on Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Kell Phenotype"}]},{"code":"13311-6","display":"MNS group Ag [Type] on Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MNS Phenotype"}]},{"code":"13316-5","display":"Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VRE (culture)"}]},{"code":"13317-3","display":"Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MRSA (culture)"}]},{"code":"13359-5","display":"Character of Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Appearance semen"}]},{"code":"133-9","display":"Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftazidime suscep (MIC)"}]},{"code":"13438-7","display":"Protein Fractions [interpretation] in Urine by Electrophoresis","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein urine (elph)"}]},{"code":"13488-2","display":"aPTT in Control Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"APTT (control)"}]},{"code":"13513-7","display":"Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iron stain"}]},{"code":"13514-5","display":"Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hb electrophoresis - alkaline"}]},{"code":"13532-7","display":"Xanthochromia [Presence] of Cerebral spinal fluid Qualitative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Xanthochromia CSF"}]},{"code":"13533-5","display":"Acid hemolysis [Presence] of Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ham's test"}]},{"code":"13539-2","display":"Phosphate [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phosphate  urine"}]},{"code":"13590-5","display":"Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"APCR"}]},{"code":"137-0","display":"Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftizoxime suscep (MIC)"}]},{"code":"13956-8","display":"Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mycobacterium tuberculosis DNA (NAAT)"}]},{"code":"13964-2","display":"Methylmalonate [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methylmalonic Acid - in serum or plasma"}]},{"code":"13965-9","display":"Homocysteine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Homocysteine"}]},{"code":"13967-5","display":"Sex hormone binding globulin [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SHBG"}]},{"code":"13969-1","display":"Creatine kinase.MB [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CKMB (mass)"}]},{"code":"13996-4","display":"Hydroxyproline/?Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hydroxyproline/creat urine 24h"}]},{"code":"14116-8","display":"IgG synthesis rate [Mass/?time] in Serum and CSF by calculation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgG Synthesis "}]},{"code":"14117-6","display":"IgG clearance/Albumin clearance [ratio] in Serum and CSF","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgG Index serum/CSF"}]},{"code":"141-2","display":"Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftriaxone suscep (MIC)"}]},{"code":"14122-6","display":"Pyruvate [Moles/?volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CSF Lactate & Pyruvate"}]},{"code":"14135-8","display":"CD3+?CD8+? (T8 suppressor cells) cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"lymphocyte markers - Cells.CD3+CD8+"}]},{"code":"14136-6","display":"CD34 cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CD34 Assay, blood"}]},{"code":"14196-0","display":"Reticulocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reticulocytes"}]},{"code":"14207-5","display":"Streptococcal DNAse B [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Strep DNAse B Ab (titre)"}]},{"code":"14210-9","display":"Giardia lamblia Ag [Presence] in Stool by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Giardia Ag faeces (IF)"}]},{"code":"14236-4","display":"Mitochondria Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mitochondria Antibody"}]},{"code":"14252-1","display":"Smooth muscle Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Smooth muscle Antibody"}]},{"code":"14272-9","display":"Liver kidney microsomal Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Liver/Kidney Ab - Presence"}]},{"code":"14286-9","display":"Carnitine free (C0) [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carnitine (free) "}]},{"code":"14314-9","display":"Benzoylecgonine [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Benzoylecgonine urine by Screen Method"}]},{"code":"14316-4","display":"Benzodiazepines [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Benzodiazepine urine by Screen method"}]},{"code":"14332-1","display":"Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"P-aminosalicylate suscep (MIC)"}]},{"code":"14334-7","display":"Lithium [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lithium"}]},{"code":"14398-2","display":"Creatinine [Mass/?volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Creatinine  CSF"}]},{"code":"14503-7","display":"Human papilloma virus 16+?18 Ag [Presence] in Cervix","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HPV Screen"}]},{"code":"14522-7","display":"Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pneumocystis jiroveci Ag"}]},{"code":"145-3","display":"Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefuroxime inject suscep (MIC)"}]},{"code":"14567-2","display":"11-Deoxycortisol [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"11Deoxycortisol"}]},{"code":"14569-8","display":"17-Hydroxyprogesterone [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"17-Hydroxy progesterone"}]},{"code":"14573-0","display":"5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"5HIAA urine 24h"}]},{"code":"14575-5","display":"Blood group antibody investigation [interpretation] in Plasma or RBC","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blood Group Ab (interpretation)  "}]},{"code":"14581-3","display":"Acetaminophen [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Paracetamol"}]},{"code":"14586-2","display":"Aldosterone [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aldosterone"}]},{"code":"14593-8","display":"Aluminum [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aluminium"}]},{"code":"14597-9","display":"Amitriptyline [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amitriptyline - moles/volume"}]},{"code":"14603-5","display":"Androstenedione [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Androstenedione"}]},{"code":"14611-8","display":"Nuclear Ab pattern [interpretation] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antinuclear Ab (pattern)"}]},{"code":"14622-5","display":"Ascorbate [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ascorbate"}]},{"code":"14628-2","display":"Bile acid [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bile Salts"}]},{"code":"14629-0","display":"Bilirubin.direct [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bilirubin (conj)"}]},{"code":"14630-8","display":"Bilirubin.indirect [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bilirubin (unconj)"}]},{"code":"14631-6","display":"Bilirubin.total [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bilirubin"}]},{"code":"14635-7","display":"Calcidiol [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vitamin D "}]},{"code":"14637-3","display":"Calcium [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcium urine 24h"}]},{"code":"14638-1","display":"Calculus analysis [interpretation] in Stone","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calculus analysis"}]},{"code":"14639-9","display":"Carbamazepine [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carbamazepine"}]},{"code":"14642-3","display":"Carotene [Moles/?volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Beta Carotene"}]},{"code":"14645-6","display":"Chlorpromazine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chlorpromazine"}]},{"code":"14646-4","display":"Cholesterol in HDL [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholesterol (HDL)"}]},{"code":"14647-2","display":"Cholesterol [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholesterol"}]},{"code":"14650-6","display":"Citrate [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Citrate urine"}]},{"code":"14651-4","display":"Clobazam [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clobazam"}]},{"code":"14652-2","display":"Clomipramine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clomipramine - moles/volume"}]},{"code":"14654-8","display":"Clomipramine+?Norclomipramine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clomipramine+Norclomipramineï¿½- moles/volume"}]},{"code":"14655-5","display":"Clonazepam [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clonazepam"}]},{"code":"14656-3","display":"Clozapine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clozapine"}]},{"code":"14665-4","display":"Copper [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Copper"}]},{"code":"14666-2","display":"Copper [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Copper urine 24hr"}]},{"code":"14674-6","display":"Corticotropin [Moles/?volume] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adrenocorticotropic hormone"}]},{"code":"14675-3","display":"Cortisol [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cortisol"}]},{"code":"14676-1","display":"Cortisol Free [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cortisol (free) urine 24h"}]},{"code":"14678-7","display":"Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cortisol (PM)"}]},{"code":"14679-5","display":"Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cortisol (AM)"}]},{"code":"14682-9","display":"Creatinine [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Creatinine"}]},{"code":"14683-7","display":"Creatinine [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Creatinine urine"}]},{"code":"14684-5","display":"Creatinine [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Creatinine urine 24h"}]},{"code":"14685-2","display":"Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vitamin B12"}]},{"code":"14688-6","display":"Dehydroepiandrosterone sulfate (DHEA-S) [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dehydroepiandrosterone Sulphate"}]},{"code":"14691-0","display":"Desipramine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Desipramine - moles/volume"}]},{"code":"14695-1","display":"Nordoxepin [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nordoxepin - moles/volume"}]},{"code":"14698-5","display":"Digoxin [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Digoxin"}]},{"code":"14702-5","display":"Disopyramide [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Disopyramide"}]},{"code":"14703-3","display":"Dopamine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dopamine"}]},{"code":"14705-8","display":"Doxepin [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Doxepin - moles/volume"}]},{"code":"14711-6","display":"Epinephrine [Moles/?volume] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adrenaline"}]},{"code":"14712-4","display":"Epinephrine [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adrenaline urine 24h"}]},{"code":"14715-7","display":"Estradiol (E2) [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oestradiol"}]},{"code":"14719-9","display":"Ethanol [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethanol"}]},{"code":"14720-7","display":"Ethosuximide [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethosuximide"}]},{"code":"14722-3","display":"Extractable nuclear Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ENA screen"}]},{"code":"14726-4","display":"Fluoride [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fluoride"}]},{"code":"14731-4","display":"Folate [Moles/volume] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Folate RBC"}]},{"code":"14732-2","display":"Folate [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Folate"}]},{"code":"14744-7","display":"Glucose [Moles/volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose CSF"}]},{"code":"14745-4","display":"Glucose [Moles/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose body fluid"}]},{"code":"14749-6","display":"Glucose [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose"}]},{"code":"14754-6","display":"Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose (1h post 50g glucose)"}]},{"code":"14761-1","display":"Glucose [Moles/volume] in Serum or Plasma --2 hours post meal","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose (2h post meal)"}]},{"code":"14770-2","display":"Fasting glucose [Moles/volume] in Capillary blood by Glucometer","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose (fasting) blood"}]},{"code":"14771-0","display":"Fasting glucose [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose (fasting)"}]},{"code":"14782-7","display":"Homovanillate [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Homovanillate urine"}]},{"code":"14783-5","display":"Homovanillate [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Homovanillate urine 24h"}]},{"code":"14785-0","display":"Hydroxyproline [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hydroxyproline urine 24h"}]},{"code":"14796-7","display":"Insulin [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Insulin (total)"}]},{"code":"14798-3","display":"Iron [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iron"}]},{"code":"14799-1","display":"Iron [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iron urine 24h"}]},{"code":"14800-7","display":"Iron binding capacity [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iron binding capacity"}]},{"code":"14801-5","display":"Iron saturation [Molar fraction] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Transferrin saturation - molar fraction"}]},{"code":"14803-1","display":"Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"LDH fluid by Lactate to pyruvate reaction"}]},{"code":"14804-9","display":"Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"LDH by Lactate to pyruvate reaction"}]},{"code":"14805-6","display":"Lactate dehydrogenase [Enzymatic activity/?volume] in Serum or Plasma by Pyruvate to lactate reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"LDH by Pyruvate to lactate reaction"}]},{"code":"14807-2","display":"Lead [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lead blood"}]},{"code":"14809-8","display":"Lead [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lead urine 24hr"}]},{"code":"14812-2","display":"Lidocaine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lignocaine"}]},{"code":"14833-8","display":"Metanephrines [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Metanephrines urine 24h"}]},{"code":"14835-3","display":"Methanol [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methanol"}]},{"code":"14836-1","display":"Methotrexate [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methotrexate"}]},{"code":"14852-8","display":"Norepinephrine [Moles/?volume] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Noradrenaline"}]},{"code":"14853-6","display":"Norepinephrine [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Noradrenaline urine"}]},{"code":"14854-4","display":"Norepinephrine [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Noradrenaline urine 24h"}]},{"code":"14856-9","display":"Nortriptyline [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nortriptyline - moles/volume"}]},{"code":"14862-7","display":"Oxalate [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxalate urine 24hr"}]},{"code":"14866-8","display":"Parathyrin.intact [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parathyroid Hormone (intact) - moles/volume"}]},{"code":"14874-2","display":"Phenobarbital [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phenobarbitone"}]},{"code":"14877-5","display":"Phenytoin [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phenytoin"}]},{"code":"14879-1","display":"Phosphate [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phosphate"}]},{"code":"14881-7","display":"Phosphate [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phosphate  urine 24h"}]},{"code":"14883-3","display":"Porphyrins [interpretation] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fluorescence"}]},{"code":"14885-8","display":"Pregnanediol [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pregnanediol urine 24h"}]},{"code":"14890-8","display":"Progesterone [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Progesterone"}]},{"code":"14899-9","display":"Quinidine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Quinidine"}]},{"code":"14905-4","display":"Retinol [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vitamin A"}]},{"code":"14909-6","display":"Salicylates [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Salicylate - moles/volume"}]},{"code":"14913-8","display":"Testosterone [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Testosterone"}]},{"code":"14914-6","display":"Testosterone Free [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Testosterone (free)"}]},{"code":"14915-3","display":"Theophylline [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Theophylline"}]},{"code":"14920-3","display":"Thyroxine (T4) free [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T4 (free)"}]},{"code":"14921-1","display":"Thyroxine (T4) [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T4 (total)"}]},{"code":"14927-8","display":"Triglyceride [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Triglycerides"}]},{"code":"14928-6","display":"Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T3 (free)"}]},{"code":"14930-2","display":"Triiodothyronine (T3) [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T3 (total)"}]},{"code":"14931-0","display":"Trimipramine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trimipramine"}]},{"code":"14933-6","display":"Urate [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urate"}]},{"code":"14934-4","display":"Urate [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urate  urine"}]},{"code":"14935-1","display":"Urate [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urate  urine 24h"}]},{"code":"14939-3","display":"Urea nitrogen [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urea  urine 24h"}]},{"code":"14946-8","display":"Valproate [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Valproate"}]},{"code":"14947-6","display":"Vanillylmandelate [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VMA urine 24h"}]},{"code":"14948-4","display":"Vanillylmandelate/Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VMA/creat urine"}]},{"code":"14949-2","display":"Vasopressin [Moles/?volume] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Arginine Vasopressin"}]},{"code":"149-5","display":"Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephalexin suscep (MIC)"}]},{"code":"14955-9","display":"Zinc [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Zinc"}]},{"code":"14956-7","display":"Microalbumin [Mass/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microalbumin urine 24h"}]},{"code":"14957-5","display":"Microalbumin [Mass/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microalbumin urine"}]},{"code":"14959-1","display":"Microalbumin/Creatinine [Mass Ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microalbumin/creat urine"}]},{"code":"14979-9","display":"aPTT in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"APTT"}]},{"code":"14995-5","display":"Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose (2h post 75g glucose)"}]},{"code":"15009-4","display":"5-Hydroxyindoleacetate [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"5HIAA urine"}]},{"code":"15032-6","display":"Angiotensin II [Moles/?volume] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Angiotensin II"}]},{"code":"15034-2","display":"Bromide [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bromide"}]},{"code":"15038-3","display":"Citrate [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Citrate"}]},{"code":"15057-3","display":"Androstanolone [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dihydrotestosterone "}]},{"code":"15058-1","display":"Dopamine [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dopamine urine"}]},{"code":"15059-9","display":"Dopamine [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dopamine urine 24h"}]},{"code":"15061-5","display":"Erythropoietin (EPO) [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Erythropoietin"}]},{"code":"15066-4","display":"Fatty acids.nonesterified [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fatty Acids (free)"}]},{"code":"15067-2","display":"Follitropin [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"FSH"}]},{"code":"15069-8","display":"Fructosamine [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fructosamine"}]},{"code":"15072-2","display":"Gastrin [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gastrin - moles/volume"}]},{"code":"15074-8","display":"Glucose [Moles/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose blood"}]},{"code":"15076-3","display":"Glucose [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose urine"}]},{"code":"15081-3","display":"Prolactin [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Prolactin"}]},{"code":"15083-9","display":"Normetanephrine [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Normetanephrine urine 24h"}]},{"code":"15087-0","display":"Parathyrin related protein [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parathyroid Hormone Related Peptide"}]},{"code":"15097-9","display":"Vanillylmandelate [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VMA urine"}]},{"code":"15099-5","display":"Amiodarone [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amiodarone"}]},{"code":"15105-0","display":"Flecainide [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Flecainide"}]},{"code":"15107-6","display":"Imipramine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Imipramine - moles/volume"}]},{"code":"15108-4","display":"Methadone [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methadone - moles/volume"}]},{"code":"15115-9","display":"Arsenic [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Arsenic urine"}]},{"code":"15117-5","display":"Cadmium [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cadmium blood"}]},{"code":"15120-9","display":"Ethanol [Moles/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethanol blood"}]},{"code":"15148-0","display":"Alkaline phosphatase [Enzymatic activity/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alk Phosphatase,fluid"}]},{"code":"15176-1","display":"Cryoproteins identified in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cryoproteins"}]},{"code":"15179-5","display":"Fibrin D-dimer [Presence] in Platelet poor plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"D-dimer (qual)"}]},{"code":"15200-9","display":"Osmolality of Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Osmolality  fluid"}]},{"code":"15210-8","display":"Thyroglobulin Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thyroglobulin Antibody - presence"}]},{"code":"15359-3","display":"dRVVT actual/normal (normalized LA screen)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dilute Russell viper venom time - actual normal"}]},{"code":"15363-5","display":"Busulfan [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Busulphan"}]},{"code":"153-7","display":"Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephaloglycin suscep (MIC)"}]},{"code":"15374-2","display":"Sulfonylurea [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulphonylurea screen"}]},{"code":"15376-7","display":"Spermatozoa Abnormal/100 spermatozoa in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Abnormal forms semen"}]},{"code":"15410-4","display":"Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Varicella zoster Ab IgG"}]},{"code":"157-8","display":"Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephaloridine suscep (MIC)"}]},{"code":"16099-4","display":"Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethionamide suscep (MIC)"}]},{"code":"161-0","display":"Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephalothin suscep (MIC)"}]},{"code":"16100-0","display":"Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rifabutin suscep (MIC)"}]},{"code":"16128-1","display":"Hepatitis C virus Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis C Ab"}]},{"code":"16130-7","display":"Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection ","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV1 DNA (NAAT)"}]},{"code":"16131-5","display":"Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV2 DNA (NAAT)"}]},{"code":"16195-0","display":"Benzodiazepines [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Benzodiazepine urine by Confirmatory method"}]},{"code":"16201-6","display":"Oxazepam [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxazepam urine by Confirmatory method"}]},{"code":"16206-5","display":"Temazepam [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Temazepam urine"}]},{"code":"16208-1","display":"Buprenorphine [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Buprenorphine urine by Confirmation method"}]},{"code":"16221-4","display":"Phenothiazines [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phenothiazines urine - by Confirmatory method"}]},{"code":"16226-3","display":"Benzoylecgonine [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Benzoylecgonine urine - by Confirmatory method"}]},{"code":"16227-1","display":"Diazepam [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Diazepam urine by Confirmatory method"}]},{"code":"16228-9","display":"Nordiazepam [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nordiazepam urine - by Confirmatory method"}]},{"code":"16235-4","display":"Methamphetamine [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methamphetamine urine by Confirmation method"}]},{"code":"16249-5","display":"Oxycodone [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxycodone urine - by Confirmatory method"}]},{"code":"16250-3","display":"Codeine [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Codeine urine - by Confirmatory method"}]},{"code":"16251-1","display":"Morphine [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Morphine urine by Confirmatory method"}]},{"code":"16254-5","display":"Phencyclidine [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phencyclidine  urine - by Confirmatory method"}]},{"code":"16276-8","display":"Bartonella henselae DNA [Presence] in Blood by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bartonella DNA (NAAT)"}]},{"code":"16284-2","display":"Polio virus Ab [Units/?volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Polio Ab"}]},{"code":"16337-8","display":"Alkaline phosphatase [Enzymatic activity/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alk Phosphatase, urine"}]},{"code":"16348-5","display":"Alpha hydroxyalprazolam [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alpha hydroxy alprazolam urine by Confirmatory method"}]},{"code":"16362-6","display":"Ammonia [Moles/?volume] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ammonia"}]},{"code":"16429-3","display":"Barbiturates [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Barbiturate urine by Confirmatory method"}]},{"code":"1648-5","display":"Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tuberculin test (3d post 5TU)"}]},{"code":"165-1","display":"Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephapirin suscep (MIC)"}]},{"code":"16550-6","display":"Carbohydrates [Identifier] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carbohydrates urine"}]},{"code":"16-6","display":"Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amoxicillin suscep (MIC)"}]},{"code":"16623-1","display":"Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clofazimine suscep (MIC)"}]},{"code":"16676-9","display":"Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C.diptheriae culture"}]},{"code":"16688-4","display":"Creatine kinase [Enzymatic activity/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CK body fluid"}]},{"code":"16835-1","display":"Escherichia coli shiga-like toxin identified in Stool by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enterohaemorrhagic E. coli (EHEC) culture - shiga-like toxin"}]},{"code":"16836-9","display":"Escherichia coli verotoxic identified in Stool by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enterohaemorrhagic E. coli (EHEC) culture - verotoxic"}]},{"code":"16853-4","display":"Fat [Mass] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fat Stl Qn"}]},{"code":"16859-1","display":"Fibrinogen [Presence] in Platelet poor plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fibrinogen (qual)"}]},{"code":"16901-1","display":"Gliadin IgA Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gliadin  Ab IgA"}]},{"code":"16902-9","display":"Gliadin IgG Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gliadin Ab  IgG"}]},{"code":"169-3","display":"Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephradine suscep (MIC)"}]},{"code":"16933-4","display":"Hepatitis B virus core Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B core Ab"}]},{"code":"16935-9","display":"Hepatitis B virus surface Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B surface Ab"}]},{"code":"1714-5","display":"Prostatic acid phosphatase [Enzymatic activity/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Acid phosphatase (prostatic)"}]},{"code":"17146-2","display":"CD4+?CD8+? cells/?100 cells in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CD4/CD8"}]},{"code":"1715-2","display":"Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Acid phosphatase"}]},{"code":"17263-5","display":"Methemalbumin [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methaemalbumin"}]},{"code":"173-5","display":"Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chloramphenicol suscep (MIC)"}]},{"code":"17395-5","display":"Oxymorphone [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxymorphone urine "}]},{"code":"1742-6","display":"Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ALT"}]},{"code":"1746-7","display":"Albumin [Mass/?volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Albumin CSF"}]},{"code":"1747-5","display":"Albumin [Mass/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Albumin body fluid"}]},{"code":"1751-7","display":"Albumin [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Albumin"}]},{"code":"17547-1","display":"Rotavirus Ag [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rotavirus Ag faeces"}]},{"code":"1756-6","display":"Albumin in CSF/?Albumin in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Albumin CSF/Serum Ratio"}]},{"code":"17571-1","display":"Scopolamine [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Scopolamine urine"}]},{"code":"17607-3","display":"Volume of Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Volume CSF"}]},{"code":"1761-6","display":"Aldolase [Enzymatic activity/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aldolase"}]},{"code":"177-6","display":"Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chlortetracycline suscep (MIC)"}]},{"code":"1777-2","display":"Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alk phosphatase (bone)"}]},{"code":"17793-1","display":"Immunoglobulin light chains [Mass/volume] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"B-J protein urine 24h"}]},{"code":"17843-4","display":"Cancer Ag 72-4 [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CA 72-4"}]},{"code":"17857-4","display":"Rheumatoid factor [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rheumatoid factor (titre)"}]},{"code":"17869-9","display":"Orotate/Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Orotate/creatinine urine"}]},{"code":"1795-4","display":"Amylase [Enzymatic activity/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amylase body fluid"}]},{"code":"1798-8","display":"Amylase [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amylase"}]},{"code":"1799-6","display":"Amylase [Enzymatic activity/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amylase urine"}]},{"code":"1-8","display":"Acyclovir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Acyclovir suscep (qual)"}]},{"code":"1805-1","display":"Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amylase (pancreatic)"}]},{"code":"181-8","display":"Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cinoxacin suscep (MIC)"}]},{"code":"1824-2","display":"Alpha-1-Antichymotrypsin [Mass/?volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alpha 1 antichymotrypsin"}]},{"code":"1825-9","display":"Alpha 1 antitrypsin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alpha 1 antitrypsin"}]},{"code":"18261-8","display":"Cholesterol in LDL [Mass/?volume] in Serum or Plasma ultracentrifugate","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholesterol in LDL "}]},{"code":"18263-4","display":"Cholesterol in HDL [Mass/?volume] in Serum or Plasma ultracentrifugate","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholesterol in HDL "}]},{"code":"18282-4","display":"Cannabinoids [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cannabinoids, urine by Screen method"}]},{"code":"18286-5","display":"Donath Landsteiner Ab [Presence] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Donath-Landsteiner Ab"}]},{"code":"1834-1","display":"Alpha-1-Fetoprotein [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alpha feto protein"}]},{"code":"18358-2","display":"Methylenedioxymethamphetamine [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MDMA Urine by Confirmation method"}]},{"code":"18390-5","display":"Opiates [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Opiates  urine by Confirmatory method"}]},{"code":"18481-2","display":"Streptococcus pyogenes Ag [Presence] in Throat","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Grp A Strep Ag throat (rapid)"}]},{"code":"185-9","display":"Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ciprofloxacin suscep (MIC)"}]},{"code":"1863-0","display":"Anion gap 4 in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anion gap 4"}]},{"code":"1869-7","display":"Apolipoprotein A-I [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Apolipoprotein A1"}]},{"code":"1884-6","display":"Apolipoprotein B [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Apolipoprotein B"}]},{"code":"18855-7","display":"5-Fluorocytosine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"5-Fluorocytosine suscep (qual)"}]},{"code":"18857-3","display":"Almecillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Almecillin suscep (qual)"}]},{"code":"18859-9","display":"Amdinocillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amdinocillin suscep (qual)"}]},{"code":"18860-7","display":"Amikacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin suscep (qual)"}]},{"code":"18861-5","display":"Amoxicillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amoxicillin suscep (qual)"}]},{"code":"18862-3","display":"Amoxicillin+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amoxicillin Clav suscep (qual)"}]},{"code":"18863-1","display":"Amphotericin B [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amphotericin B suscep (qual)"}]},{"code":"18864-9","display":"Ampicillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ampicillin suscep (qual)"}]},{"code":"18865-6","display":"Ampicillin+Sulbactam [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ampicillin Sulb suscept (qual)"}]},{"code":"18866-4","display":"Azithromycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Azithromycin suscep (qual)"}]},{"code":"18867-2","display":"Azlocillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Azlocillin suscep (qual)"}]},{"code":"18868-0","display":"Aztreonam [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aztreonam suscep (qual)"}]},{"code":"18869-8","display":"Bacampicillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bacampicillin suscep (qual)"}]},{"code":"18870-6","display":"Bacitracin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bacitracin suscep (qual)"}]},{"code":"18871-4","display":"Butirosin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Butirosin suscep (qual)"}]},{"code":"18872-2","display":"Capreomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Capreomycin suscep (qual)"}]},{"code":"18873-0","display":"Carbenicillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carbenicillin suscep (qual)"}]},{"code":"18874-8","display":"Cefaclor [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefaclor suscep (qual)"}]},{"code":"18875-5","display":"Cefadroxil [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefadroxil suscep (qual)"}]},{"code":"18876-3","display":"Cefamandole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefamandole suscep (qual)"}]},{"code":"18877-1","display":"Cefatrizine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefatrizine suscep (qual)"}]},{"code":"18878-9","display":"Cefazolin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefazolin suscep (qual)"}]},{"code":"18879-7","display":"Cefepime [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefepime suscep (qual)"}]},{"code":"18880-5","display":"Cefixime [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefixime suscep (qual)"}]},{"code":"18881-3","display":"Cefmetazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefmetazole suscep (qual)"}]},{"code":"18882-1","display":"Cefodizime [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefodizime suscep (qual)"}]},{"code":"18883-9","display":"Cefonicid [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefonicid suscep (qual)"}]},{"code":"18884-7","display":"Cefoperazone [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefoperazone suscep (qual)"}]},{"code":"18885-4","display":"Ceforanide [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceforanide suscep (qual)"}]},{"code":"18886-2","display":"Cefotaxime [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotaxime suscep (qual)"}]},{"code":"18887-0","display":"Cefotetan [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotetan suscep (qual)"}]},{"code":"18888-8","display":"Cefoxitin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefoxitin suscep (qual)"}]},{"code":"18889-6","display":"Cefpirome [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefpirome suscep (qual)"}]},{"code":"18890-4","display":"Cefpodoxime [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefpodoxime suscep (qual)"}]},{"code":"18891-2","display":"Cefprozil [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefprozil suscep (qual)"}]},{"code":"18892-0","display":"Cefsulodin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefsulodin suscep (qual)"}]},{"code":"18893-8","display":"Ceftazidime [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftazidime suscep (qual)"}]},{"code":"18894-6","display":"Ceftizoxime [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftizoxime suscep (qual)"}]},{"code":"18895-3","display":"Ceftriaxone [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftriaxone suscep (qual)"}]},{"code":"18896-1","display":"Cefuroxime Parenteral [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefuroxime inject suscep qual"}]},{"code":"18897-9","display":"Cephalexin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephalexin suscep (qual)"}]},{"code":"18898-7","display":"Cephaloglycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephaloglycin suscep (qual)"}]},{"code":"18899-5","display":"Cephaloridine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephaloridine suscep (qual)"}]},{"code":"18900-1","display":"Cephalothin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephalothin suscep (qual)"}]},{"code":"18901-9","display":"Cephapirin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephapirin suscep (qual)"}]},{"code":"18902-7","display":"Cephradine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephradine suscep (qual)"}]},{"code":"18903-5","display":"Chloramphenicol [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chloramphenicol suscep (qual)"}]},{"code":"18904-3","display":"Chlortetracycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chlortetracycline suscep qual"}]},{"code":"18905-0","display":"Cinoxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cinoxacin suscep (qual)"}]},{"code":"18906-8","display":"Ciprofloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ciprofloxacin suscep (qual)"}]},{"code":"18907-6","display":"Clarithromycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clarithromycin suscep (qual)"}]},{"code":"18908-4","display":"Clindamycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clindamycin suscep (qual)"}]},{"code":"18909-2","display":"Clotrimazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clotrimazole suscep (qual)"}]},{"code":"189-1","display":"Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clarithromycin suscep (MIC)"}]},{"code":"18910-0","display":"Cloxacillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cloxacillin suscep (qual)"}]},{"code":"18911-8","display":"Colistimethate","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Colistimethate suscep (qual)"}]},{"code":"18912-6","display":"Colistin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Colistin suscep (qual)"}]},{"code":"18913-4","display":"Cyclacillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cyclacillin suscep (qual)"}]},{"code":"18914-2","display":"Cycloserine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cycloserine suscep (qual)"}]},{"code":"18915-9","display":"Demeclocycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Demeclocycline suscep (qual)"}]},{"code":"18916-7","display":"Dicloxacillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dicloxacillin suscep (qual)"}]},{"code":"18917-5","display":"Doxycycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Doxycycline suscep (qual)"}]},{"code":"18918-3","display":"Enoxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enoxacin suscep (qual)"}]},{"code":"18919-1","display":"Erythromycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Erythromycin suscep (qual)"}]},{"code":"18921-7","display":"Ethambutol [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethambutol suscep (qual)"}]},{"code":"18922-5","display":"Ethionamide [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethionamide suscep (qual)"}]},{"code":"18923-3","display":"Floxacillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Floxacillin suscep (qual)"}]},{"code":"18924-1","display":"Fluconazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fluconazole suscep (qual)"}]},{"code":"18926-6","display":"Framycetin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Framycetin suscep (qual)"}]},{"code":"18927-4","display":"Fusidate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fusidate suscep (qual)"}]},{"code":"18928-2","display":"Gentamicin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gentamicin suscep (qual)"}]},{"code":"18929-0","display":"Gentamicin.high potency [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gentamicin high suscep (qual)"}]},{"code":"18930-8","display":"Gramicidin D [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gramicidin D suscep (qual)"}]},{"code":"18931-6","display":"Hetacillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hetacillin suscep (qual)"}]},{"code":"18932-4","display":"Imipenem [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Imipenem suscep (qual)"}]},{"code":"18934-0","display":"Isoniazid [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid suscep (qual)"}]},{"code":"18935-7","display":"Kanamycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Kanamycin suscep (qual)"}]},{"code":"18936-5","display":"Kanamycin.high potency [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Kanamycin high suscep (qual)"}]},{"code":"18937-3","display":"Ketoconazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ketoconazole suscep (qual)"}]},{"code":"18938-1","display":"Lincomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lincomycin suscep (qual)"}]},{"code":"18939-9","display":"Lomefloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lomefloxacin suscep (qual)"}]},{"code":"18940-7","display":"Loracarbef [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Loracarbef suscep (qual)"}]},{"code":"18941-5","display":"Lymecycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymecycline suscep (qual)"}]},{"code":"18942-3","display":"Meclocycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Meclocycline suscep (qual)"}]},{"code":"18943-1","display":"Meropenem [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Meropenem suscep (qual)"}]},{"code":"18944-9","display":"Methacycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methacycline suscep (qual)"}]},{"code":"18945-6","display":"Methicillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methicillin suscep (qual)"}]},{"code":"18946-4","display":"Metronidazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Metronidazole suscep (qual)"}]},{"code":"18947-2","display":"Mezlocillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mezlocillin suscep (qual)"}]},{"code":"18948-0","display":"Minocycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Minocycline suscep (qual)"}]},{"code":"18949-8","display":"Miocamycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Miocamycin suscep (qual)"}]},{"code":"18950-6","display":"Moxalactam [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxalactam suscep (qual)"}]},{"code":"18951-4","display":"Nafcillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nafcillin suscep (qual)"}]},{"code":"18952-2","display":"Nalidixate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nalidixate suscep (qual)"}]},{"code":"18953-0","display":"Neomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neomycin suscep (qual)"}]},{"code":"18954-8","display":"Netilmicin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Netilmicin suscep (qual)"}]},{"code":"18955-5","display":"Nitrofurantoin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nitrofurantoin suscep (qual)"}]},{"code":"18956-3","display":"Norfloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Norfloxacin suscep (qual)"}]},{"code":"18957-1","display":"Novobiocin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Novobiocin suscep (qual)"}]},{"code":"18958-9","display":"Nystatin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nystatin suscep (qual)"}]},{"code":"18959-7","display":"Ofloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ofloxacin suscep (qual)"}]},{"code":"18960-5","display":"Oleandomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oleandomycin suscep (qual)"}]},{"code":"18961-3","display":"Oxacillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxacillin suscep (qual)"}]},{"code":"18962-1","display":"Oxytetracycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxytetracycline suscep (qual)"}]},{"code":"18963-9","display":"Pefloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pefloxacin suscep (qual)"}]},{"code":"18964-7","display":"Penicillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Penicillin suscep (qual)"}]},{"code":"18965-4","display":"Penicillin G [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Penicillin G suscep (qual)"}]},{"code":"18966-2","display":"Penicillin V [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Penicillin V suscep (qual)"}]},{"code":"18967-0","display":"Phenethicillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phenethicillin suscep (qual)"}]},{"code":"18968-8","display":"Pipemidate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pipemidate suscep (qual)"}]},{"code":"18969-6","display":"Piperacillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Piperacillin suscep (qual)"}]},{"code":"18970-4","display":"Piperacillin+Tazobactam [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Piperacillin Tazob suscep qual"}]},{"code":"18971-2","display":"Pivampicillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pivampicillin suscep (qual)"}]},{"code":"18972-0","display":"Polymyxin B [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Polymyxin B suscep (qual)"}]},{"code":"18973-8","display":"Pyrazinamide [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyrazinamide suscep (qual)"}]},{"code":"18974-6","display":"Rifampin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rifampin suscep (qual)"}]},{"code":"18975-3","display":"Ristocetin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ristocetin suscep (qual)"}]},{"code":"18976-1","display":"Rolitetracycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rolitetracycline suscep (qual)"}]},{"code":"18977-9","display":"Rosoxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rosoxacin suscep (qual)"}]},{"code":"18978-7","display":"Roxithromycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Roxithromycin suscep (qual)"}]},{"code":"18979-5","display":"Sisomicin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sisomicin suscep (qual)"}]},{"code":"18980-3","display":"Spectinomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Spectinomycin suscep (qual)"}]},{"code":"18981-1","display":"Spiramycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Spiramycin suscep (qual)"}]},{"code":"18982-9","display":"Streptomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Streptomycin suscep (qual)"}]},{"code":"18983-7","display":"Streptomycin.high potency [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Streptomycin high suscep qual"}]},{"code":"18984-5","display":"Sulfadiazine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulfadiazine suscep (qual)"}]},{"code":"18985-2","display":"Sulfamethoxazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulfamethoxazole suscep (qual)"}]},{"code":"18986-0","display":"Sulfisoxazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulfisoxazole suscep (qual)"}]},{"code":"18987-8","display":"Sulfonamide [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulfonamide suscep (qual)"}]},{"code":"18988-6","display":"Talampicillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Talampicillin suscep (qual)"}]},{"code":"18989-4","display":"Teicoplanin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Teicoplanin suscep (qual)"}]},{"code":"18990-2","display":"Temafloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Temafloxacin suscep (qual)"}]},{"code":"18991-0","display":"Temocillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Temocillin suscep (qual)"}]},{"code":"18992-8","display":"Terbinafine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Terbinafine suscep (qual)"}]},{"code":"18993-6","display":"Tetracycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tetracycline suscep (qual)"}]},{"code":"18994-4","display":"Ticarcillin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ticarcillin suscep (qual)"}]},{"code":"18995-1","display":"Ticarcillin+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ticarcillin Clav suscep (qual)"}]},{"code":"18996-9","display":"Tobramycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tobramycin suscep (qual)"}]},{"code":"18997-7","display":"Trimethoprim [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trimethoprim suscep (qual)"}]},{"code":"18998-5","display":"Trimethoprim+Sulfamethoxazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trimethoprim Sulfa suscep qual"}]},{"code":"18999-3","display":"Troleandomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Troleandomycin suscep (qual)"}]},{"code":"19000-9","display":"Vancomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vancomycin suscep (qual)"}]},{"code":"19001-7","display":"Viomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Viomycin suscep (qual)"}]},{"code":"19048-8","display":"Nucleated erythrocytes/100 leukocytes [Ratio] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RBC (nucleated)/100 WBC"}]},{"code":"19057-9","display":"ABO +? Rh group [Type] in Blood from newborn","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ABO + Rh Group New Born"}]},{"code":"19072-8","display":"Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcium (pH 7.4 adjusted)"}]},{"code":"19077-7","display":"Cells identified in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Other cells body fluid"}]},{"code":"19080-1","display":"Choriogonadotropin [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"hCG"}]},{"code":"19090-0","display":"Colony count [#/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Colony count urine"}]},{"code":"19113-0","display":"IgE [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgE"}]},{"code":"19141-1","display":"Propoxyphene [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Propoxyphene urine"}]},{"code":"19149-4","display":"Rifabutin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rifabutin suscep (qual)"}]},{"code":"19176-7","display":"Alpha-1-Fetoprotein [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alpha fetoprotein"}]},{"code":"19180-9","display":"Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"hCG (beta free)"}]},{"code":"1920-8","display":"Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"AST"}]},{"code":"19261-7","display":"Amphetamines [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amphetamines-type substances urine by Screen method"}]},{"code":"19270-8","display":"Barbiturates [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Barbiturate urine by Screen method"}]},{"code":"1928-1","display":"Immunoglobulin light chains [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"B-J protein urine (qual)"}]},{"code":"19289-8","display":"Cannabinoids [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cannabinoids, urine by Confirmatory method"}]},{"code":"19295-5","display":"Opiates [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Opiates  urine by Screen method"}]},{"code":"1929-9","display":"Immunoglobulin light chains [Mass/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"B-J protein urine"}]},{"code":"193-3","display":"Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clindamycin suscep (MIC)"}]},{"code":"19360-7","display":"Cocaine [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cocaine urine - by Confirmatory method"}]},{"code":"19411-8","display":"Codeine [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Codeine urine - by Screen method"}]},{"code":"1942-2","display":"Beta galactosidase [Enzymatic activity/?mass] in Tissue","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Disaccharidase tissue"}]},{"code":"19429-0","display":"Propoxyphene [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Propoxyphene urine - by Screen method"}]},{"code":"1952-1","display":"Beta-2-Microglobulin [Mass/volume] in Serum or","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Beta2-microglubulin "}]},{"code":"1953-9","display":"Beta-2-Microglobulin [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Beta2-microglubulin urine"}]},{"code":"19550-3","display":"Methadone [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methadone  urine by Screen method"}]},{"code":"19554-5","display":"Methamphetamine [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methamphetamine urine by Screen method"}]},{"code":"19561-0","display":"Methylenediamine [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MDA Urine by Sceen method"}]},{"code":"19564-4","display":"Methylenediamine cutoff [Mass/?volume] in Urine for Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MDA Urine by Confirmation method"}]},{"code":"19568-5","display":"Methylenedioxymethamphetamine [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MDMA Urine by Screen method"}]},{"code":"19577-6","display":"Methylphenidate [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methylphenidate urine by Screen method"}]},{"code":"19578-4","display":"Methylphenidate [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methylphenidate urine - by Confirmatory method"}]},{"code":"1959-6","display":"Bicarbonate [Moles/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bicarbonate blood "}]},{"code":"19597-4","display":"Morphine [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Morphine urine by Screen method"}]},{"code":"19624-6","display":"Nordiazepam [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nordiazepam urine by Screen method"}]},{"code":"1963-8","display":"Bicarbonate [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bicarbonate"}]},{"code":"19638-6","display":"Oxazepam [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxazepam urine by Screen method"}]},{"code":"19642-8","display":"Oxycodone [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxycodone urine - by Screen method"}]},{"code":"19659-2","display":"Phencyclidine [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phencyclidine  urine - by Screen method"}]},{"code":"19670-9","display":"Phenothiazines [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phenothiazines urine - by Screen  method"}]},{"code":"19710-3","display":"Tramadol [Presence] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tramadol urine"}]},{"code":"197-4","display":"Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cloxacillin suscep (MIC)"}]},{"code":"19762-4","display":"General categories [interpretation] of Cervical or vaginal smear or scraping by Cyto stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cervical cytology general category"}]},{"code":"19763-2","display":"Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cervical cytology specimen site"}]},{"code":"19764-0","display":"Statement of adequacy [interpretation] of Cervical or vaginal smear or scraping by Cyto stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cervical cytology statement of adequacy"}]},{"code":"19765-7","display":"Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cervical cytology interpretation"}]},{"code":"19772-3","display":"Preparation techniques [Type] in Cervical or vaginal smear or scraping by Cyto stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cervical cytology preparation technique"}]},{"code":"19773-1","display":"Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cervical cytology recommendation"}]},{"code":"1988-5","display":"C reactive protein [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CRP"}]},{"code":"1992-7","display":"Calcitonin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcitonin"}]},{"code":"1995-0","display":"Calcium.ionized [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcium (ionised)"}]},{"code":"2000-8","display":"Calcium [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcium"}]},{"code":"2004-0","display":"Calcium [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcium urine"}]},{"code":"201-4","display":"Colistimethate by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Colistimethate suscep (MIC)"}]},{"code":"20388-5","display":"Nitrofurazone [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Furacin topical suscep (qual)"}]},{"code":"20389-3","display":"Mupirocin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mupirocin suscep (qual)"}]},{"code":"20390-1","display":"Silver sulfadiazine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Silvadine topical suscep qual"}]},{"code":"20391-9","display":"Mafenide [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mafenide suscep (qual)"}]},{"code":"2039-6","display":"Carcinoembryonic Ag [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CEA"}]},{"code":"20396-8","display":"Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Levofloxacin suscep (MIC)"}]},{"code":"20397-6","display":"Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sparfloxacin suscep (MIC)"}]},{"code":"20402-4","display":"CD16+?CD56+? cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"lymphocyte markers - Cells.CD16+CD56+"}]},{"code":"20404-0","display":"Fibronectin.fetal [Presence] in Vaginal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Foetal Fibronectin (rapid)"}]},{"code":"20447-9","display":"HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HIV Viral Load (#/volume)"}]},{"code":"20453-7","display":"Epithelial cells [Presence] in Urine sediment by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Epithelial Cells urine"}]},{"code":"20454-5","display":"Protein [Presence] in Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein urine (dipstick)"}]},{"code":"20460-2","display":"Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefuroxime oral suscep (MIC)"}]},{"code":"20483-4","display":"Mitochondria Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mitochondria Ab (titre)"}]},{"code":"20490-9","display":"Epstein Barr virus capsid IgG Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV VCA IgG (titre)"}]},{"code":"20491-7","display":"Epstein Barr virus capsid IgM Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV VCA IgM (titre)"}]},{"code":"20495-8","display":"Gliadin IgA Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gliadin  Ab IgA - units/volume"}]},{"code":"20496-6","display":"Gliadin IgG Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gliadin Ab  IgG  - units/volume"}]},{"code":"20507-0","display":"Reagin Ab [Presence] in Serum by RPR","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Syphilis  RPR (qual)"}]},{"code":"20510-4","display":"Lipoprotein fractions [interpretation] in Serum or Plasma by Electrophoresis","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lipoprotein (electrophoresis)"}]},{"code":"20521-1","display":"Carboxy tetrahydrocannabinol [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carboxy tetrahydronnabinol urine"}]},{"code":"205-5","display":"Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Colistin suscep (MIC)"}]},{"code":"20559-1","display":"Temazepam [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Temazepam, urine"}]},{"code":"20563-3","display":"Carboxyhemoglobin/Hemoglobin.total in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carboxyhaemoglobin"}]},{"code":"20565-8","display":"Carbon dioxide, total [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CO2 blood ( total)"}]},{"code":"20569-0","display":"Creatine kinase.MB/Creatine kinase.total in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CKMB/CK total"}]},{"code":"20570-8","display":"Hematocrit [Volume Fraction] of Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haematocrit"}]},{"code":"20575-7","display":"Hepatitis A virus Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis A Ab (qual)"}]},{"code":"20576-5","display":"Galactose 1 phosphate uridyl transferase [Presence] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Galactose 1 phosphate uridyl transferase blood (qual)"}]},{"code":"20578-1","display":"Vancomycin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vancomycin"}]},{"code":"20626-8","display":"Reducing substances [Units/?volume] in Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reducing substances urine"}]},{"code":"20629-2","display":"Levofloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Levofloxacin suscep (qual)"}]},{"code":"2064-4","display":"Ceruloplasmin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceruloplasmin"}]},{"code":"20662-3","display":"Allergens tested for in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Allergy Testing"}]},{"code":"2069-3","display":"Chloride [Moles/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chloride blood"}]},{"code":"20719-1","display":"Brucella abortus Ab [Titer] in Serum by Tube agglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Br. abortus Ab (SAT)"}]},{"code":"2072-7","display":"Chloride [Moles/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chloride   fluid"}]},{"code":"20728-2","display":"Brucella abortus Ab [Presence] in Serum by Complement fixation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Br. abortus Ab (qual)"}]},{"code":"2075-0","display":"Chloride [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chloride"}]},{"code":"2077-6","display":"Chloride [Moles/?volume] in Sweat","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chloride sweat"}]},{"code":"2078-4","display":"Chloride [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chloride  urine - moles/volume"}]},{"code":"2079-2","display":"Chloride [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chloride  urine - moles/time"}]},{"code":"20-8","display":"Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amoxicillin Clav suscep (MIC)"}]},{"code":"209-7","display":"Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cyclacillin suscep (MIC)"}]},{"code":"20981-7","display":"Verotoxin identified in Isolate","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Verotoxin"}]},{"code":"2098-2","display":"Cholinesterase [Enzymatic activity/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholinesterase"}]},{"code":"2099-0","display":"Cholinesterase [Enzymatic activity/?volume] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholinesterase RBC"}]},{"code":"21027-8","display":"Platelet aggregation [interpretation] in Platelet poor plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Plat Aggs"}]},{"code":"2106-3","display":"Choriogonadotropin (pregnancy test) [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"hCG urine (qual)"}]},{"code":"21070-8","display":"Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antibiotic XXX suscep (MIC)"}]},{"code":"2118-8","display":"Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"hCG (qual)"}]},{"code":"21198-7","display":"Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"hCG (beta)"}]},{"code":"21233-2","display":"Cryptosporidium sp Ag [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cryptosporidia Ag faeces"}]},{"code":"21259-7","display":"Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Entamoeba histolytica Ab"}]},{"code":"21363-7","display":"Legionella pneumophila DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Legionella  DNA (NAAT)"}]},{"code":"21365-2","display":"Leptin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Leptin"}]},{"code":"21387-6","display":"Methylhippurate [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Xylene urine"}]},{"code":"213-9","display":"Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cycloserine suscep (MIC)"}]},{"code":"21436-1","display":"Ovary Ab [Presence] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ovarian autoantibody"}]},{"code":"21566-5","display":"Tolazamide [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tolazamide"}]},{"code":"21567-3","display":"Tolbutamide [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tolbutamide"}]},{"code":"2157-6","display":"Creatine kinase [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CK"}]},{"code":"21582-2","display":"Tryptase [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tryptase"}]},{"code":"21613-5","display":"Chlamydia trachomatis DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C. trachomatis DNA (NAAT)"}]},{"code":"2164-2","display":"Creatinine renal clearance in 24 hour","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Creatinine clearance"}]},{"code":"217-0","display":"Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Demeclocycline suscep (MIC)"}]},{"code":"221-2","display":"Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dicloxacillin suscep (MIC)"}]},{"code":"22150-7","display":"Brucella abortus Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Br. abortus Ab (titre)"}]},{"code":"22244-8","display":"Cytomegalovirus IgG Ab [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV IgG (qual)"}]},{"code":"22246-3","display":"Cytomegalovirus IgG Ab [Titer] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV IgG (titre)"}]},{"code":"22249-7","display":"Cytomegalovirus IgM Ab [Titer] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV IgM (titre)"}]},{"code":"22298-4","display":"Epstein Barr virus nuclear IgG Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV NA IgG (titre)"}]},{"code":"22312-3","display":"Hepatitis A virus Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis A Ab"}]},{"code":"22313-1","display":"Hepatitis A virus IgG Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis A IgG"}]},{"code":"22314-9","display":"Hepatitis A virus IgM Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis A IgM (qual)"}]},{"code":"22320-6","display":"Hepatitis B virus e Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B e Ab"}]},{"code":"22322-2","display":"Hepatitis B virus surface Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B surface Ab (qual)"}]},{"code":"22396-6","display":"Legionella pneumophila Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Legionella  Ab (titre)"}]},{"code":"22425-3","display":"Mycoplasma pneumoniae Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"M. pneumoniae Ab (titre)"}]},{"code":"22466-7","display":"Respiratory syncytial virus Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RSV Ab"}]},{"code":"22496-4","display":"Rubella virus Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rubella Ab (qual)"}]},{"code":"22497-2","display":"Rubella virus Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rubella Ab (titre)"}]},{"code":"225-3","display":"Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Doxycycline suscep (MIC)"}]},{"code":"22568-0","display":"Streptolysin O Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Streptolysin O Ab (titre)"}]},{"code":"22580-5","display":"Toxoplasma gondii IgG Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. gondii IgG (qual)"}]},{"code":"22582-1","display":"Toxoplasma gondii IgG Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. gondii IgG (titre)"}]},{"code":"22584-7","display":"Toxoplasma gondii IgM Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. gondii IgM (titre)"}]},{"code":"22664-7","display":"Urea [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urea"}]},{"code":"22689-4","display":"Zinc [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Zinc urine 24hr"}]},{"code":"22700-9","display":"Urea [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urea  urine"}]},{"code":"22704-1","display":"Carnitine free (C0)/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carnitine urine (free) "}]},{"code":"22708-2","display":"Homovanillate/Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Homovanillate/creat urine"}]},{"code":"2271-5","display":"Fat [Mass/time] in 72 hour Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fat faeces 72h (per 24h)"}]},{"code":"22745-4","display":"Ethanol [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethanol urine"}]},{"code":"22748-8","display":"Cholesterol in LDL [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholesterol (LDL) (assay)"}]},{"code":"22749-6","display":"Amylase.pancreatic [Enzymatic activity/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amylase (pancreatic) urine"}]},{"code":"2276-4","display":"Ferritin [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ferritin"}]},{"code":"229-5","display":"Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enoxacin suscep (MIC)"}]},{"code":"2306-9","display":"Galactose [Presence] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Galactose blood (qual)"}]},{"code":"23159-7","display":"Leishmania sp DNA [Identifier] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Leishmania DNA (NAAT)"}]},{"code":"23198-5","display":"Leptospira sp Ab [Titer] in Serum by Agglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Leptospira Ab (MAT)"}]},{"code":"2324-2","display":"Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"GGT"}]},{"code":"2333-3","display":"Gastrin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gastrin - mass/volume"}]},{"code":"2335-8","display":"Hemoglobin.gastrointestinal [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Occult blood (non-spec screen)"}]},{"code":"233-7","display":"Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Erythromycin suscep (MIC)"}]},{"code":"2338-2","display":"Glucagon [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucagon"}]},{"code":"2356-4","display":"Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"G6PD (screen)"}]},{"code":"23627-3","display":"Clofazimine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clofazimine suscep (qual)"}]},{"code":"23628-1","display":"Sparfloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sparfloxacin suscep (qual)"}]},{"code":"23629-9","display":"Para aminosalicylate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"P-aminosalicylate suscep qual"}]},{"code":"23636-4","display":"Cefdinir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefdinir suscep (qual)"}]},{"code":"23637-2","display":"Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefdinir suscep (MIC)"}]},{"code":"23638-0","display":"Grepafloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Grepafloxacin suscep (qual)"}]},{"code":"23639-8","display":"Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Grepafloxacin suscep (MIC)"}]},{"code":"23640-6","display":"Quinupristin+Dalfopristin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Quinupristin Dalfo suscep qual"}]},{"code":"23641-4","display":"Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Quinupristin Dalfo suscep MIC"}]},{"code":"23642-2","display":"Trovafloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trovafloxacin suscep (qual)"}]},{"code":"23643-0","display":"Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trovafloxacin suscep (MIC)"}]},{"code":"23658-8","display":"Other Antibiotic [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antibiotic XXX suscep (qual)"}]},{"code":"23659-6","display":"Apramycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Apramycin suscep (qual)"}]},{"code":"23709-9","display":"Ceftiofur [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftiofur suscep (qual)"}]},{"code":"23712-3","display":"Enrofloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enrofloxacin suscep (qual)"}]},{"code":"23713-1","display":"Ethylene glycol [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethylene glycol"}]},{"code":"23740-4","display":"Florfenicol [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Florfenicol suscep (qual)"}]},{"code":"23826-1","display":"Bordetella pertussis DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"B. pertussis DNA (NAAT)"}]},{"code":"23831-1","display":"Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"B. pertussis toxin IgG"}]},{"code":"2387-9","display":"Glycerol [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glycerol"}]},{"code":"23883-2","display":"Inhibin A [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Inhibin A"}]},{"code":"23905-3","display":"Mycophenolate [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mycophenolic Acid"}]},{"code":"23971-5","display":"Epstein Barr virus early IgG Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV EA IgG (titre)"}]},{"code":"23991-3","display":"Dengue virus IgG Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dengue virus IgG Ab"}]},{"code":"23992-1","display":"Dengue virus IgM Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dengue virus IgM Ab"}]},{"code":"2399-4","display":"Glycosaminoglycans [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glycosamino Glycan urine (quant)"}]},{"code":"24-0","display":"Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amphotericin B suscep (MIC)"}]},{"code":"241-0","display":"Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethambutol suscep (MIC)"}]},{"code":"24108-3","display":"Cancer Ag 19-9 [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CA 19-9"}]},{"code":"24109-1","display":"Progesterone [Moles/?volume] in Saliva (oral fluid)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Progesterone saliva"}]},{"code":"24110-9","display":"Treponema pallidum Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. pallidum Ab (EIA)"}]},{"code":"24111-7","display":"Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"N. gonorrhoeae DNA (NAAT)"}]},{"code":"24117-4","display":"Ross river virus IgG Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ross River virus IgG Ab"}]},{"code":"24118-2","display":"Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Barmah Forest virus IgM Ab"}]},{"code":"24120-8","display":"Ross river virus IgM Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ross River virus IgM Ab"}]},{"code":"24121-6","display":"Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Barmah Forest virus IgG Ab"}]},{"code":"24124-0","display":"Casts [Presence] in Urine sediment by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Casts urine sediment"}]},{"code":"24125-7","display":"Androgen free Index in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Testosterone (free index)"}]},{"code":"24312-1","display":"Treponema pallidum Ab [Presence] in Serum by Agglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Syphilis Ab Screen (Aggl)"}]},{"code":"24377-4","display":"Platelet aggregation ADP induced [Presence] in Platelet rich plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Platelet aggregtion-ADP"}]},{"code":"24378-2","display":"Platelet aggregation epinephrine induced [Presence] in Platelet rich plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Platelet aggregtion-epinephrine"}]},{"code":"24379-0","display":"Platelet aggregation collagen induced [Presence] in Platelet rich plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Platelet aggregtion-collagen"}]},{"code":"24380-8","display":"Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Platelet aggregtion-ristocetin"}]},{"code":"24383-2","display":"Intrinsic factor Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Intrinsic factor Ab (qual)"}]},{"code":"24390-7","display":"Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cortisol (30m p 250ug Synacth)"}]},{"code":"24391-5","display":"Cortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cortisol (1h p 250ug Synacth)"}]},{"code":"24393-1","display":"Cortisol [Moles/volume] in Serum or Plasma --10 hours post 1 mg dexamethasone PO overnight","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cortisol (10h p 1mg Dexameth)"}]},{"code":"24419-4","display":"Pathology report gross observation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gross observation"}]},{"code":"24467-3","display":"CD3+?CD4+? (T4 helper) cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"lymphocyte markers - Cells.CD3+CD4+"}]},{"code":"24471-5","display":"Platelet function (closure time) collagen+?Epinephrine induced [Time] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PFA Col/Epi"}]},{"code":"24472-3","display":"Platelet function (closure time) collagen+?ADP induced [Time] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PFA Col/ADP"}]},{"code":"245-1","display":"Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Floxacillin suscep (MIC)"}]},{"code":"24518-3","display":"Calcium/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcium/creatinine urine"}]},{"code":"24521-7","display":"Epinephrine [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adrenaline urine"}]},{"code":"24522-5","display":"Epinephrine/Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adrenaline/creat urine"}]},{"code":"24523-3","display":"Norepinephrine/Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Noradrenaline/creat urine"}]},{"code":"24524-1","display":"Dopamine/Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dopamine/creat urine"}]},{"code":"2458-8","display":"IgA [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgA"}]},{"code":"2460-4","display":"IgD [Mass/?volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgD"}]},{"code":"2464-6","display":"IgG [Mass/?volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgG CSF"}]},{"code":"2465-3","display":"IgG [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgG"}]},{"code":"2466-1","display":"IgG subclass 1 [Mass/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgG subclass 1"}]},{"code":"2467-9","display":"IgG subclass 2 [Mass/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgG subclass 2"}]},{"code":"2468-7","display":"IgG subclass 3 [Mass/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgG subclass 3"}]},{"code":"2469-5","display":"IgG subclass 4 [Mass/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgG subclass 4"}]},{"code":"2470-3","display":"IgG/?Albumin [Mass Ratio] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgG/Albumin CSF"}]},{"code":"2472-9","display":"IgM [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IgM"}]},{"code":"2483-6","display":"Insulin-like growth factor binding protein 3 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IGF Binding Protein 3"}]},{"code":"2484-4","display":"Insulin-like growth factor-I [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IGF1"}]},{"code":"249-3","display":"Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fluconazole suscep (MIC)"}]},{"code":"2495-0","display":"Iodine [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iodine urine - mass/volume"}]},{"code":"25095-1","display":"Deoxypyridinoline/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"DPD / creat  urine"}]},{"code":"25142-1","display":"5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Flucytosine peak"}]},{"code":"25143-9","display":"5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Flucytosine trough"}]},{"code":"25145-4","display":"Bacteria [Presence] in Urine sediment by Light microscopy ","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bacteria urine sediment (microscopy)"}]},{"code":"2514-8","display":"Ketones [Presence] in Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ketones urine (dipstick)"}]},{"code":"25168-6","display":"Perhexiline [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Perhexiline"}]},{"code":"25170-2","display":"Mercury [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mercury blood"}]},{"code":"2520-5","display":"Lactate [Moles/?volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lactate CSF"}]},{"code":"2524-7","display":"Lactate [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lactate "}]},{"code":"25302-1","display":"Alanine aminotransferase [Enzymatic activity/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ALT, fluid"}]},{"code":"253-5","display":"5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"5-Fluorocytosine suscep (MIC)"}]},{"code":"25358-3","display":"C peptide [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C-Peptide urine 24hr"}]},{"code":"25360-9","display":"Cadmium [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cadmium urine"}]},{"code":"25361-7","display":"Caffeine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Caffeine"}]},{"code":"25374-0","display":"Chromium [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chromium"}]},{"code":"25375-7","display":"Chymotrypsin [Enzymatic activity/?mass] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chymotrypsin faeces"}]},{"code":"25378-1","display":"Cobalt [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cobalt"}]},{"code":"25386-4","display":"Creatinine [Moles/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Creatinine body fluid"}]},{"code":"25393-0","display":"Desethylamiodarone [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Desethylamiodarone"}]},{"code":"25411-0","display":"Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fleroxacin suscep (MIC)"}]},{"code":"25428-4","display":"Glucose [Presence] in Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose urine (dipstick)"}]},{"code":"25447-4","display":"Insulin Free [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Insulin (free)"}]},{"code":"25451-6","display":"Isoniazid [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid"}]},{"code":"25452-4","display":"Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Itraconazole suscep (MIC)"}]},{"code":"25458-1","display":"Lamotrigine [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lamotrigine - moles/volume"}]},{"code":"25466-4","display":"Manganese [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Manganese blood - moles/volume"}]},{"code":"25471-4","display":"Mercury [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mercury urine 24hr"}]},{"code":"25474-8","display":"Metanephrines [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Metanephrines"}]},{"code":"25489-6","display":"Normetanephrine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Normetanephrines"}]},{"code":"25501-8","display":"Phosphate [Moles/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phosphate fluid"}]},{"code":"2550-2","display":"Lactate/?Pyruvate [Molar ratio] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lactate/pyruvate blood"}]},{"code":"25514-1","display":"Rubella virus IgG Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rubella IgG (qual)"}]},{"code":"25521-6","display":"Selenium [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Selenium"}]},{"code":"25524-0","display":"Serotonin [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Serotonin blood"}]},{"code":"25541-4","display":"Topiramate [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Topiramate"}]},{"code":"25542-2","display":"Toxoplasma gondii IgM Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. gondii IgM (qual)"}]},{"code":"25548-9","display":"Urate [Moles/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urate fluid"}]},{"code":"25549-7","display":"Urea [Moles/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urea  fluid"}]},{"code":"25595-0","display":"Econazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Econazole suscep (qual)"}]},{"code":"25596-8","display":"Fosfomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fosfomycin suscep (qual)"}]},{"code":"25597-6","display":"Josamycine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Josamycine suscep (qual)"}]},{"code":"25607-3","display":"Miconazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Miconazole suscep (qual)"}]},{"code":"25608-1","display":"Nitroxoline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nitroxoline suscep (qual)"}]},{"code":"25637-0","display":"Econazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Econazole suscep (MIC)"}]},{"code":"25638-8","display":"Eosinophil cationic protein (ECP) [Mass/?volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ECP"}]},{"code":"25653-7","display":"Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fosfomycin suscep (MIC)"}]},{"code":"256-8","display":"Foscarnet [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Foscarnet suscep (qual)"}]},{"code":"25702-2","display":"Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Josamycine suscep (MIC)"}]},{"code":"25721-2","display":"Mianserin [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mianserin"}]},{"code":"25722-0","display":"Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Miconazole suscep (MIC)"}]},{"code":"25723-8","display":"Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nitroxoline suscep (MIC)"}]},{"code":"2572-6","display":"Lipoprotein lipase [Enzymatic activity/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Liporotein lipase"}]},{"code":"258-4","display":"Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Framycetin suscep (MIC)"}]},{"code":"25867-3","display":"Echinococcus sp Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Echinococcus Ab (titre)"}]},{"code":"2589-0","display":"Lysozyme [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Muramidase"}]},{"code":"25907-7","display":"Elastase.pancreatic [Mass/?mass] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Elastase faeces"}]},{"code":"25909-3","display":"Epinephrine/Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adrenaline/creat urine 24h"}]},{"code":"25931-7","display":"Homovanillate/Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Homovanillate/creat urine 24h"}]},{"code":"2596-5","display":"Magnesium [Moles/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Magnesium  fluid"}]},{"code":"2597-3","display":"Magnesium [Moles/?volume] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Magnesium RBC"}]},{"code":"2598-1","display":"Magnesium [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Magnesium urine"}]},{"code":"2599-9","display":"Magnesium [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Magnesium urine 24h"}]},{"code":"26004-2","display":"Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VMA/creat urine 24h"}]},{"code":"26009-1","display":"Treponema pallidum Ab [Titer] in Serum by Hemagglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. pallidum Ab (HA)"}]},{"code":"2601-3","display":"Magnesium [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Magnesium"}]},{"code":"26023-2","display":"Extractable nuclear Ab identified in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ENA Identification"}]},{"code":"26043-0","display":"HLA-B27 [Presence] by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HLA B27"}]},{"code":"2606-2","display":"Melanin [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Melanogen urine (qual)"}]},{"code":"2614-6","display":"Methemoglobin/Hemoglobin.total in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methaemoglobin"}]},{"code":"262-6","display":"Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fusidate suscep (MIC)"}]},{"code":"2639-3","display":"Myoglobin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Myoglobin"}]},{"code":"2640-1","display":"Myoglobin [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Myoglobin  urine"}]},{"code":"26444-0","display":"Basophils [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Basophils"}]},{"code":"26446-5","display":"Blasts/100 leukocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blasts (%)"}]},{"code":"26449-9","display":"Eosinophils [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Eosinophils"}]},{"code":"26450-7","display":"Eosinophils/100 leukocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Eosinophils (%)"}]},{"code":"26453-1","display":"Erythrocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RBC"}]},{"code":"26454-9","display":"Erythrocytes [#/volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RBC CSF"}]},{"code":"26455-6","display":"Erythrocytes [#/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RBC body fluid"}]},{"code":"26464-8","display":"Leukocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"WBC"}]},{"code":"26465-5","display":"Leukocytes [#/volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"WBC CSF"}]},{"code":"26466-3","display":"Leukocytes [#/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"WBC body fluid"}]},{"code":"26474-7","display":"Lymphocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphocytes"}]},{"code":"26475-4","display":"Lymphocytes [#/volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphocytes CSF"}]},{"code":"26476-2","display":"Lymphocytes [#/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphocytes body fluid"}]},{"code":"26477-0","display":"Variant lymphocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphocytes (atypical)"}]},{"code":"26478-8","display":"Lymphocytes/100 leukocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphocytes (%)"}]},{"code":"26484-6","display":"Monocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Monocytes"}]},{"code":"26485-3","display":"Monocytes/100 leukocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Monocytes (%)"}]},{"code":"26489-5","display":"Mononuclear cells [#/volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mononuclear cells CSF"}]},{"code":"26490-3","display":"Mononuclear cells [#/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mononuclear cells body fluid"}]},{"code":"26499-4","display":"Neutrophils [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophils"}]},{"code":"26500-9","display":"Neutrophils [#/volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophils CSF"}]},{"code":"26507-4","display":"Band form neutrophils [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophils (band)"}]},{"code":"26508-2","display":"Band form neutrophils/100 leukocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophils (band) (%)"}]},{"code":"26511-6","display":"Neutrophils/100 leukocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophils (%)"}]},{"code":"26515-7","display":"Platelets [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Platelets"}]},{"code":"26523-1","display":"Promyelocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Promyelocytes"}]},{"code":"265-9","display":"Ganciclovir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ganciclovir suscep (qual)"}]},{"code":"26621-3","display":"Legionella sp Ag [Presence] in Unspecified specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Legionella Ag"}]},{"code":"26705-4","display":"Epstein Barr virus nuclear IgM Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV NA IgM (titre)"}]},{"code":"267-5","display":"Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gentamicin suscep (MIC)"}]},{"code":"2676-5","display":"Organic acids [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Organic acids urine"}]},{"code":"26784-9","display":"Diazepam [Mass/?volume] in Serum or Plasma by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Diazepam by Confirmatory method"}]},{"code":"26833-4","display":"Hippurate [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hippurate urine"}]},{"code":"2685-6","display":"Alpha-1-Acid glycoprotein [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alpha 1 glycoprotein"}]},{"code":"26885-4","display":"Ova and parasites identified in Unspecified specimen by Concentration.","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ova cysts parasites"}]},{"code":"2692-2","display":"Osmolality of Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Osmolality "}]},{"code":"2695-5","display":"Osmolality of Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Osmolality  urine"}]},{"code":"26960-5","display":"Trypsin [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trypsin faeces"}]},{"code":"26969-6","display":"Parietal cell Ab [Presence] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parietal cell Ab (qual)"}]},{"code":"27071-0","display":"CD45 (Lymphs) cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"lymphocyte markers - Cells.CD45"}]},{"code":"27081-9","display":"Itraconazole+?Hydroxyitraconazole [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Itraconazole"}]},{"code":"27109-8","display":"Paroxetine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Paroxetine urine"}]},{"code":"271-7","display":"Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gramicidin D suscep (MIC)"}]},{"code":"27198-1","display":"Bilirubin.total [Units/?volume] in Amniotic fluid by Spectrophotometry direct","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bilirubin  amniotic fluid"}]},{"code":"27200-5","display":"Nuclear Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antinuclear Ab"}]},{"code":"2721-9","display":"Pancreatic polypeptide [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pancreatic Polypeptide"}]},{"code":"27252-6","display":"Choriogonadotropin.alpha subunit [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gonadotrophin Alpha subunit (total)"}]},{"code":"27265-8","display":"Giardia sp Ag [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Giardia Ag faeces"}]},{"code":"2731-8","display":"Parathyrin.intact [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parathyroid Hormone (intact) - mass/volume"}]},{"code":"27320-1","display":"Parietal cell Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parietal cell Ab (titre)"}]},{"code":"27403-5","display":"Gamma glutamyl transferase [Enzymatic activity/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"GGT urine"}]},{"code":"2742-5","display":"Angiotensin converting enzyme [Enzymatic activity/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Angiotensin converting enzyme"}]},{"code":"2748-2","display":"pH of Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"pH body fluid"}]},{"code":"2752-4","display":"pH of Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"pH semen"}]},{"code":"275-8","display":"Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hetacillin suscep (MIC)"}]},{"code":"2758-1","display":"Phenol [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phenol urine"}]},{"code":"27811-9","display":"Antithrombin actual/?normal in Platelet poor plasma by Chromogenic method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antithrombin"}]},{"code":"27812-7","display":"Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antithrombin Ag"}]},{"code":"27815-0","display":"Coagulation factor XIII activity actual/?normal in Platelet poor plasma by Chromogenic method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor XIII assay"}]},{"code":"27816-8","display":"von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VWF:Ag"}]},{"code":"27818-4","display":"Protein C actual/?normal in Platelet poor plasma by Chromogenic method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein C  - by Chromogenic method"}]},{"code":"27819-2","display":"Protein C actual/?normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein C  - by Coagulation assay"}]},{"code":"27820-0","display":"Protein C Ag actual/normal in Platelet poor plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein C Ag"}]},{"code":"27821-8","display":"Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein S, Free"}]},{"code":"27822-6","display":"Protein S actual/normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein S"}]},{"code":"279-0","display":"Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Imipenem suscep (MIC)"}]},{"code":"27977-8","display":"Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Noradrenaline/creat urine 24h"}]},{"code":"27978-6","display":"Metanephrines/?Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Metanephrines/creat urine 24h"}]},{"code":"2809-2","display":"Porphobilinogen [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphobilinogen urine (qual)"}]},{"code":"28-1","display":"Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ampicillin suscep (MIC)"}]},{"code":"2811-8","display":"Porphobilinogen [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphobilinogen urine"}]},{"code":"2812-6","display":"Porphobilinogen deaminase [Enzymatic activity/?volume] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphobilinogen deaminase RBC"}]},{"code":"2821-7","display":"Potassium [Moles/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Potassium  fluid"}]},{"code":"2823-3","display":"Potassium [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Potassium"}]},{"code":"2828-2","display":"Potassium [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Potassium urine"}]},{"code":"2829-0","display":"Potassium [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Potassium urine 24h"}]},{"code":"28539-5","display":"MCH [Entitic mass]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MCH"}]},{"code":"28540-3","display":"MCHC [Mass/volume]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MCHC"}]},{"code":"28542-9","display":"Platelet mean volume [Entitic volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MPV"}]},{"code":"2857-1","display":"Prostate specific Ag [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PSA"}]},{"code":"287-3","display":"Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid suscep (MIC)"}]},{"code":"2880-3","display":"Protein [Mass/volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein CSF"}]},{"code":"2881-1","display":"Protein [Mass/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein body fluid"}]},{"code":"2885-2","display":"Protein [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein"}]},{"code":"2888-6","display":"Protein [Mass/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein urine"}]},{"code":"2889-4","display":"Protein [Mass/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein urine 24h"}]},{"code":"2890-2","display":"Protein/Creatinine [Mass Ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein/creat urine"}]},{"code":"2903-3","display":"Pyrimidine-5'-Nucleotidase [Enzymatic activity/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyrimidine 5'Nucleotidase"}]},{"code":"291-5","display":"Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Kanamycin suscep (MIC)"}]},{"code":"2915-7","display":"Renin [Enzymatic activity/?volume] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Renin Activity "}]},{"code":"29247-4","display":"Sirolimus [Mass/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sirolimus blood"}]},{"code":"29254-0","display":"Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Linezolid suscep (MIC)"}]},{"code":"29257-3","display":"Mycoplasma pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"M. pneumoniae DNA (NAAT)"}]},{"code":"29258-1","display":"Linezolid [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Linezolid suscep (qual)"}]},{"code":"29265-6","display":"Calcium [Moles/volume] corrected for albumin in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcium (albumin adjusted)"}]},{"code":"29300-1","display":"Procedure type","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sample procedure"}]},{"code":"2947-0","display":"Sodium [Moles/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sodium blood"}]},{"code":"2950-4","display":"Sodium [Moles/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sodium  fluid"}]},{"code":"2951-2","display":"Sodium [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sodium"}]},{"code":"29520-4","display":"5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"5HIAA/creat urine"}]},{"code":"29541-0","display":"HIV 1 RNA [Log #/volume] (viral load) in Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HIV Viral Load (log#/volume)"}]},{"code":"2954-6","display":"Sodium [Moles/?volume] in Sweat","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sodium sweat"}]},{"code":"2955-3","display":"Sodium [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sodium urine"}]},{"code":"29558-4","display":"Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enterovirus RNA (NAAT) CSF"}]},{"code":"295-6","display":"Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ketoconazole suscep (MIC)"}]},{"code":"2956-1","display":"Sodium [Moles/time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sodium urine 24h"}]},{"code":"29577-4","display":"Fungal susceptibility panel","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fungal susceptibility"}]},{"code":"29591-5","display":"Enterovirus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enterovirus RNA (NAAT)"}]},{"code":"2963-7","display":"Somatotropin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Growth Hormone"}]},{"code":"29652-5","display":"Dothiepin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dothiepin - mass/volume"}]},{"code":"29653-3","display":"Dothiepin [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dothiepin - moles/volume"}]},{"code":"29659-0","display":"Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bordetella IgG Ab (qual)"}]},{"code":"29660-8","display":"Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parvovirus Ab  IgG"}]},{"code":"29662-4","display":"Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Varicella zoster Ab IgM"}]},{"code":"29747-3","display":"Tocopherols [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vitamin E"}]},{"code":"29764-8","display":"Iron [Moles/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iron fluid"}]},{"code":"29765-5","display":"Cholesterol [Moles/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholesterol body fluid"}]},{"code":"29766-3","display":"Triglyceride [Moles/?volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Triglyceride fluid"}]},{"code":"29771-3","display":"Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Occult blood (human Hb spec) "}]},{"code":"29877-8","display":"Methylmalonate [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methylmalonic Acid - in urine"}]},{"code":"29891-9","display":"Helicobacter pylori [Presence] in Stomach by urea breath test","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urea Breath Test"}]},{"code":"29904-0","display":"Toxoplasma gondii DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. gondii (NAAT)"}]},{"code":"29908-1","display":"Parainfluenza virus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parainfluenza virus 1 RNA (NAAT)"}]},{"code":"29909-9","display":"Parainfluenza virus 2 RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parainfluenza virus 2 RNA (NAAT)"}]},{"code":"29910-7","display":"Parainfluenza virus 3 RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parainfluenza virus 3 RNA (NAAT)"}]},{"code":"29953-7","display":"Nuclear Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antinuclear Ab (titre)"}]},{"code":"29954-5","display":"Extractable nuclear Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ENA screen (EIA)"}]},{"code":"299-8","display":"Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lincomycin suscep (MIC)"}]},{"code":"29990-9","display":"Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Semen (post vasectomy) (qual)"}]},{"code":"30000-4","display":"Microalbumin/?Creatinine [Ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microalblumin:Creatinine Ratio"}]},{"code":"3002-3","display":"Thiocyanate [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thiocyanate"}]},{"code":"3004-9","display":"Thiocyanate [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thiocyanate urine"}]},{"code":"3013-0","display":"Thyroglobulin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thyroglobulin"}]},{"code":"30131-7","display":"Complement total hemolytic CH50 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CH50"}]},{"code":"3016-3","display":"Thyrotropin [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"TSH"}]},{"code":"30173-9","display":"Cortisol Free [Moles/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cortisol (free) urine"}]},{"code":"30180-4","display":"Basophils/100 leukocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Basophils (%)"}]},{"code":"30206-7","display":"Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"hCG (alpha free)"}]},{"code":"30246-3","display":"Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV DNA (NAAT) (Serum/Plasma)"}]},{"code":"30248-9","display":"Transferrin receptor.soluble [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Transferrin Receptor - mass/volume"}]},{"code":"30298-4","display":"Lamivudine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lamivudine suscep (qual)"}]},{"code":"30299-2","display":"Amprenavir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amprenavir suscep (qual)"}]},{"code":"30300-8","display":"Didanosine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Didanosine suscep (qual)"}]},{"code":"30301-6","display":"Zalcitabine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Zalcitabine suscep (qual)"}]},{"code":"30302-4","display":"Stavudine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Stavudine suscep (qual)"}]},{"code":"30303-2","display":"Abacavir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Abacavir suscep (qual)"}]},{"code":"30304-0","display":"Adefovir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adefovir suscep (qual)"}]},{"code":"30305-7","display":"Delavirdine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Delavirdine suscep (qual)"}]},{"code":"30306-5","display":"Efavirenz [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Efavirenz suscep (qual)"}]},{"code":"30307-3","display":"Indinavir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Indinavir suscep (qual)"}]},{"code":"30308-1","display":"Ritonavir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ritonavir suscep (qual)"}]},{"code":"30309-9","display":"Nelfinavir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nelfinavir suscep (qual)"}]},{"code":"30310-7","display":"Saquinavir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Saquinavir suscep (qual)"}]},{"code":"30311-5","display":"Nevirapine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nevirapine suscep (qual)"}]},{"code":"30313-1","display":"Hemoglobin [Mass/?volume] in Arterial blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haemoglobin blood "}]},{"code":"30316-4","display":"Alpha subunit free [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gonadotrophin Alpha subunit (free)"}]},{"code":"30325-5","display":"Cytomegalovirus IgM Ab [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV IgM (qual)"}]},{"code":"30339-6","display":"Epstein Barr virus capsid IgG Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV  VCA IgG"}]},{"code":"30340-4","display":"Epstein Barr virus capsid IgM Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV  VCA IgM"}]},{"code":"30341-2","display":"Erythrocyte sedimentation rate","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ESR"}]},{"code":"3034-6","display":"Transferrin [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Transferrin"}]},{"code":"30376-8","display":"Blasts [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blasts"}]},{"code":"303-8","display":"Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lomefloxacin suscep (MIC)"}]},{"code":"30385-9","display":"Erythrocyte distribution width [Ratio]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RDW"}]},{"code":"30391-7","display":"Erythrocytes [#/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RBC urine"}]},{"code":"30392-5","display":"Nucleated erythrocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RBC (nucleated)"}]},{"code":"30397-4","display":"Hairy cells [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hairy Cells"}]},{"code":"3040-3","display":"Lipase [Enzymatic activity/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lipase"}]},{"code":"30405-5","display":"Leukocytes [#/volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"WBC urine"}]},{"code":"3041-1","display":"Trichloroacetate [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trichloroacetic acid urine"}]},{"code":"30412-1","display":"Lymphocytes Abnormal [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphocytes (abnormal)"}]},{"code":"30422-0","display":"Lymphoma cells [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphoma cells"}]},{"code":"30428-7","display":"MCV [Entitic volume]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MCV"}]},{"code":"30433-7","display":"Metamyelocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Metamyelocytes"}]},{"code":"30446-9","display":"Myelocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Myelocytes"}]},{"code":"30449-3","display":"Neutrophils.hypersegmented [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophils (hyperseg)"}]},{"code":"30450-1","display":"Neutrophils.hypersegmented/100 leukocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophils (hyperseg) (%)"}]},{"code":"30458-4","display":"Plasma cells [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Plasma cells"}]},{"code":"30464-2","display":"Prolymphocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Prolymphocytes"}]},{"code":"30480-8","display":"Orotate [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Orotate  urine"}]},{"code":"30522-7","display":"C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CRP (high sensitivity)"}]},{"code":"30524-3","display":"Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Triglycerides (fasting)"}]},{"code":"3056-9","display":"Trimethylamine [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trimethylamine urine"}]},{"code":"307-9","display":"Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Loracarbef suscep (MIC)"}]},{"code":"30894-0","display":"Aldosterone/?Renin [Ratio] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aldosterone/Renin"}]},{"code":"30899-9","display":"Blood volume by Scintigraphy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blood volume"}]},{"code":"30903-9","display":"Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophil oxidative burst"}]},{"code":"31022-7","display":"Filaria identified in Unspecified specimen by Concentration","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Filaria blood (conc)"}]},{"code":"31036-7","display":"Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gatifloxacin suscep (MIC)"}]},{"code":"31037-5","display":"Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxifloxacin suscep (MIC)"}]},{"code":"31038-3","display":"Gatifloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gatifloxacin suscep (qual)"}]},{"code":"31039-1","display":"Moxifloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxifloxacin suscep (qual)"}]},{"code":"311-1","display":"Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymecycline suscep (MIC)"}]},{"code":"31146-4","display":"Reagin Ab [Titer] in Cerebral spinal fluid by VDRL","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VDRL CSF (titre)"}]},{"code":"31152-2","display":"Immunoglobulin light chains [Presence] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"B-J protein urine 24h (qual)"}]},{"code":"31156-3","display":"Hemoglobin Barts/?Hemoglobin.total in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hb Bart's"}]},{"code":"31204-1","display":"Hepatitis B virus core IgM Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B core IgM"}]},{"code":"31208-2","display":"Specimen source identified","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Specimen type/site"}]},{"code":"3129-4","display":"Menadione [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vitamin K"}]},{"code":"31348-6","display":"DNA double strand Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"DS DNA Ab (qual)"}]},{"code":"31418-7","display":"Heterophile Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Infectious mono screen"}]},{"code":"315-2","display":"Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Meclocycline suscep (MIC)"}]},{"code":"3160-9","display":"Volume of Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Volume semen"}]},{"code":"31616-6","display":"Rubella virus IgM Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rubella IgM (qual)"}]},{"code":"31627-3","display":"Smith extractable nuclear Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Smith extractable nuclear Ab"}]},{"code":"3174-0","display":"Antithrombin [Units/?volume] in Platelet poor plasma by Chromogenic method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antithrombin - units/volume"}]},{"code":"31798-2","display":"Dengue virus Ag [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dengue virus Ag"}]},{"code":"3181-5","display":"Cardiolipin IgG Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cardiolipin Ab IgG"}]},{"code":"3182-3","display":"Cardiolipin IgM Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cardiolipin Ab IgM"}]},{"code":"31834-5","display":"Haemophilus influenzae B Ag [Presence] in Unspecified specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haemophilus inflenzae B Ag"}]},{"code":"31843-6","display":"Helicobacter pylori Ag [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"H. pylori Ag faeces"}]},{"code":"31844-4","display":"Hepatitis B virus e Ag [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B e Ag"}]},{"code":"3185-6","display":"Coagulation factor IX inhibitor [Units/?volume] in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor IX Inhibitor assay"}]},{"code":"3186-4","display":"Coagulation factor IX activated [Units/?volume] in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor IX assay - units/volume"}]},{"code":"31868-3","display":"Legionella pneumophila 1 Ag [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Legionella sero-group 1 Ag (urine)"}]},{"code":"31870-9","display":"Legionella pneumophila Ag [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Legionella Ag (urine)"}]},{"code":"3187-2","display":"Coagulation factor IX activity actual/?normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor IX assay"}]},{"code":"31910-3","display":"Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Unspecified specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"N. meningitidis A+?C+?w135+?Y Ag"}]},{"code":"31913-7","display":"Neisseria meningitidis serogroup B Ag [Presence] in Unspecified specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"N. meningitidis B Ag"}]},{"code":"3193-0","display":"Coagulation factor V activity actual/?normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor V assay"}]},{"code":"319-4","display":"Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methacycline suscep (MIC)"}]},{"code":"31969-9","display":"Streptococcus pneumoniae Ag [Presence] in Unspecified specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pneumococcal Ag"}]},{"code":"3198-9","display":"Coagulation factor VII activity actual/?normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor VII assay"}]},{"code":"32018-4","display":"Hepatitis A virus IgG Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis A IgG (qual)"}]},{"code":"32042-4","display":"Thyroperoxidase Ab [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thyroid peroxidase Antibody"}]},{"code":"3204-5","display":"Coagulation factor VIII inhibitor [Units/?volume] in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor VIII inhibitor assay"}]},{"code":"3209-4","display":"Coagulation factor VIII activity actual/?normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor VIII assay"}]},{"code":"32095-2","display":"Methanol [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methanol  urine"}]},{"code":"32098-6","display":"Mexiletine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mexiletine"}]},{"code":"3210-2","display":"Coagulation factor VIII activity [Units/?volume] in Platelet poor plasma by Chromogenic method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor VIII assay - units/volume"}]},{"code":"32117-4","display":"Thiopental [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thiopentone"}]},{"code":"32140-6","display":"Hemoglobin F [Presence] in Blood by Kleihauer-Betke method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HbF (qual, Kleihauer)"}]},{"code":"3218-5","display":"Coagulation factor X activity actual/?normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor X "}]},{"code":"32210-7","display":"Protein Fractions [interpretation] in 24 hour Urine by Electrophoresis","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Protein urine 24h (elph)"}]},{"code":"32217-2","display":"von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VWF Multimers"}]},{"code":"32218-0","display":"Cyclic citrullinated peptide Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CCP Ab"}]},{"code":"3226-8","display":"Coagulation factor XI activity actual/?normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor XI "}]},{"code":"32286-7","display":"Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis C genotype "}]},{"code":"32294-1","display":"Albumin/?Creatinine [Ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Albumin:creatinine ratio"}]},{"code":"32295-8","display":"Aluminum [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aluminium urine 24hr"}]},{"code":"32-3","display":"Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ampicillin Sulb suscep (MIC)"}]},{"code":"32309-7","display":"Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholesterol (total/HDL)"}]},{"code":"3232-6","display":"Coagulation factor XII activity actual/?normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor XII "}]},{"code":"32352-7","display":"Alkaline phosphatase.heat stable [Enzymatic activity/volume] in Serum or Plasma by Heat stability","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alk phosphatase (heat stable)"}]},{"code":"32356-8","display":"Yeast [Presence] in Urine sediment by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Yeasts urine"}]},{"code":"323-6","display":"Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methicillin suscep (MIC)"}]},{"code":"32364-2","display":"Herpes virus 8 DNA [Presence] in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Herpes virus 8 DNA (NAAT)"}]},{"code":"32368-3","display":"Ureaplasma sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ureaplasma (culture)"}]},{"code":"32372-5","display":"Fleroxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fleroxacin suscep (qual)"}]},{"code":"32373-3","display":"Arbekacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Arbekacin suscep (qual)"}]},{"code":"32374-1","display":"Cefotiam [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotiam suscep (qual)"}]},{"code":"32375-8","display":"Cefmenoxime [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefmenoxime suscep (qual)"}]},{"code":"32376-6","display":"Clinafloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clinafloxacin suscep (qual)"}]},{"code":"32377-4","display":"Cefetamet [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefetamet suscep (qual)"}]},{"code":"32378-2","display":"Caspofungin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Caspofungin suscep (qual)"}]},{"code":"32379-0","display":"Voriconazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Voriconazole suscep (qual)"}]},{"code":"32381-6","display":"Isepamicin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isepamicin suscep (qual)"}]},{"code":"32383-2","display":"Pristinamycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pristinamycin suscep (qual)"}]},{"code":"32384-0","display":"Thiacetazone [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thiacetazone suscep (qual)"}]},{"code":"3241-7","display":"Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor XIII screen"}]},{"code":"3243-3","display":"Thrombin time","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thrombin time"}]},{"code":"3244-1","display":"Clot Lysis [Time] in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Euglobulin clot lysis time"}]},{"code":"32546-4","display":"Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"G6PD"}]},{"code":"32547-2","display":"Ketones [Moles/?volume] in Serum or Plasma by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ketones"}]},{"code":"32552-2","display":"Pyruvate kinase [Enzymatic activity/mass] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyruvate kinase"}]},{"code":"32554-8","display":"Thiamine [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vitamin B1 blood"}]},{"code":"3255-7","display":"Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fibrinogen"}]},{"code":"32597-7","display":"Natamycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Natamycin suscep (qual)"}]},{"code":"32603-3","display":"Itraconazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Itraconazole suscep (qual)"}]},{"code":"32610-8","display":"Amino acids [Moles/?volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amino Acids CSF (quant)"}]},{"code":"32631-4","display":"Nitroblue Tetrazolium Test (NBT) [Presence] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"NBT Test"}]},{"code":"32637-1","display":"Urease [Presence] in Tissue","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CLO test"}]},{"code":"32654-6","display":"6-Methylmercaptopurine [Entitic substance] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"6-Methylmercatopurine"}]},{"code":"32660-3","display":"6-Thioguanine [Entitic substance] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"6-Thioguanine nucleotides  blood"}]},{"code":"32661-1","display":"Adrenal Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adrenal Ab (titre)"}]},{"code":"32672-8","display":"Cold agglutinin [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cold Agglutinin (screen)"}]},{"code":"32673-6","display":"Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CKMB"}]},{"code":"32674-4","display":"Cryptococcus sp Ag [Titer] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cryptococcus Ag CSF (titre)"}]},{"code":"32677-7","display":"DNA double strand Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"DS DNA Ab (EIA)"}]},{"code":"32693-4","display":"Lactate [Moles/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lactate blood"}]},{"code":"32709-8","display":"Neutrophils [#/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophils body fluid"}]},{"code":"3271-4","display":"LMW Heparin [Units/?volume] in Platelet poor plasma by Chromogenic method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anti Xa"}]},{"code":"32724-7","display":"Trichomonas sp [Presence] in Urine by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trichomonas urine (microscopy)"}]},{"code":"32766-8","display":"Trichomonas vaginalis [Presence] in Unspecified specimen by Wet preparation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trichomonas (microscopy)"}]},{"code":"327-7","display":"Metronidazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Metronidazole suscep (MIC)"}]},{"code":"32786-6","display":"Thyroperoxidase Ab [Titer] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thyroid microsomal Ab (titre)"}]},{"code":"32789-0","display":"Viscosity of Semen Qualitative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Viscosity semen"}]},{"code":"3289-6","display":"Prothrombin activity actual/?normal in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor II assay"}]},{"code":"3299-5","display":"Acetaminophen [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Paracetamol urine"}]},{"code":"33006-8","display":"Cytomegalovirus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV Viral load "}]},{"code":"33007-6","display":"Protoporphyrin.zinc [Mass/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Zinc protoporphyrin blood"}]},{"code":"33037-3","display":"Anion gap in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anion gap"}]},{"code":"33048-0","display":"Eosin-5-Maleimide binding [Presence] in Blood by Flow cytometry (FC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EMA Binding"}]},{"code":"331-9","display":"Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mezlocillin suscep (MIC)"}]},{"code":"3319-1","display":"Amikacin [Mass/volume] in Serum or Plasma --peak","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin peak"}]},{"code":"33204-9","display":"Troponin T.cardiac [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Troponin T (qual)"}]},{"code":"33210-6","display":"Transferrin receptor.soluble [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Transferrin Receptor - moles/volume"}]},{"code":"3321-7","display":"Amikacin [Mass/volume] in Serum or Plasma --trough","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin trough"}]},{"code":"33271-8","display":"Microscopic observation [Identifier] in Blood by Malaria thin smear","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Malaria thin blood film"}]},{"code":"33288-2","display":"Galactose 1 phosphate uridyl transferase [Presence] in DBS","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Galactose 1 phosphate uridyl transferase dried blood spot (qual)"}]},{"code":"33295-7","display":"JC virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"JC virus (NAAT)"}]},{"code":"33313-8","display":"Rheumatoid factor IgA [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rheumatoid factor IgA"}]},{"code":"33314-6","display":"Rheumatoid factor IgG [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rheumatoid factor IgG"}]},{"code":"3333-2","display":"Amitriptyline [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amitriptyline - mass/volume"}]},{"code":"3335-7","display":"Amitriptyline+?Nortriptyline [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amitriptyline+Nortriptylineï¿½"}]},{"code":"3349-8","display":"Amphetamines [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amphetamine-type substances, urine"}]},{"code":"335-0","display":"Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Minocycline suscep (MIC)"}]},{"code":"33525-7","display":"Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thrombin time (+ N plasma)"}]},{"code":"33526-5","display":"Reptilase time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reptilase time (+ N plasma)"}]},{"code":"33614-9","display":"Transferrin.carbohydrate deficient.XXX/Transferrin.total in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carbohydrate Deficient Transferrin "}]},{"code":"33617-2","display":"HLA-DR+? cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"lymphocyte markers - Cells.HLA-DR+"}]},{"code":"33627-1","display":"Tenofovir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tenofovir suscep (qual)"}]},{"code":"33628-9","display":"Cidofovir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cidofovir suscep (qual)"}]},{"code":"33666-9","display":"Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dysmorphic RBC urine"}]},{"code":"33673-5","display":"Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thrombin time (+protamine SO4)"}]},{"code":"33721-2","display":"Bone marrow Pathology biopsy report","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bone marrow trephine"}]},{"code":"33723-8","display":"Specimen length ","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Size"}]},{"code":"33725-3","display":"Tumor site","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tumour site"}]},{"code":"33728-7","display":"Size.maximum dimension in Tumor","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Width of tumour"}]},{"code":"33732-9","display":" Histology grade [Identifier] in Cancer specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Histological grade (tumour differentiation)"}]},{"code":"33739-4","display":"Lymphatic.small vessel.invasion [Identifier] in Specimen by CAP cancer protocols","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphatic invasion"}]},{"code":"33748-5","display":"Distance from anal verge","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Distance from anal verge"}]},{"code":"33763-4","display":"Natriuretic peptide.B prohormone N-Terminal [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ProBNP"}]},{"code":"3377-9","display":"Barbiturates [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Barbiturate urine"}]},{"code":"33783-2","display":"Atrial natriuretic factor [Moles/?volume] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Atrial Naturietic Peptide"}]},{"code":"33824-4","display":"Iron [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iron urine"}]},{"code":"33872-3","display":"Cystine [Moles/?mass] in Leukocytes","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cystine (WBC) blood"}]},{"code":"33899-6","display":"Bilirubin.conjugated+?indirect [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bilirubin neonatal"}]},{"code":"3390-2","display":"Benzodiazepines [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Benzodiazepine urine"}]},{"code":"339-2","display":"Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Miocamycin suscep (MIC)"}]},{"code":"3393-6","display":"Benzoylecgonine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Benzoylecgonine urine"}]},{"code":"33941-6","display":"Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Herpes virus 6 DNA (NAAT)"}]},{"code":"33944-0","display":"Lambda light chains.free [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Immunoglobulin Light Chains lambda (free)"}]},{"code":"33950-7","display":"Magnesium/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Magnesium/creatinine urine"}]},{"code":"33959-8","display":"Procalcitonin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Procalcitonin"}]},{"code":"3397-7","display":"Cocaine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cocaine urine"}]},{"code":"3-4","display":"Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Almecillin suscep (MIC)"}]},{"code":"3414-0","display":"Buprenorphine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Buprenorphine urine"}]},{"code":"34235-2","display":"Amylase/Creatinine [Ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amylase/creat urine"}]},{"code":"34268-3","display":"Cobalt [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cobalt urine"}]},{"code":"34304-6","display":"Fluoride [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fluoride urine"}]},{"code":"34320-2","display":"Iodine [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iodine urine - moles/volume"}]},{"code":"34338-4","display":"Mercury [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mercury urine"}]},{"code":"343-4","display":"Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxalactam suscep (MIC)"}]},{"code":"34343-4","display":"Nickel [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nickel urine"}]},{"code":"34350-9","display":"Oxalate/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxalate/creat urine"}]},{"code":"34357-4","display":"Porphobilinogen/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphobilinogen/creat urine"}]},{"code":"34375-6","display":"Streptokinase Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Streptokinase Ab (titre)"}]},{"code":"34382-2","display":"Treponema pallidum Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. pallidum Ab (IF)"}]},{"code":"34385-5","display":"Urate/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urate/creatinine urine"}]},{"code":"34387-1","display":"Zinc [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Zinc urine"}]},{"code":"34413-5","display":"Moclobemide [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moclobemide"}]},{"code":"34487-9","display":"Influenza virus A RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza A RNA (NAAT)"}]},{"code":"3453-8","display":"Cephalexin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cephalexin"}]},{"code":"34571-0","display":"aPTT.lupus sensitive (LA screen)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"aPTT.lupus sensitive"}]},{"code":"34594-2","display":"Schistosoma sp Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Schistosomal Ab (titre)"}]},{"code":"34615-5","display":"Iron.microscopic observation [Identifier] in Blood by Potassium ferrocyanide stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iron stain blood"}]},{"code":"34616-3","display":"Amino acids [Identifier] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amino acids CSF (ident)"}]},{"code":"34628-8","display":"Methotrexate [Moles/?volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methotrexate  CSF"}]},{"code":"34645-2","display":"Chlamydophila pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C. pneumoniae DNA (NAAT)"}]},{"code":"34701-3","display":"Heparin induced platelet AB [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HITS"}]},{"code":"34713-8","display":"Clostridioides difficile toxin A+B [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cl. difficile toxin faeces"}]},{"code":"34717-9","display":"Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Coxiella Ab"}]},{"code":"3472-8","display":"Chlorpromazine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chlorpromazine urine"}]},{"code":"347-5","display":"Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nafcillin suscep (MIC)"}]},{"code":"3491-8","display":"Clomipramine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clomipramine - mass/volume"}]},{"code":"34918-3","display":"Sezary cells [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sezary Cells"}]},{"code":"34926-6","display":"Promonocytes [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Promonocytes"}]},{"code":"3493-4","display":"Clomipramine+?Norclomipramine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clomipramine+Norclomipramineï¿½- mass/volume"}]},{"code":"34993-6","display":"Smudge cells [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Smear cells"}]},{"code":"35026-4","display":"Monocytes [#/volume] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Monocytes CSF"}]},{"code":"35039-7","display":"Lymphocytes Plasmacytoid [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphocytes (plasmacytoid)"}]},{"code":"3507-1","display":"Codeine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Codeine urine"}]},{"code":"35076-9","display":"Monocytes [#/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Monocytes body fluid"}]},{"code":"35082-7","display":"Lymphocytes Large Granular [#/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphocytes (large granular)"}]},{"code":"35112-2","display":"Floxacillin [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Flucloxacillin"}]},{"code":"351-7","display":"Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nalidixate suscep (MIC)"}]},{"code":"3520-4","display":"Cyclosporine [Mass/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cyclosporin blood"}]},{"code":"35275-7","display":"Measles virus IgG Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Measles IgG"}]},{"code":"35276-5","display":"Measles virus IgM Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Measles IgM"}]},{"code":"35279-9","display":"Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophil cytoplasmic Ab"}]},{"code":"35280-7","display":"Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"TTG  Ab IgA (qual)"}]},{"code":"3531-1","display":"Desipramine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Desipramine - mass/volume"}]},{"code":"35352-4","display":"Mycobacterium tuberculosis genotype [Identifier] in Isolate","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"M. TB (genotype)"}]},{"code":"3548-5","display":"Diazepam [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Diazepam"}]},{"code":"35491-0","display":"Leptospira sp DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Leptospira DNA (NAAT)"}]},{"code":"3550-1","display":"Diazepam [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Diazepam urine"}]},{"code":"35570-1","display":"Renin [Mass/?volume] in Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Renin"}]},{"code":"355-8","display":"Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neomycin suscep (MIC)"}]},{"code":"35668-3","display":"Gentamicin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gentamicin"}]},{"code":"35670-9","display":"Tobramycin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tobramycin"}]},{"code":"35698-0","display":"Metformin [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MetFORMIN [Mass/Vol]"}]},{"code":"35745-9","display":"Fat/?Total solids [Mass Ratio] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Steatocrit faeces"}]},{"code":"35755-8","display":"Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Avilamycin suscep (MIC)"}]},{"code":"35756-6","display":"Avilamycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Avilamycin suscep (qual)"}]},{"code":"35761-6","display":"Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefditoren suscep (MIC)"}]},{"code":"35762-4","display":"Cefditoren [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefditoren suscep (qual)"}]},{"code":"35765-7","display":"Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefetamet suscep (MIC)"}]},{"code":"35770-7","display":"Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotaxime Clav suscep (MIC)"}]},{"code":"35771-5","display":"Cefotaxime+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotaxime Clav suscep (qual)"}]},{"code":"35773-1","display":"Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotiam suscep (MIC)"}]},{"code":"35775-6","display":"Ceftazidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftazidime Clav suscep (MIC)"}]},{"code":"35776-4","display":"Ceftazidime+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftazidime Clav suscep (qual)"}]},{"code":"35778-0","display":"Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftibuten suscep (MIC)"}]},{"code":"35779-8","display":"Ceftibuten [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftibuten suscep (qual)"}]},{"code":"35781-4","display":"Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftiofur suscep (MIC)"}]},{"code":"35783-0","display":"Cefuroxime Oral [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefuroxime oral suscep (qual)"}]},{"code":"35786-3","display":"Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clinafloxacin suscep (MIC)"}]},{"code":"35788-9","display":"Daptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Daptomycin suscep (MIC)"}]},{"code":"35789-7","display":"Daptomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Daptomycin suscep (qual)"}]},{"code":"3579-0","display":"Doxepin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Doxepin - mass/volume"}]},{"code":"35791-3","display":"Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Difloxacin suscep (MIC)"}]},{"code":"35792-1","display":"Difloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Difloxacin suscep (qual)"}]},{"code":"35794-7","display":"Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dirithromycin suscep (MIC)"}]},{"code":"35795-4","display":"Dirithromycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dirithromycin suscep (qual)"}]},{"code":"35798-8","display":"Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enrofloxacin suscep (MIC)"}]},{"code":"35801-0","display":"Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ertapenem suscep (MIC)"}]},{"code":"35802-8","display":"Ertapenem [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ertapenem suscep (qual)"}]},{"code":"35804-4","display":"Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bambermycins suscep (MIC)"}]},{"code":"35805-1","display":"Bambermycins [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bambermycins suscep (qual)"}]},{"code":"35808-5","display":"Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Florfenicol suscep (MIC)"}]},{"code":"35812-7","display":"Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Garenoxacin suscep (MIC)"}]},{"code":"35813-5","display":"Garenoxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Garenoxacin suscep (qual)"}]},{"code":"35815-0","display":"Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gemifloxacin suscep (MIC)"}]},{"code":"35816-8","display":"Gemifloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gemifloxacin suscep (qual)"}]},{"code":"35821-8","display":"Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isepamicin suscep (MIC)"}]},{"code":"35823-4","display":"Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mupirocin suscep (MIC)"}]},{"code":"35826-7","display":"Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Orbifloxacin suscep (MIC)"}]},{"code":"35827-5","display":"Orbifloxacin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Orbifloxacin suscep (qual)"}]},{"code":"35830-9","display":"Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pirlimycin suscep (MIC)"}]},{"code":"35831-7","display":"Pirlimycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pirlimycin suscep (qual)"}]},{"code":"35834-1","display":"Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pristinamycin suscep (MIC)"}]},{"code":"35837-4","display":"Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Salinomycin suscep (MIC)"}]},{"code":"35838-2","display":"Salinomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Salinomycin suscep (qual)"}]},{"code":"35844-0","display":"Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Telithromycin suscep (MIC)"}]},{"code":"35845-7","display":"Telithromycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Telithromycin suscep (qual)"}]},{"code":"35847-3","display":"Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tiamulin suscep (MIC)"}]},{"code":"35848-1","display":"Tiamulin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tiamulin suscep (qual)"}]},{"code":"35850-7","display":"Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tilmicosin suscep (MIC)"}]},{"code":"35851-5","display":"Tilmicosin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tilmicosin suscep (qual)"}]},{"code":"35853-1","display":"Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trospectinomycin suscep (MIC)"}]},{"code":"35854-9","display":"Trospectinomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trospectinomycin suscep (qual)"}]},{"code":"35857-2","display":"Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tylosin suscep (MIC)"}]},{"code":"35858-0","display":"Tylosin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tylosin suscep (qual)"}]},{"code":"35860-6","display":"Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Virginiamycin suscep (MIC)"}]},{"code":"35861-4","display":"Virginiamycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Virginiamycin suscep (qual)"}]},{"code":"35863-0","display":"Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Voriconazole suscep (MIC)"}]},{"code":"359-0","display":"Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Netilmicin suscep (MIC)"}]},{"code":"363-2","display":"Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nitrofurantoin suscep (MIC)"}]},{"code":"36-4","display":"Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Azithromycin suscep (MIC)"}]},{"code":"3644-2","display":"Fluoxetine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fluoxetine"}]},{"code":"3663-2","display":"Gentamicin [Mass/volume] in Serum or Plasma --peak","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gentamicin peak"}]},{"code":"3665-7","display":"Gentamicin [Mass/volume] in Serum or Plasma --trough","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gentamicin trough"}]},{"code":"367-3","display":"Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Norfloxacin suscep (MIC)"}]},{"code":"36903-3","display":"Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lymphogranuloma venerum DNA (NAAT)"}]},{"code":"3690-5","display":"Imipramine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Imipramine - mass/volume"}]},{"code":"36916-5","display":"Kappa light chains.free [Mass/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Immunoglobulin Light Chains kappa (free)"}]},{"code":"36921-5","display":"Herpes simplex virus 1+?2 IgG Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV Ab (Type 1 and 2)"}]},{"code":"371-5","display":"Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Novobiocin suscep (MIC)"}]},{"code":"375-6","display":"Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ofloxacin suscep (MIC)"}]},{"code":"3772-1","display":"Methadone [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methadone - mass/volume"}]},{"code":"3773-9","display":"Methadone [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methadone  urine"}]},{"code":"379-8","display":"Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oleandomycin suscep (MIC)"}]},{"code":"38180-6","display":"Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis C Viral Load (logIU/mL)"}]},{"code":"3827-3","display":"Morphine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Morphine"}]},{"code":"383-0","display":"Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxacillin suscep (MIC)"}]},{"code":"3830-7","display":"Morphine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Morphine urine"}]},{"code":"38370-3","display":"Voriconazole [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Voriconazole"}]},{"code":"38379-4","display":"Mycobacterium tuberculosis complex DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mycobacterium  complexDNA (NAAT) "}]},{"code":"38387-7","display":"C3 nephritic factor [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C3 nephritic factor"}]},{"code":"38445-3","display":"Calprotectin [Mass/?mass] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calprotectin faeces"}]},{"code":"38504-7","display":"Thyroglobulin Ab [Titer] in Serum by Immunoflourescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thyroglob Ab Titr Ser IF"}]},{"code":"3862-0","display":"Nordoxepin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nordoxepin - mass/volume"}]},{"code":"387-1","display":"Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxytetracycline suscep (MIC)"}]},{"code":"3872-9","display":"Nortriptyline [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nortriptyline - mass/volume"}]},{"code":"3879-4","display":"Opiates [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Opiates  urine"}]},{"code":"38917-1","display":"Human metapneumovirus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Metapneumovirus (NAAT)"}]},{"code":"3893-5","display":"Oxycodone [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oxycodone"}]},{"code":"390-5","display":"Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pefloxacin suscep (MIC)"}]},{"code":"392-1","display":"Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Penicillin G suscep (MIC)"}]},{"code":"3924-8","display":"Pentobarbital [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pentobarbitone"}]},{"code":"39354-6","display":"Cholinesterase in Serum or Plasma --dibucaine/Cholinesterase","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholinesterase phenotype"}]},{"code":"3936-2","display":"Phencyclidine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phencyclidine  urine"}]},{"code":"39469-2","display":"Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholesterol (LDL) (calculated)"}]},{"code":"39528-5","display":"Adenovirus DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adenovirus DNA (NAAT)"}]},{"code":"39536-8","display":"Influenza virus A Ab [Units/?volume] in Serum by Complement fixation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza A Ab"}]},{"code":"396-2","display":"Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Penicillin V suscep (MIC)"}]},{"code":"39771-1","display":"Porphyrins [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphyrins urine"}]},{"code":"39774-5","display":"Porphyrins [Moles/?mass] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphyrins faeces"}]},{"code":"39782-8","display":"Delta aminolevulinate/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ALA/creatinine  urine"}]},{"code":"39784-4","display":"Porphyrins [Moles/?volume] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphyrin RBC"}]},{"code":"39798-4","display":"Warfarin [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Warfarin"}]},{"code":"400-2","display":"Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Phenethicillin suscep (MIC)"}]},{"code":"4020-4","display":"Quinine [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Quinine - presence"}]},{"code":"4023-8","display":"Salicylates [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Salicylate -presence"}]},{"code":"4025-3","display":"Salicylates [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Salicylate urine"}]},{"code":"40417-8","display":"Chromium [Moles/?time] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chromium urine 24hr"}]},{"code":"404-4","display":"Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pipemidate suscep (MIC)"}]},{"code":"40440-0","display":"XXX microorganism serotype [Identifier] in Isolate by Agglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Micro-organism (serotyping)"}]},{"code":"40498-8","display":"Yersinia enterocolitica Ab [Titer] in Serum by Agglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Yersinia Ab"}]},{"code":"4057-6","display":"Tobramycin [Mass/volume] in Serum or Plasma --peak","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tobramycin peak"}]},{"code":"4059-2","display":"Tobramycin [Mass/volume] in Serum or Plasma --trough","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tobramycin trough"}]},{"code":"40-6","display":"Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Azlocillin suscep (MIC)"}]},{"code":"40614-0","display":"Brucella sp Ab [Presence] in Serum by Agglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Brucella sp Ab (qual)"}]},{"code":"40658-7","display":"Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parvovirus Ab IgM"}]},{"code":"40674-4","display":"Toxocara canis IgG Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Toxocara Ab IgG"}]},{"code":"40727-0","display":"Hepatitis D virus Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis D Ab"}]},{"code":"40745-2","display":"Filaria identified in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Filaria blood"}]},{"code":"40768-4","display":"Cryptococcus sp Ag [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cryptococcus Ag (titre)"}]},{"code":"408-5","display":"Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Piperacillin suscep (MIC)"}]},{"code":"4092-3","display":"Vancomycin [Mass/volume] in Serum or Plasma --trough","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vancomycin trough"}]},{"code":"40958-1","display":"Cryptosporidium parvum identified in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cryptosporidium identification faeces"}]},{"code":"40982-1","display":"Influenza virus B RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza B RNA (NAAT)"}]},{"code":"40988-8","display":"Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RSV (NAAT)"}]},{"code":"41001-9","display":"Human coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Coronavirus RNA (NAAT)"}]},{"code":"41010-0","display":"Parainfluenza virus 4 RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parainfluenza virus 4 RNA (NAAT)"}]},{"code":"41163-7","display":"Treponema pallidum DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. pallidum (NAAT) "}]},{"code":"41171-0","display":"Collagen crosslinked C-telopeptide [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C- Telopeptide"}]},{"code":"412-7","display":"Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Piperacillin Tazob suscep MIC"}]},{"code":"41479-7","display":"BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"BK virus (NAAT)"}]},{"code":"41499-5","display":"Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Legionella sero-group 1 Ag (urine) (EIA)"}]},{"code":"41647-9","display":"Carbon dioxide, total [Moles/?volume] in Arterial blood by calculation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CO2 blood ( total) In Arterial blood"}]},{"code":"41662-8","display":"Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aztreonam Clav suscep (MIC)"}]},{"code":"41665-1","display":"Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Biapenem suscep (MIC)"}]},{"code":"41672-7","display":"Cefotetan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotetan Clav suscep (MIC)"}]},{"code":"41675-0","display":"Cefoxitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefoxitin Clav suscep (MIC)"}]},{"code":"41679-2","display":"Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefpodoxime Clav suscep (MIC)"}]},{"code":"416-8","display":"Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pivampicillin suscep (MIC)"}]},{"code":"41681-8","display":"Ceftriaxone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftriaxone Clav suscep (MIC)"}]},{"code":"41687-5","display":"Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clavulanate suscep (MIC)"}]},{"code":"41689-1","display":"Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dalbavancin suscep (MIC)"}]},{"code":"41694-1","display":"Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Everninomicin suscep (MIC)"}]},{"code":"41708-9","display":"Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oritavancin suscep (MIC)"}]},{"code":"41710-5","display":"Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ramoplanin suscep (MIC)"}]},{"code":"41713-9","display":"Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rosamicin suscep (MIC)"}]},{"code":"41718-8","display":"Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulbactam suscep (MIC)"}]},{"code":"41721-2","display":"Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tazobactam suscep (MIC)"}]},{"code":"41725-3","display":"Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thiamphenicol suscep (MIC)"}]},{"code":"41727-9","display":"Aztreonam+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aztreonam Clav suscep (qual)"}]},{"code":"41728-7","display":"Biapenem [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Biapenem suscep (qual)"}]},{"code":"41729-5","display":"Cefotetan+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefotetan Clav suscep (qual)"}]},{"code":"41730-3","display":"Cefoxitin+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefoxitin Clav suscep (qual)"}]},{"code":"41731-1","display":"Cefpodoxime+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefpodoxime Clav suscep (qual)"}]},{"code":"41732-9","display":"Ceftriaxone+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftriaxone Clav suscep (qual)"}]},{"code":"41733-7","display":"Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clavulanate suscep (qual)"}]},{"code":"41734-5","display":"Dalbavancin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dalbavancin suscep (qual)"}]},{"code":"41735-2","display":"Everninomicin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Everninomicin suscep (qual)"}]},{"code":"41736-0","display":"Oritavancin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Oritavancin suscep (qual)"}]},{"code":"41737-8","display":"Ramoplanin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ramoplanin suscep (qual)"}]},{"code":"41738-6","display":"Rosamicin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rosamicin suscep (qual)"}]},{"code":"41739-4","display":"Sulbactam [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulbactam suscep (qual)"}]},{"code":"41740-2","display":"Tazobactam [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tazobactam suscep (qual)"}]},{"code":"41853-3","display":"Orthopoxvirus DNA [Presence] in Specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Orthopoxvirus DNA NAA+probe Ql (Specimen)"}]},{"code":"41858-2","display":"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EDDP urine"}]},{"code":"41984-6","display":"Lipoprotein analysis status/?results Set CPHS","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lipid Interpretation"}]},{"code":"41993-7","display":"Atazanavir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Atazanavir suscep (qual)"}]},{"code":"420-0","display":"Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Polymyxin B suscep (MIC)"}]},{"code":"42180-0","display":"C peptide [Moles/?volume] in Serum or Plasma --fasting","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C-Peptide "}]},{"code":"42200-6","display":"DNA double strand Ab [Units/?volume] in Serum by Radioimmunoassay (RIA)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"DS DNA Ab (RIA)"}]},{"code":"42217-0","display":"Striated muscle IgG Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Skeletal muscle Ab"}]},{"code":"42219-6","display":"Chromium [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chromium urine"}]},{"code":"42221-2","display":"Manganese [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Manganese urine -  moles/volume"}]},{"code":"42247-7","display":"Hemoglobin pattern [interpretation] in Blood by HPLC Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HPLC Chromatogram"}]},{"code":"42330-1","display":"Bordetella pertussis IgG Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bordetella IgG Ab"}]},{"code":"42351-7","display":"Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefepime Clav suscep (MIC)"}]},{"code":"42353-3","display":"Cefepime+Clavulanate [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefepime Clavu suscep (qual)"}]},{"code":"42355-8","display":"Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tigecycline suscep (MIC)"}]},{"code":"42357-4","display":"Tigecycline [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tigecycline suscep (qual)"}]},{"code":"424-2","display":"Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyrazinamide suscep (MIC)"}]},{"code":"42535-5","display":"Tipranavir [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tipranavir suscep (qual)"}]},{"code":"42595-9","display":"Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B Viral Load (IU/mL)"}]},{"code":"42807-8","display":"Parasite identified in Isolate","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parasite (ident)"}]},{"code":"428-3","display":"Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rifampin suscep (MIC)"}]},{"code":"43092-6","display":"Arbovirus NOS Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Arbovirus Ab (titre)"}]},{"code":"43180-9","display":"Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV Ab (Type 2)"}]},{"code":"43198-1","display":"Gamma hydroxybutyrate [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gamma hydroxybutyrate urine - mass/volume"}]},{"code":"432-5","display":"Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ristocetin suscep (MIC)"}]},{"code":"43271-6","display":"Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftobiprole suscep (MIC)"}]},{"code":"43272-4","display":"Ceftobiprole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ceftobiprole suscep (qual)"}]},{"code":"43279-9","display":"Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B virus mutation"}]},{"code":"43583-4","display":"Lipoprotein a [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lipoprotein (a) - moles/volume"}]},{"code":"43590-9","display":"Rabies virus Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rabies Ab"}]},{"code":"436-6","display":"Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rolitetracycline suscep (MIC)"}]},{"code":"43913-3","display":"Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bordetella DNA (NAAT)"}]},{"code":"43979-4","display":"Aspergillus sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aspergillus culture"}]},{"code":"440-8","display":"Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rosoxacin suscep (MIC)"}]},{"code":"44357-2","display":"Galactomannan Ag [Units/?volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Galactomannan Ag"}]},{"code":"444-0","display":"Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Roxithromycin suscep (MIC)"}]},{"code":"44448-9","display":"Beta 2 glycoprotein 1 IgG Ab [Units/?volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Beta-2-Glycoprotein 1 antibodies"}]},{"code":"44534-6","display":"HLA Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HLA Antibodies (qual)"}]},{"code":"4476-8","display":"Complement C1 esterase inhibitor.functional [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C1 Inhibitor function"}]},{"code":"4477-6","display":"Complement C1 esterase inhibitor [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C1 inhibitor"}]},{"code":"44798-7","display":"Burkholderia sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Burkholderia (culture)"}]},{"code":"44-8","display":"Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aztreonam suscep (MIC)"}]},{"code":"448-1","display":"Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sisomicin suscep (MIC)"}]},{"code":"4484-2","display":"Complement C2 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C2"}]},{"code":"4485-9","display":"Complement C3 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C3"}]},{"code":"44918-1","display":"Dopamine/Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dopamine/creat urine 24h"}]},{"code":"44924-9","display":"Normetanephrine/?Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Normetanephrine/creat urine 24h"}]},{"code":"4498-2","display":"Complement C4 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C4"}]},{"code":"4505-4","display":"Complement C5 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C5"}]},{"code":"4507-0","display":"Complement C6 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C6"}]},{"code":"4508-8","display":"Complement C7 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C7"}]},{"code":"4509-6","display":"Complement C8 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C8"}]},{"code":"4510-4","display":"Complement C9 [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C9"}]},{"code":"4519-5","display":"Complement factor H [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Factor H, I, CD46 Complement [Complement Factor H]"}]},{"code":"452-3","display":"Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Spectinomycin suscep (MIC)"}]},{"code":"45323-3","display":"Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tuberculin test (interferon)"}]},{"code":"45335-7","display":"Bacteria Identification [Presence] in Isolate by Culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Micro-organism (ident)"}]},{"code":"4542-7","display":"Haptoglobin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haptoglobin"}]},{"code":"4548-4","display":"Hemoglobin A1c/Hemoglobin.total in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HbA1c"}]},{"code":"4551-8","display":"Hemoglobin A2/Hemoglobin.total in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HbA2"}]},{"code":"456-4","display":"Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Spiramycin suscep (MIC)"}]},{"code":"4576-5","display":"Hemoglobin F/Hemoglobin.total in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HbF"}]},{"code":"460-6","display":"Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Streptomycin suscep (MIC)"}]},{"code":"46094-9","display":"Plasmodium sp Ag [Presence] in Blood by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Malaria Ag (EIA)"}]},{"code":"46126-9","display":"Endomysium IgA Ab [Presence] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Endomysial   Ab IgA"}]},{"code":"46127-7","display":"Haptoglobin [Mass/volume] in Serum or Plasma by Nephelometry","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haptoglobin by Nephelometry"}]},{"code":"46128-5","display":"Tissue transglutaminase IgA Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"TTG  Ab IgA"}]},{"code":"46130-1","display":"Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pre albumin"}]},{"code":"46218-4","display":"5-Fluorocytosine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Flucytosine"}]},{"code":"46266-3","display":"Myeloperoxidase Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Myeloperoxidase Ab"}]},{"code":"46267-1","display":"Proteinase 3 Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Proteinase 3 Ab"}]},{"code":"46268-9","display":"ABO +? Rh group [Type] in Blood from Blood product unit--after transfusion reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ABO +? Rh Group (Blood Product Post Tx Rxn)"}]},{"code":"46270-5","display":"ABO group [Type] in Blood--after transfusion reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ABO Group (Post Tx Rxn)"}]},{"code":"46271-3","display":"Blood group antibody screen [Presence] in Serum or Plasma --after transfusion reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blood Group Ab (screen Post Tx Rxn)"}]},{"code":"46272-1","display":"Appearance of Urine--after transfusion reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Appearance Urine (Post Tx Rxn)"}]},{"code":"46273-9","display":"Appearance of Serum--after transfusion reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Appearance Serum (Post Tx Rxn)"}]},{"code":"46274-7","display":"Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells --after transfusion reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"AHG (direct, polyspecific Post Tx Rxn)"}]},{"code":"46276-2","display":"Rh [Type] in Blood--after transfusion reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rh Group (Post Tx Rxn)"}]},{"code":"4633-4","display":"Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HbF (Kleihauer)"}]},{"code":"4639-1","display":"Unstable Hemoglobin [Presence] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hb (unstable)"}]},{"code":"4644-1","display":"Hemosiderin [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haemosiderin"}]},{"code":"464-8","display":"Sulfadiazine [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulfadiazine suscep (MIC)"}]},{"code":"4679-7","display":"Reticulocytes/100 erythrocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reticulocytes (%)"}]},{"code":"4685-4","display":"Sulfhemoglobin/Hemoglobin.total in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulphaemoglobin"}]},{"code":"468-9","display":"Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulfamethoxazole suscep (MIC)"}]},{"code":"4691-2","display":"Viscosity of Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Viscosity"}]},{"code":"47092-2","display":"Natriuretic peptide B [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"BNP"}]},{"code":"472-1","display":"Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulfisoxazole suscep (MIC)"}]},{"code":"47255-5","display":"Procollagen type I.N-terminal propeptide [Mass/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Procollagen"}]},{"code":"47299-3","display":"DNA double strand Ab [Units/?volume] in Serum by Farr method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"DS DNA Ab (Farr)"}]},{"code":"47309-0","display":"Haemophilus influenzae B IgG Ab [Ratio] in Serum --2nd specimen/?1st specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"H Influenza Type2 vaccine response"}]},{"code":"47393-4","display":"Gliadin peptide IgA Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"DGP/MGP  Ab IgA"}]},{"code":"47394-2","display":"Gliadin peptide IgG Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gliadin peptide"}]},{"code":"47532-7","display":"Mumps virus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mumps RNA (NAAT)"}]},{"code":"47545-9","display":"5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"5HIAA/creat urine 24h"}]},{"code":"47596-2","display":"Calcium.ionized [Moles/?volume] in Blood by Ion-selective membrane electrode (ISE)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcium ( ionised) blood"}]},{"code":"476-2","display":"Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulfonamide suscep (MIC)"}]},{"code":"47828-9","display":"Adiponectin [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adiponectin"}]},{"code":"47994-9","display":"Bilirubin.total [Moles/?volume] in Cord blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bilirubin cord"}]},{"code":"480-4","display":"Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Talampicillin suscep (MIC)"}]},{"code":"48062-4","display":"Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cryptosporidium & Giardia Ag faeces (IF)"}]},{"code":"48063-2","display":"Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cryptosporidium & Giardia Ag"}]},{"code":"48111-9","display":"Glutathione.reduced [Moles/?mass] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reduced glutathione"}]},{"code":"48326-3","display":"Glipizide [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glipizide"}]},{"code":"48327-1","display":"Glyburide [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glibenclamide"}]},{"code":"48329-7","display":"Chlorpropamide [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chlorpropamide"}]},{"code":"48344-6","display":"Activated clotting time.kaolin induced of Platelet poor plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"KCT"}]},{"code":"48357-8","display":"Testosterone [Moles/?volume] in Saliva (oral fluid)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Testosterone saliva"}]},{"code":"48359-4","display":"Echinococcus granulosus Ab [Titer] in Serum by Hemagglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hydatid Ab (titre)"}]},{"code":"48377-6","display":"Mullerian inhibiting substance [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mullerian Hormone Ab"}]},{"code":"48378-4","display":"Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Immunoglobulin Light Chains (free)"}]},{"code":"48391-7","display":"Carbon dioxide, total [Moles/?volume] in Venous blood by calculation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CO2 blood ( total) in Venous blood"}]},{"code":"48398-2","display":"Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B Viral Load (log IU/mL)"}]},{"code":"48419-6","display":"Immune complex.IgG [Mass/?volume] in Serum or Plasma by C1q binding assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C1q Binding Assay"}]},{"code":"48425-3","display":"Troponin T.cardiac [Mass/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Troponin T (rapid)"}]},{"code":"48432-9","display":"Fructose [Molar amount] in unspecified time Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fructose seminal fluid (unspecified time)"}]},{"code":"484-6","display":"Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Teicoplanin suscep (MIC)"}]},{"code":"48508-6","display":"Measles virus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Measles RNA (NAAT)"}]},{"code":"48509-4","display":"Influenza virus A and B RNA [Identifier] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza A+B RNA (NAAT)"}]},{"code":"48618-3","display":"Cholesterol in VLDL [Mass/?volume] in Serum or Plasma ultracentrifugate","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cholesterol in VLDL"}]},{"code":"48721-5","display":"Bartonella henselae IgG Ab [Units/?volume] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bartonella Ab"}]},{"code":"48807-2","display":"Bone marrow aspiration report","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bone marrow aspirate"}]},{"code":"488-7","display":"Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Temafloxacin suscep (MIC)"}]},{"code":"48-9","display":"Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bacampicillin suscep (MIC)"}]},{"code":"49117-5","display":"Norovirus Ag [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Norovirus Ag faeces"}]},{"code":"49233-0","display":"Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Rapid, less than 30 minutes","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cryptosporidium & Giardia Ag Rapid"}]},{"code":"49243-9","display":"Alkaline phosphatase isoenzymes [interpretation] in Serum or Plasma Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alk Phosphatase isoenzymes"}]},{"code":"49244-7","display":"Alpha 1 antitrypsin phenotype [Interpretation] in Serum or Plasma Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alpha 1 antitrypsin phenotyping"}]},{"code":"49248-8","display":"Amino acid pattern [interpretation] in Urine Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amino Acids urine (pattern)"}]},{"code":"49252-0","display":"Calculus analysis [interpretation] in Stone Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calculus analysis stone"}]},{"code":"49268-6","display":"Glycosaminoglycans pattern [interpretation] in Urine Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glycosamino Glycan urine (pattern)"}]},{"code":"49279-3","display":"Lactate dehydrogenase isoenzymes [interpretation] in Serum or Plasma Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"LDH isoenzymes (electrophoresis) "}]},{"code":"492-9","display":"Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Temocillin suscep (MIC)"}]},{"code":"49290-0","display":"Porphyrins [interpretation] in Stool Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphyrin full analysis faeces"}]},{"code":"49291-8","display":"Porphyrins [interpretation] in Urine Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphyrin full analysis (HPLC) urine"}]},{"code":"49308-0","display":"Neutrophil cytoplasmic Ab pattern [interpretation] in Serum by Immunofluorescence Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Neutrophil cytoplasmic Ab (interpretation)"}]},{"code":"49316-3","display":"Hemoglobin pattern [interpretation] in Blood by Electrophoresis","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haemoglobin pattern"}]},{"code":"49323-9","display":"Hemoglobin pattern [interpretation] in Blood by Electrophesis citrate agar","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hb electrophoresis - acid gel"}]},{"code":"496-0","display":"Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tetracycline suscep (MIC)"}]},{"code":"49671-1","display":"Neisseria meningitidis DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"N. meningitidis DNA (NAAT)"}]},{"code":"49755-2","display":"Crystals [Presence] in Urine sediment by Light microscopy ","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Crystals urine - presence"}]},{"code":"49836-0","display":"Platelet function (closure time) [interpretation] in Blood Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PFA interpretation"}]},{"code":"49863-4","display":"Aspergillus sp DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aspergillus DNA (NAAT)"}]},{"code":"4996-5","display":"Cytomegalovirus DNA [Presence] in Blood by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV DNA (NAAT) (Blood)"}]},{"code":"5000-5","display":"Cytomegalovirus DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV DNA (NAAT) "}]},{"code":"500-9","display":"Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ticarcillin suscep (MIC)"}]},{"code":"5014-6","display":"Herpes simplex virus DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV DNA (NAAT)"}]},{"code":"50377-1","display":"von Willebrand factor (vWf).collagen binding activity actual/?normal in Platelet poor plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VWF:CBA"}]},{"code":"50378-9","display":"von Willebrand factor (vWf).collagen binding activity/von Willebrand factor Ag [Ratio] in Platelet poor plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VWF:CBA - ratio"}]},{"code":"504-1","display":"Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ticarcillin Clav suscep (MIC)"}]},{"code":"50410-0","display":"dRVVT/dRVVT W excess phospholipid (screen to confirm ratio)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dilute Russell viper venom time - screen to confirm ratio"}]},{"code":"5043-5","display":"Adrenal Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adrenal Ab (titre) by Immunofluorescence"}]},{"code":"5052-6","display":"Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aspergillus Ab (precipitins)"}]},{"code":"50544-6","display":"Everolimus [Mass/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Everolimus blood"}]},{"code":"50548-7","display":"Respiratory virus DNA+RNA [Identifier] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Resp virus DNA+RNA XXX NAA+probe"}]},{"code":"50592-5","display":"Ecgonine methyl ester [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ecgonine"}]},{"code":"5064-1","display":"Borrelia burgdorferi IgM Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lyme Disease Ab"}]},{"code":"50761-6","display":"A IgG Ab [Titer] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anti-A IgG (titre)"}]},{"code":"50762-4","display":"A IgM Ab [Titer] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anti-A (IgM) Titre"}]},{"code":"50763-2","display":"B IgM Ab [Titer] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anti-B (IgM) Titre"}]},{"code":"50764-0","display":"B IgG Ab [Titer] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anti-B IgG (Titre)"}]},{"code":"508-2","display":"Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tobramycin suscep (MIC)"}]},{"code":"50903-4","display":"Selenium [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Selenium urine"}]},{"code":"50936-4","display":"Vanadium [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vanadium urine"}]},{"code":"50968-7","display":"HLA Ab [Type] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HLA Antibodies (ident)"}]},{"code":"51164-2","display":"CD34 blasts [Units/?volume] in Bone marrow","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CD34 Assay, bone marrow"}]},{"code":"512-4","display":"Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trimethoprim suscep (MIC)"}]},{"code":"5133-4","display":"Streptococcal DNAse B [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Strep DNAse B Ab"}]},{"code":"51480-2","display":"Bacteria [#/volume] in Urine by Automated count","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bacteria count urine (auto)"}]},{"code":"51597-3","display":"Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose (1h post 75g glucose)"}]},{"code":"516-5","display":"Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trimethoprim Sulfa suscep MIC"}]},{"code":"51694-8","display":"Carumonam [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carumonam suscep (qual)"}]},{"code":"51698-9","display":"Dapsone [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dapsone suscep (qual)"}]},{"code":"51710-2","display":"Leishmania sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Leishmania culture"}]},{"code":"51719-3","display":"Paromomycin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Paramomycin suscep (qual)"}]},{"code":"51724-3","display":"Cefuroxime [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefuroxime suscep (qual)"}]},{"code":"51774-8","display":"Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefuroxime suscep (MIC)"}]},{"code":"51775-5","display":"Chromatin Ab [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chromatin Ab"}]},{"code":"51776-3","display":"7-Aminoclonazepam [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"7-aminoclonazepam urine"}]},{"code":"51777-1","display":"7-Aminoflunitrazepam [Mass/?volume] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"7-aminoflunitrazepam urine by Confirmatory method"}]},{"code":"51781-3","display":"Carbon dioxide, total [Moles/?volume] in Capillary blood by calculation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CO2 blood ( total) - in Capillary blood"}]},{"code":"51844-9","display":"Cortisol [Moles/?volume] in Saliva (oral fluid)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cortisol  saliva"}]},{"code":"51916-5","display":"Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV Ab (Type 1)"}]},{"code":"5195-3","display":"Hepatitis B virus surface Ag [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis B surface Ag"}]},{"code":"5199-5","display":"Hepatitis C virus Ab [Presence] in Serum by Immunoblot","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis C Ab (IB)"}]},{"code":"520-7","display":"Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Troleandomycin suscep (MIC)"}]},{"code":"52-1","display":"Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Butirosin suscep (MIC)"}]},{"code":"52114-6","display":"Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"AHG (direct, IgG)"}]},{"code":"5226-6","display":"HTLV I+II Ab [Units/volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HTLV 1+2 Ab"}]},{"code":"5230-8","display":"Influenza virus B Ab [Titer] in Serum by Complement fixation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza B Ab"}]},{"code":"524-9","display":"Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vancomycin suscep (MIC)"}]},{"code":"5253-0","display":"Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"M. pneumoniae Ab (qual)"}]},{"code":"5265-4","display":"Pancreatic islet cell Ab [Presence] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Islet cell autoantibody"}]},{"code":"5271-2","display":"Parietal cell Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parietal cell Ab (titre) by Immunofluorescence"}]},{"code":"528-0","display":"Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Viomycin suscep (MIC)"}]},{"code":"52901-6","display":"Vanadium/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vanadium/creat urine"}]},{"code":"5290-2","display":"Reagin Ab [Presence] in Cerebral spinal fluid by VDRL","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VDRL CSF (qual)"}]},{"code":"52913-1","display":"Selenium [Moles/?volume] in Red Blood Cells","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Selenium RBC"}]},{"code":"52915-6","display":"Aluminum [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aluminium urine"}]},{"code":"52929-7","display":"Mercury/?Creatinine [Molar ratio] in 24 hour Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mercury/creat urine 24hr"}]},{"code":"5295-1","display":"Respiratory syncytial virus Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RSV Ab (IF)"}]},{"code":"52961-0","display":"Paraquat [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Paraquat  urine"}]},{"code":"52984-2","display":"Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV IgG avidity"}]},{"code":"53007-1","display":"PM-SCL extractable nuclear Ab [Presence] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PM-Scl Ab (IF)"}]},{"code":"53020-4","display":"Complement C1q Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C1q Ab"}]},{"code":"53115-2","display":"Immature granulocytes [#/?volume] in Blood by Automated count","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Immature Granulocytes"}]},{"code":"531-4","display":"Zidovudine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Zidovudine suscep (qual)"}]},{"code":"53523-7","display":"Vasoactive intestinal peptide [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vasoactive Intestinal Peptide"}]},{"code":"53556-7","display":"Erythrocytes.Plasmodium sp infected/?100 erythrocytes in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Malaria parasite load"}]},{"code":"53622-7","display":"von Willebrand factor (vWf) cleaving protease actual/?normal in Platelet poor plasma by Chromogenic method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ADAMSTS-13"}]},{"code":"5369-4","display":"Streptokinase Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Streptokinase Ab"}]},{"code":"5370-2","display":"Streptolysin O Ab [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Streptolysin O Ab"}]},{"code":"53731-6","display":"Posaconazole [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Posaconazole"}]},{"code":"53812-4","display":"Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Micafungin (MIC)"}]},{"code":"5381-9","display":"Thyroglobulin Ab [Titer] in Serum by Latex agglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thyroglob Ab Titr Ser LA"}]},{"code":"53819-9","display":"Thiopurine methyltransferase [Enzymatic activity/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thiopurine Methyl Transferase blood"}]},{"code":"5386-8","display":"Toxocara canis Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Toxocara Ab"}]},{"code":"53903-1","display":"Collection method - Specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Spec collection/description"}]},{"code":"5393-4","display":"Treponema pallidum Ab [Presence] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Syphilis Confirmation "}]},{"code":"53946-0","display":"Escherichia coli shiga-like toxin identified in Unspecified specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enterohaemorrhagic E. coli (EHEC) toxin antigen (verotoxin, shiga toxin) - specimen"}]},{"code":"54067-4","display":"Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cl. difficile DNA (NAAT)"}]},{"code":"54091-4","display":"Rubella virus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rubella (NAAT)"}]},{"code":"54187-0","display":"Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Posaconazole suscep (MIC)"}]},{"code":"54188-8","display":"Posaconazole [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Posaconazole suscep (qual)"}]},{"code":"54218-3","display":"CD3+?CD4+? (T4 helper) cells/?CD3+?CD8+? (T8 suppressor cells) cells [# Ratio] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"lymphocyte markers - Cells.CD3+CD4+/Cells.CD3+CD8+"}]},{"code":"54285-2","display":"Glycerol [Moles/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glycerol urine"}]},{"code":"54309-0","display":"Lactate/?Pyruvate [Molar ratio] in Cerebral spinal fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lactate/Pyruvate CSF"}]},{"code":"543-9","display":"Mycobacterium sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mycobacterium (culture)"}]},{"code":"54905-5","display":"Norovirus Genogroup I RNA [Presence] in Stool by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Norovirus GI RNA (NAAT)"}]},{"code":"54906-3","display":"Norovirus Genogroup II RNA [Presence] in Stool by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Norovirus GII RNA (NAAT)"}]},{"code":"54914-7","display":"Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis C Ag"}]},{"code":"54941-0","display":"Tungsten [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tungsten urine"}]},{"code":"55100-2","display":"Respiratory syncytial virus [Presence] in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RSV culture"}]},{"code":"55343-8","display":"Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anidulafungin suscep (MIC)"}]},{"code":"55580-5","display":"Sulfapyridine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulphapyridine"}]},{"code":"55581-3","display":"Sulfasalazine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sulphasalazine"}]},{"code":"5568-1","display":"Acetone [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Acetone"}]},{"code":"5570-7","display":"Acetone [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Acetone urine"}]},{"code":"55805-6","display":"Cyclosporine [Mass/?volume] in Blood by LC/?MS/?MS","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cyclosporin blood - by LC/MS/MS"}]},{"code":"5581-4","display":"Antimony [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antimony urine"}]},{"code":"5590-5","display":"Barium [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Barium urine"}]},{"code":"5598-8","display":"Bismuth [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bismuth urine"}]},{"code":"560-3","display":"Chlamydia sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chlamydia (culture)"}]},{"code":"56126-6","display":"Copper [Mass/?mass] in Liver","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Copper liver"}]},{"code":"56145-6","display":"CD55+?CD59 deficient RBC+?Granulocytes [interpretation] in Blood Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PNH by flow cytometry"}]},{"code":"56-2","display":"Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Capreomycin suscep (MIC)"}]},{"code":"562-9","display":"Clostridioides difficile [Presence] in Stool by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cl.difficile culture"}]},{"code":"5646-5","display":"Ethylene glycol [Mass/volume] in Serum, Plasma or Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethylene glycol - mass/volume"}]},{"code":"5647-3","display":"Ethylene glycol [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethylene glycol urine"}]},{"code":"56536-6","display":"Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thyroglob Ab Ser EIA-aCnc"}]},{"code":"56537-4","display":"Tissue transglutaminase IgG Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"TTG  Ab IgG"}]},{"code":"56539-0","display":"Intrinsic factor Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Intrinsic factor Ab"}]},{"code":"56540-8","display":"Glutamate decarboxylase 65 Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"GAD Ab"}]},{"code":"56717-2","display":"Histone Ab [Presence] in Serum by Immunoblot","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Histone Ab"}]},{"code":"56718-0","display":"Islet cell 512 Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"IA2 Ab"}]},{"code":"56721-4","display":"PM-SCL extractable nuclear Ab [Presence] in Serum by Immunoblot","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PM-Scl Ab (IB)"}]},{"code":"56722-2","display":"Soluble liver Ab [Presence] in Serum by Immunoblot","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Soluble liver antibody"}]},{"code":"567-8","display":"Diphtheria identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C. diphtheriae (culture)"}]},{"code":"5681-2","display":"Manganese [Mass/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Manganese blood - mass/volume"}]},{"code":"5684-6","display":"Manganese [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Manganese urine - mass/volume"}]},{"code":"56888-1","display":"HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HIV 1+2 Ab plus HIV1 Ag (qual)"}]},{"code":"56940-0","display":"Inhibin B [Mass/?volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Inhibin B"}]},{"code":"56972-3","display":"Prolactin [Mass/?volume] in Serum or Plasma --post precipitation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Macroprolaction"}]},{"code":"56991-3","display":"Toxoplasma gondii IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. gondii IgG avidity"}]},{"code":"5699-4","display":"Molybdenum [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Molybdenum urine"}]},{"code":"57028-3","display":"Iron [Mass/?mass] in Liver","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Iron liver"}]},{"code":"57095-2","display":"Anidulafungin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anidulafungin suscep (qual)"}]},{"code":"5711-7","display":"Pentachlorophenol [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pentachlorophenol urine"}]},{"code":"5722-4","display":"Selenium [Mass/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Selenium blood"}]},{"code":"5734-9","display":"Silver [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Silver"}]},{"code":"5735-6","display":"Silver [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Silver urine"}]},{"code":"57378-2","display":"Porphyrins/?Creatinine [Molar ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Porphyrins/creat urine"}]},{"code":"57416-0","display":"Thyrotropin receptor Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"TSH receptorAb"}]},{"code":"5745-5","display":"Thallium [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thallium urine"}]},{"code":"57502-7","display":"11-Deoxycortisol [Moles/?volume] in Serum or Plasma --1 day post dose metyrapone","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"11-Deoxycortisol (1d p metyrapone)"}]},{"code":"5770-3","display":"Bilirubin.total [Presence] in Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bilirubin urine (dipstick)"}]},{"code":"57734-6","display":"Ketones [Presence] in Urine by Automated test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ketones urine (qual)"}]},{"code":"57744-5","display":"Striated muscle Ab [Presence] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Striated muscle Antibody"}]},{"code":"57745-2","display":"Adrenal Ab [Presence] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adrenal Ab(qual)"}]},{"code":"57746-0","display":"Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gamma hydroxybutyrate urine"}]},{"code":"57761-9","display":"Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HITS - by Immunoassay"}]},{"code":"5782-8","display":"Crystals [type] in Urine sediment by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Crystals urine - type"}]},{"code":"57838-5","display":"dRVVT W excess phospholipid (LA confirm)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"dRVVT excess phospholipid (PPP) [Time]"}]},{"code":"57844-3","display":"Imatinib mesylate [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Imatinib"}]},{"code":"57901-1","display":"Clostridioides difficile glutamate dehydrogenase [Presence] in Stool","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cl. difficile Ag"}]},{"code":"5794-3","display":"Hemoglobin [Presence] in Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haemoglobin urine (dipstick)"}]},{"code":"5799-2","display":"Leukocyte esterase [Presence] in Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Leuc esterase urine (dipstick)"}]},{"code":"580-1","display":"Fungus identified in Unspecified specimen by Culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Fungi (culture)"}]},{"code":"5802-4","display":"Nitrite [Presence] in Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Nitrite urine (dipstick)"}]},{"code":"5803-2","display":"pH of Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"pH urine (dipstick)"}]},{"code":"5811-5","display":"Specific gravity of Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SG urine (dipstick)"}]},{"code":"5818-0","display":"Urobilinogen [Presence] in Urine by Test strip","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Urobilinogen urine (dipstick)"}]},{"code":"58416-9","display":"MLH1 gene methylation [Presence] in Blood or Tissue by Molecular genetics method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MLH12 promoter methylation testing"}]},{"code":"58436-7","display":"Casts [Type] in Urine sediment by Light microscopy ","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Casts urine sediment (type)"}]},{"code":"5843-8","display":"Enterovirus identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enterovirus culture"}]},{"code":"5846-1","display":"Herpes simplex virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV1 Ag (IF)"}]},{"code":"5849-5","display":"Herpes simplex virus 2 Ag [Presence] in Unspecified specimen by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV2 Ag (IF)"}]},{"code":"5854-5","display":"Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV Ag (EIA)"}]},{"code":"5855-2","display":"Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV Ag (IF)"}]},{"code":"58570-3","display":"Corticotropin [Moles/?volume] in Plasma --1 day post dose metyrapone","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ACTH (1d p metyrapone)"}]},{"code":"5859-4","display":"Herpes simplex virus identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HSV (culture)"}]},{"code":"586-8","display":"Streptococcus agalactiae [Presence] in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Group B Streptococcus (cult)"}]},{"code":"587-6","display":"Helicobacter pylori [Presence] in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"H.pylori culture"}]},{"code":"5877-6","display":"Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"RSV Ag"}]},{"code":"58897-0","display":"Methyl ethyl ketone/?Creatinine [Mass Ratio] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methylethylketone urine"}]},{"code":"58900-2","display":"HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HIV 1+2 Ab plus HIV1 Ag"}]},{"code":"5894-1","display":"Prothrombin time (PT) actual/Normal","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PR"}]},{"code":"590-0","display":"Legionella sp identified in Sputum by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Legionella (culture)"}]},{"code":"5901-4","display":"Prothrombin time (PT) in control Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Prothrombin time (control)"}]},{"code":"5902-2","display":"Prothrombin time (PT)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Prothrombin time"}]},{"code":"59070-3","display":"Paraquat [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Paraquat"}]},{"code":"5909-7","display":"Blood smear finding [Identifier] in Blood by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blood film morphology"}]},{"code":"59176-8","display":"Zopiclone [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Zopiclone urine"}]},{"code":"59186-7","display":"Cyanide [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cyanide blood"}]},{"code":"59261-8","display":"Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HbA1c by IFCC protocol"}]},{"code":"59287-3","display":"Benzylpiperazine [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Benzylpiperazine (BZP) urine"}]},{"code":"59394-7","display":"Glomerular basement membrane Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"GBM Ab"}]},{"code":"594-2","display":"Leptospira sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Leptospira (culture)"}]},{"code":"59420-0","display":"Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HPV DNA (NAAT) - in Cervix"}]},{"code":"5942-8","display":"Reptilase time in control Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reptilase time (control)"}]},{"code":"5946-9","display":"aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"APTT (+ N plasma)"}]},{"code":"59472-1","display":"Calcium.ionized [Mass/?volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Calcium (ph 7.4), blood"}]},{"code":"5949-3","display":"aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"APTT (+ N plasma, control)"}]},{"code":"5955-0","display":"Thrombin time in control Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thrombin time (control)"}]},{"code":"5956-8","display":"Prothrombin time (PT) factor substitution in control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PT (+ N plasma, control)"}]},{"code":"5959-2","display":"Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Prothrombin time (+ N plasma)"}]},{"code":"59965-4","display":"Quinine [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Quinine - moles volume"}]},{"code":"60017-1","display":"Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"LDH fluid by Pyruvate to lactate reaction"}]},{"code":"60023-9","display":"Lactate dehydrogenase [Enzymatic activity/?volume] in Cerebral spinal fluid by Pyruvate to lactate reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"LDH CSF by Pyruvate to lactate reaction"}]},{"code":"60024-7","display":"Lactate dehydrogenase [Enzymatic activity/?volume] in Cerebral spinal fluid by Lactate to pyruvate reaction","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"LDH CSF by Lactate to pyruvate reaction"}]},{"code":"60088-2","display":"Hyoscyamine [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hyoscyamine urine"}]},{"code":"6014-5","display":"von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VWF:Rco - by Platelet aggregation"}]},{"code":"60-4","display":"Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Carbenicillin suscep (MIC)"}]},{"code":"60422-3","display":"Measles virus genotype [Identifier] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Measles genotype"}]},{"code":"60463-7","display":"Insulin Ab [Moles/?volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Insulin Ab"}]},{"code":"60517-0","display":"Iron/?Transferrin [Ratio] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Transferrin saturation - ratio"}]},{"code":"61030-3","display":"7-Aminoclonazepam [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"7-aminoclonazepam  urine"}]},{"code":"61033-7","display":"7-Aminoflunitrazepam [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"7-aminoflunitrazepam urine"}]},{"code":"61036-0","display":"Alpha hydroxyalprazolam [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alpha hydroxy alprazolam urine"}]},{"code":"61152-5","display":"Albumin [Mass/?volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Albumin by BCP"}]},{"code":"61365-3","display":"Parainfluenza virus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parainfluenza virus RNA (NAAT)"}]},{"code":"61406-5","display":"XXX blood group Ab [Titer] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blood Group Ab (titre)"}]},{"code":"614-8","display":"Mycobacterium sp identified in Isolate by Mycobacterial subtyping","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mycobacterium (ident)"}]},{"code":"62238-1","display":"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (CKD-EPI)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"eGFR"}]},{"code":"623-9","display":"Bacteria identified in Sputum by Cystic fibrosis respiratory culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sputum (cystic fibrosis, cult)"}]},{"code":"62467-6","display":"Galactomannan Ag [Units/?volume] in Unspecified specimen by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Galactomannan Ag unspecified specimen"}]},{"code":"6298-4","display":"Potassium [Moles/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Potassium blood"}]},{"code":"6301-6","display":"INR in Platelet poor plasma by Coagulation assay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"INR"}]},{"code":"6303-2","display":"dRVVT (LA screen)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dilute Russell viper venom time"}]},{"code":"6306-5","display":"Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Adenovirus faecal Ag"}]},{"code":"6317-2","display":"Bordetella sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bordetella (culture)"}]},{"code":"6325-5","display":"Brucella abortus Ab [Titer] in Serum by Complement fixation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Br. abortus Ab "}]},{"code":"63437-8","display":"Brucella abortus Ab [Titer] in Serum by Antihuman globulin","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Br. abortus Ab (AHG)"}]},{"code":"635-3","display":"Bacteria identified in Unspecified specimen by Anaerobe culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anaerobes (culture)"}]},{"code":"6354-5","display":"Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C. trachomatis Ag (EIA)"}]},{"code":"6355-2","display":"Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C. trachomatis Ag (IF)"}]},{"code":"637-9","display":"Plasmodium sp identified in Blood by Thick film","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Malaria thick blood film"}]},{"code":"64013-6","display":"Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Enterohaemorrhagic E. coli (EHEC) toxin antigen (verotoxin, shiga toxin) - stool"}]},{"code":"64233-0","display":"Benzylpiperazine [Presence] in Urine by Confirmatory method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Benzylpiperazine (BZP) urine by Confirmatory method"}]},{"code":"6450-1","display":"Legionella sp Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Legionella sp Ab (IF)"}]},{"code":"64-6","display":"Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefadroxil suscep (MIC)"}]},{"code":"6463-4","display":"Bacteria identified in Unspecified specimen by Culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bacteria  (culture)"}]},{"code":"6476-6","display":"Mumps virus IgG Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mumps IgG"}]},{"code":"6478-2","display":"Mumps virus IgM Ab [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mumps IgM"}]},{"code":"6486-5","display":"Mycoplasma sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mycoplasma (culture)"}]},{"code":"65340-2","display":"Micafungin [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Micafungin (qual)"}]},{"code":"6562-3","display":"Treponema pallidum IgM Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Syphilis Ab IgM"}]},{"code":"6579-7","display":"Vibrio sp identified in Stool by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vibrio culture"}]},{"code":"6584-7","display":"Virus identified in Unspecified specimen by Culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Viruses (culture)"}]},{"code":"6598-7","display":"Troponin T.cardiac [Mass/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Troponin T"}]},{"code":"660-1","display":"Microscopic observation [Identifier] in Unspecified specimen by Dark field examination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microscopy (dark field exam)"}]},{"code":"6604-3","display":"Influenza virus identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza culture"}]},{"code":"6609-2","display":"Listeria sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Listeria (culture)"}]},{"code":"6630-8","display":"Schistosoma sp Ab [Presence] in Serum by Hemagglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Schistosomal Ab (qual)"}]},{"code":"664-3","display":"Microscopic observation [Identifier] in Unspecified specimen by Gram stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microscopy (Gram stain)"}]},{"code":"6644-9","display":"Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefepime suscep (MIC)"}]},{"code":"6652-2","display":"Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Meropenem suscep (MIC)"}]},{"code":"666-8","display":"Microscopic observation [Identifier] in Unspecified specimen by India ink prep","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microscopy (Indian ink prep)"}]},{"code":"66736-0","display":"Normalized silica clotting time of Platelet poor plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Silica clotting time"}]},{"code":"667-6","display":"Microscopic observation [Identifier] in Unspecified specimen by KOH preparation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microscopy (KOH prep)"}]},{"code":"6683-7","display":"Reptilase time","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reptilase time"}]},{"code":"66878-0","display":"Skin Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Skin Ab"}]},{"code":"6689-4","display":"Glucose [Mass/volume] in Blood -- 2 hours post meal","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Glucose (2h post meal) blood"}]},{"code":"6-7","display":"Amantadine [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amantadine suscep (qual)"}]},{"code":"6709-0","display":"Hippurate [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hippurate urine - mass/volume"}]},{"code":"675-9","display":"Enterobius vermicularis [Presence] in Unspecified specimen by Pinworm exam","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pinworm examination"}]},{"code":"6768-6","display":"Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Alkaline phosphatase"}]},{"code":"678-3","display":"Microscopic observation [Identifier] in Unspecified specimen by Trichrome stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microscopy (Trichrome stain)"}]},{"code":"680-9","display":"Microscopic observation [Identifier] in Unspecified specimen by Wet preparation","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Microscopy (wet prep)"}]},{"code":"6825-4","display":"Crystals [type] in Body fluid by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Crystals body fluid"}]},{"code":"6827-0","display":"Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bacitracin suscep (MIC)"}]},{"code":"68324-3","display":"von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"VWF:Rco - by Immunoassay"}]},{"code":"6864-3","display":"Hemoglobin S [Presence] in Blood by Solubility test","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HbS (solubility)"}]},{"code":"68-7","display":"Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefamandole suscep (MIC)"}]},{"code":"6873-4","display":"Beta hydroxybutyrate [Moles/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Beta hydroxybutyrate"}]},{"code":"6875-9","display":"Cancer Ag 15-3 [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CA 15-3"}]},{"code":"68916-6","display":"dRVVT W excess phospholipid actual/normal (normalized LA confirm)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dilute Russell viper venom time - phospholipid actual/normal"}]},{"code":"68936-4","display":"Baker's yeast Ab [Units/?volume] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Anti Saccharomyces Cerevisiae Antibodies"}]},{"code":"68969-5","display":"Relative activated clotting time (ACT) of Platelet poor plasma by Kaolin induced method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"KCTI"}]},{"code":"6913-8","display":"Chlamydophila pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C. pneumoniae Ab (titre)"}]},{"code":"6916-1","display":"Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"C. psittaci Ab"}]},{"code":"6932-8","display":"Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Penicillin suscep (MIC)"}]},{"code":"6933-6","display":"Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Streptomycin high suscep (MIC)"}]},{"code":"6948-4","display":"Lamotrigine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lamotrigine - mass/volume"}]},{"code":"6954-2","display":"Bartonella henselae IgG Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bartonella Ab (titre)"}]},{"code":"698-1","display":"Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"N. gonorrhoeae (culture)"}]},{"code":"6984-9","display":"Beta lactamase.extended spectrum [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"B-lactamase ESBL (qual)"}]},{"code":"6985-6","display":"Beta lactamase.usual [Susceptibility]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"B-lactamase usual (qual)"}]},{"code":"69935-5","display":"Mycoplasma genitalium DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mycoplasma DNA (NAAT)"}]},{"code":"69937-1","display":"Trichomonas vaginalis DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Trichomonas (NAAT)"}]},{"code":"69938-9","display":"Astrovirus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Astrovirus RNA (NAAT)"}]},{"code":"69949-6","display":"Epstein Barr virus capsid IgG Ab avidity [Presence] in Serum by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV VCA IgG avidity"}]},{"code":"69951-2","display":"Amylase.pancreatic/Creatinine(Ratio) in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amylase (pancreatic)/creat ur"}]},{"code":"70061-7","display":"Human papilloma virus 16 and 18 DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HPV DNA (NAAT) - Specimen"}]},{"code":"70147-4","display":"Methadone [Mass/?volume] in Urine by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methadone  urine - mass/volume by Screen method"}]},{"code":"7018-5","display":"Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gentamicin high suscep (MIC)"}]},{"code":"70205-0","display":"Clonazepam [Moles/?volume] in Serum or Plasma by Screen method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clonazepam - by Screen method"}]},{"code":"7024-3","display":"Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Kanamycin high suscep (MIC)"}]},{"code":"70569-9","display":"Plasmodium sp Ag [Identifier] in Blood by Rapid immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Malaria antigen"}]},{"code":"7106-8","display":"Aspergillus sp IgE Ab [Units/?volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aspergillus IgE"}]},{"code":"716-1","display":"Heinz bodies [Presence] in Blood by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Heinz bodies"}]},{"code":"71792-6","display":"Procollagen type III.N-terminal propeptide [Mass/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"P3NP"}]},{"code":"71793-4","display":"Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. pallidum Ab (PA)"}]},{"code":"718-7","display":"Hemoglobin [Mass/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haemoglobin"}]},{"code":"72111-8","display":"Sapovirus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sapovirus RNA (NAAT)"}]},{"code":"72160-5","display":"Holo-transcobalamin II [Moles/?volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Active B12"}]},{"code":"72493-0","display":"Cytomegalovirus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV Viral load (serum/plasma)"}]},{"code":"725-2","display":"Hemoglobin [Presence] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haemoglobin urine"}]},{"code":"72624-0","display":"Rivaroxaban [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rivaroxaban Assay"}]},{"code":"72625-7","display":"Dabigatran [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Dabigatran assay"}]},{"code":"72-9","display":"Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefatrizine suscep (MIC)"}]},{"code":"73654-6","display":"Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis C genotyping (NS3)"}]},{"code":"73655-3","display":"Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis C genotyping (NS5)"}]},{"code":"73723-9","display":"Riboflavin [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vitamin B2 blood"}]},{"code":"74096-9","display":"Tacrolimus [Mass/?volume] in Blood by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tacrolimus blood - by Immunoassay"}]},{"code":"74097-7","display":"Tacrolimus [Mass/?volume] in Blood by LC/?MS/?MS","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Tacrolimus blood - by LC/MS/MS"}]},{"code":"74442-5","display":"Pyridoxal phosphate [Moles/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Vitamin B6 blood"}]},{"code":"75050-5","display":"Coenzyme Q10 [Moles/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Coenzyme Q10"}]},{"code":"75515-7","display":"Lupus anticoagulant aPTT and dRVVT screening panel W Reflex","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lupus anticoagulant two screening tests W Reflex panel Coag (PPP)"}]},{"code":"76-0","display":"Cefazolin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefazolin suscep (MIC)"}]},{"code":"76346-6","display":"Microorganism identified in Isolate by MS.MALDI-TOF","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Micro-organism (ident MS.MALDI-TOF)"}]},{"code":"7799-0","display":"Fibrin D-dimer [Units/volume] in Platelet poor plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"D-dimer"}]},{"code":"7808-9","display":"Aspergillus sp Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Aspergillus precipitins"}]},{"code":"7852-7","display":"Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV IgG"}]},{"code":"7853-5","display":"Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CMV IgM"}]},{"code":"7883-2","display":"Epstein Barr virus nuclear IgG Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"EBV NA IgG "}]},{"code":"7905-3","display":"Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hep B (HBsAg) Surface Ag (Neut)"}]},{"code":"7906-1","display":"Hepatitis D virus RNA [Presence] in Serum by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Hepatitis D DNA (NAAT)"}]},{"code":"7918-6","display":"HIV 1+2 Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HIV1+2 Ab (screen)"}]},{"code":"7948-3","display":"Legionella pneumophila 1 Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Legionella sero-group 1 Ab (IF)"}]},{"code":"7959-0","display":"Leptospira sp Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Leptospira Ab (screen) (titre)"}]},{"code":"7968-1","display":"Mumps virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Mumps RNA (NAAT) CSF"}]},{"code":"7993-9","display":"Rhinovirus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rhinoviurs (NAAT)"}]},{"code":"7994-7","display":"Rickettsia sp Ab [Units/?volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rickettsia Ab"}]},{"code":"8012-7","display":"Rotavirus dsRNA [Presence] in Stool by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rotavirus RNA (NAAT)"}]},{"code":"8013-5","display":"Rubella virus Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rubella Ab"}]},{"code":"8014-3","display":"Rubella virus IgG Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rubella IgG"}]},{"code":"8015-0","display":"Rubella virus IgM Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rubella IgM"}]},{"code":"80-2","display":"Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefixime suscep (MIC)"}]},{"code":"8039-0","display":"Toxoplasma gondii IgG Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. gondii IgG"}]},{"code":"8040-8","display":"Toxoplasma gondii IgM Ab [Units/volume] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T. gondii IgM"}]},{"code":"80515-0","display":"Kappa light chains.free [Mass/volume] in Serum by Nephelometry","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Immunoglobulin Light Chains kappa (free Nephelometry)"}]},{"code":"80516-8","display":"Lambda light chains.free [Mass/volume] in Serum by Nephelometry","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Immunoglobulin Light Chains (free Nephelometry)"}]},{"code":"80517-6","display":"Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum by Nephelometry","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Immunoglobulin Light Chains lambda (free Nephelometry)"}]},{"code":"8061-4","display":"Nuclear Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Antinuclear Ab (qual)"}]},{"code":"8076-2","display":"Jo-1 extractable nuclear Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Jo-1 extractable nuclear Ab"}]},{"code":"8091-1","display":"Ribonucleoprotein extractable nuclear Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ribonucleoprotein extractable nuclear Ab "}]},{"code":"8092-9","display":"SCL-70 extractable nuclear Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SCL-70 extractable nuclear Ab"}]},{"code":"8093-7","display":"Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sjogrens syndrome-A extractable nuclear Ab"}]},{"code":"8094-5","display":"Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sjogrens syndrome-B extractable nuclear Ab "}]},{"code":"8095-2","display":"Smooth muscle Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Smooth muscle Ab (titre)"}]},{"code":"8098-6","display":"Thyroglobulin Ab [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thyroglobulin Antibody - units/volume"}]},{"code":"8099-4","display":"Thyroperoxidase Ab [Units/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Thyroperoxidase Ab"}]},{"code":"8116-6","display":"CD19 cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"lymphocyte markers - CD19 cells"}]},{"code":"81169-5","display":"Residual tumor [Interpretation] Cancer Narrative --postoperative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Margin - polypectomy"}]},{"code":"8122-4","display":"CD3 cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Immunodeficiency Lymphocyte Markers (Subsets)"}]},{"code":"81317-0","display":"Additional pathological findings [Identifier] in Specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Other pathological finding"}]},{"code":"8150-5","display":"Amphetamines [Mass/?volume] in Urine","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amphetamines-type substances urine - mass/volume"}]},{"code":"8161-2","display":"Bismuth [Mass/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bismuth blood"}]},{"code":"81691-8","display":"DNA mismatch repair protein Mlh1 [Presence] in Cancer specimen by Immune stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MMR prot Mlh1 Ca spec Ql ImStn"}]},{"code":"81692-6","display":"DNA mismatch repair protein Msh2 [Presence] in Cancer specimen by Immune stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MMR prot Msh2 Ca spec Ql ImStn"}]},{"code":"81693-4","display":"DNA mismatch repair protein Msh6 [Presence] in Cancer specimen by Immune stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MMR prot Msh6 Ca spec Ql ImStn"}]},{"code":"81694-2","display":"Mismatch repair endonuclease PMS2 [Presence] in Cancer specimen by Immune stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MMR endo PMS2 Ca spec Ql ImStn"}]},{"code":"8275-0","display":"Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefpirome suscep (MIC)"}]},{"code":"8-3","display":"Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amdinocillin suscep (MIC)"}]},{"code":"83121-4","display":"Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Free T4 IA [Moles/Vol]"}]},{"code":"83126-3","display":"Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Free T3 IA [Moles/Vol]"}]},{"code":"84-4","display":"Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefaclor suscep (MIC)"}]},{"code":"84882-0","display":"Histologic type in Colorectal cancer specimen by WHO classification","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Main diagnosis"}]},{"code":"84883-8","display":"Deepest extent of tumor invasion [Type] in Colorectal cancer specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Depth of invasion"}]},{"code":"85291-3","display":"Surgical margin tumor involvement.deep [Presence] in Colorectal cancer specimen by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Deep margin status"}]},{"code":"85299-6","display":"BRAF V600E mutant protein [Presence] in Cancer specimen by Immune stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"BRAF V600E mutation status"}]},{"code":"882-1","display":"ABO and Rh group [Type] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"ABO and Rh group"}]},{"code":"88-5","display":"Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefmetazole suscep (MIC)"}]},{"code":"888-8","display":"Blood group antibodies identified in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blood Group Ab (ident)  "}]},{"code":"890-4","display":"Blood group antibody screen [Presence] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blood Group Ab (screen)"}]},{"code":"897-9","display":"Blood group antibody screen [Presence] in Serum or Plasma by Elution","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blood Group Ab Elution"}]},{"code":"89873-4","display":"Unique identifier [Identifier] of Initial sample","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Specimen identifier"}]},{"code":"92-7","display":"Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefodizime suscep (MIC)"}]},{"code":"92837-4","display":"Perineural invasion [Presence] in Cancer specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Perineural invasion"}]},{"code":"933-2","display":"Blood product type","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Blood Product Type"}]},{"code":"9335-1","display":"Appearance of Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Appearance body fluid"}]},{"code":"94306-8","display":"SARS-CoV-2 (COVID-19) RNA panel - Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Unsp spec)"}]},{"code":"94307-6","display":"SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N1","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 Ql (Unsp spec)"}]},{"code":"94308-4","display":"SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N2","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N2 Ql (Unsp spec)"}]},{"code":"94309-2","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Unsp spec)"}]},{"code":"94310-0","display":"SARS-like Coronavirus N gene [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-like CoV N gene NAA+probe Ql (Unsp spec)"}]},{"code":"94311-8","display":"SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N1","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N1 (Unsp spec) [ThreshNum]"}]},{"code":"94312-6","display":"SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N2","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+probe CDC primer-probe set N2 (Unsp spec) [ThreshNum]"}]},{"code":"94313-4","display":"SARS-like Coronavirus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-like CoV N gene NAA+probe (Unsp spec) [ThreshNum]"}]},{"code":"94314-2","display":"SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Unsp spec)"}]},{"code":"94315-9","display":"SARS-related coronavirus E gene [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-related coronavirus E gene NAA+probe Ql (Unsp spec)"}]},{"code":"94316-7","display":"SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Unsp spec)"}]},{"code":"94499-1","display":"Respiratory viral pathogens DNA and RNA panel - Respiratory specimen Qualitative by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Respiratory viral pathogens DNA and RNA panel NAA+probe Ql (Resp)"}]},{"code":"94500-6","display":"SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 RNA NAA+probe Ql (Resp)"}]},{"code":"94501-4","display":"Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"MERS-CoV RNA NAA+probe Ql (Resp)"}]},{"code":"94502-2","display":"SARS coronavirus+SARS-like coronavirus+SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-related CoV RNA NAA+probe Ql (Resp)"}]},{"code":"94503-0","display":"SARS coronavirus 2 IgG and IgM panel - Serum or Plasma Qualitative by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgG and IgM panel IA.rapid Ql"}]},{"code":"94504-8","display":"SARS coronavirus 2 IgG and IgM panel - Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgG and IgM panel IA"}]},{"code":"94505-5","display":"SARS coronavirus 2 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgG IA Qn"}]},{"code":"94506-3","display":"SARS coronavirus 2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgM IA Qn"}]},{"code":"94507-1","display":"SARS coronavirus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgG IA.rapid Ql"}]},{"code":"94508-9","display":"SARS coronavirus 2 IgM Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgM IA.rapid Ql"}]},{"code":"94509-7","display":"SARS coronavirus 2 E gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 E gene NAA+probe (Unsp spec) [ThreshNum]"}]},{"code":"94510-5","display":"SARS coronavirus 2 N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 N gene NAA+probe (Unsp spec) [ThreshNum]"}]},{"code":"94511-3","display":"SARS coronavirus 2 ORF1ab region [Cycle Threshold #] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 ORF1ab region NAA+probe (Unsp spec) [ThreshNum]"}]},{"code":"94531-1","display":"SARS Coronavirus 2 RNA panel - Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 RNA panel NAA+probe (Resp)"}]},{"code":"94532-9","display":"SARS coronavirus+SARS-like coronavirus+SARS coronavirus 2+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-related CoV+MERS coronavirus RNA NAA+probe Ql (Resp)"}]},{"code":"94533-7","display":"SARS coronavirus 2 N gene [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 N gene NAA+probe Ql (Resp)"}]},{"code":"94534-5","display":"SARS coronavirus 2 RdRp gene [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 RdRp gene NAA+probe Ql (Resp)"}]},{"code":"94547-7","display":"SARS coronavirus 2 IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgG+IgM IA Ql"}]},{"code":"94558-4","display":"SARS coronavirus 2 Ag [Presence] in Respiratory specimen by Rapid immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 Ag IA.rapid Ql (Resp)"}]},{"code":"94559-2","display":"SARS coronavirus 2 ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 ORF1ab region NAA+probe Ql (Resp)"}]},{"code":"94562-6","display":"SARS coronavirus 2 IgA Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgA IA Ql"}]},{"code":"94563-4","display":"SARS coronavirus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgG IA Ql"}]},{"code":"94564-2","display":"SARS coronavirus 2 IgM Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgM IA Ql"}]},{"code":"94565-9","display":"SARS coronavirus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 RNA NAA+non-probe Ql (Nph)"}]},{"code":"94639-2","display":"SARS coronavirus 2 ORF1ab region [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 ORF1ab region NAA+probe Ql (Unsp spec)"}]},{"code":"94640-0","display":"SARS coronavirus 2 S gene [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 S gene NAA+probe Ql (Resp)"}]},{"code":"94641-8","display":"SARS coronavirus 2 S gene [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 S gene NAA+probe Ql (Unsp spec)"}]},{"code":"94642-6","display":"SARS coronavirus 2 S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 S gene NAA+probe (Resp) [ThreshNum]"}]},{"code":"94643-4","display":"SARS coronavirus 2 S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 S gene NAA+probe (Unsp spec) [ThreshNum]"}]},{"code":"94644-2","display":"SARS coronavirus 2 ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 ORF1ab region NAA+probe (Resp) [ThreshNum]"}]},{"code":"94645-9","display":"SARS coronavirus 2 RdRp gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 RdRp gene NAA+probe (Unsp spec) [ThreshNum]"}]},{"code":"94646-7","display":"SARS coronavirus 2 RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 RdRp gene NAA+probe (Resp) [ThreshNum]"}]},{"code":"94647-5","display":"SARS-related coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-related CoV RNA NAA+probe Ql (Unsp spec)"}]},{"code":"94660-8","display":"SARS coronavirus 2 RNA [Presence] in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 RNA NAA+probe Ql"}]},{"code":"94661-6","display":"SARS coronavirus 2 Ab [Interpretation] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 Ab [Interp]"}]},{"code":"94720-0","display":"SARS coronavirus 2 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 IgA IA Qn"}]},{"code":"94745-7","display":"SARS coronavirus 2 RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) RNA NAA+probe (Resp) [ThreshNum]"}]},{"code":"94746-5","display":"SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RNA NAA+probe (Specimen) [ThreshNum]"}]},{"code":"94756-4","display":"SARS coronavirus 2 N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 N gene NAA+probe CDC primer-probe set N1 Ql (Resp)"}]},{"code":"94757-2","display":"SARS coronavirus 2 N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N2","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 N gene NAA+probe CDC primer-probe set N2 Ql (Resp)"}]},{"code":"94758-0","display":"SARS coronavirus 2 E gene [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 E gene NAA+probe Ql (Resp)"}]},{"code":"94759-8","display":"SARS coronavirus 2 RNA [Presence] in Nasopharynx by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Nph)"}]},{"code":"94760-6","display":"SARS-CoV-2 (COVID19) N gene [Presence] in Nasopharynx by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) N gene NAA+probe Ql (Nph)"}]},{"code":"94761-4","display":"SARS coronavirus 2 IgG Ab [Presence] in DBS by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) IgG IA Ql (DBS)"}]},{"code":"94762-2","display":"SARS coronavirus 2 Ab [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) Ab IA Ql"}]},{"code":"94763-0","display":"SARS coronavirus 2 [Presence] in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) Org specific cx Ql (Unsp spec)"}]},{"code":"94764-8","display":"SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) genome sequence Nom (Islt/Spec)"}]},{"code":"94765-5","display":"SARS coronavirus 2 E gene [Presence] in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 E gene NAA+probe Ql"}]},{"code":"94766-3","display":"SARS coronavirus 2 N gene [Presence] in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 N gene NAA+probe Ql"}]},{"code":"94767-1","display":"SARS coronavirus 2 S gene [Presence] in Serum or Plasma by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 S gene NAA+probe Ql"}]},{"code":"94768-9","display":"SARS coronavirus 2 IgA Ab [Presence] in Serum or Plasma by Rapid immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) IgA IA.rapid Ql"}]},{"code":"94769-7","display":"SARS coronavirus 2 Ab [Units/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) Ab IA Qn"}]},{"code":"94819-0","display":"SARS coronavirus 2 RNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) RNA NAA+probe (Unsp spec) [Log #/Vol]"}]},{"code":"94822-4","display":"SARS coronavirus 2 RNA [Presence] in Saliva (oral fluid) by Sequencing","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) RNA Sequencing Ql (Sal)"}]},{"code":"94845-5","display":"SARS coronavirus 2 RNA [Presence] in Saliva (oral fluid) by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Sal)"}]},{"code":"95125-1","display":"SARS-CoV-2 (COVID19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) IgA+IgM IA Ql"}]},{"code":"95209-3","display":"SARS-CoV+SARS-CoV-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV+SARS-CoV-2 (COVID19) Ag IA.rapid Ql (Resp)"}]},{"code":"95380-2","display":"Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel NAA+probe (Resp)"}]},{"code":"95383-6","display":"Symptom resolution status","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Symptomatic"}]},{"code":"95406-5","display":"SARS-CoV-2 (COVID19) RNA [Presence] in Nose by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) RNA NAA+probe Ql (Nose)"}]},{"code":"95409-9","display":"SARS-CoV-2 (COVID19) N gene [Presence] in Nose by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) N gene NAA+probe Ql (Nose)"}]},{"code":"95410-7","display":"SARS-CoV-2 (COVID19) neutralizing antibody [Titer] in Serum by pVNT","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) neut ab pVNT (S) [Titer]"}]},{"code":"95411-5","display":"SARS-CoV-2 (COVID19) neutralizing antibody [Presence] in Serum by pVNT","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID19) neut ab pVNT Ql (S)"}]},{"code":"95416-4","display":"SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) IgM IA Ql (DBS)"}]},{"code":"95422-2","display":"Long Common NameInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Resp)"}]},{"code":"95423-0","display":"Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza virus A and B and SARS-CoV-2 (COVID-19) identified NAA+probe Nom (Resp)"}]},{"code":"95424-8","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RNA Sequencing Ql (Resp)"}]},{"code":"95425-5","display":"Long Common NameSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+probe Ql (Sal)"}]},{"code":"95427-1","display":"SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) IgA IF [Titer]"}]},{"code":"95428-9","display":"SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) IgM IF [Titer]"}]},{"code":"95429-7","display":"SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) IgG IF [Titer]"}]},{"code":"95521-1","display":"Long Common NameSARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+probe (Resp) [#/Vol]"}]},{"code":"95522-9","display":"SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+probe (Resp) [Log #/Vol]"}]},{"code":"95542-7","display":"SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) IgG+IgM IA.rapid Ql (S/P/Bld)"}]},{"code":"9558-8","display":"CD20 cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"CD20 assay"}]},{"code":"9559-6","display":"CD5 cells [#/?volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"lymphocyte markers - CD5 cells"}]},{"code":"95608-6","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RNA NAA+non-probe Ql (Resp)"}]},{"code":"95609-4","display":"SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) S gene Sequencing Ql (Resp)"}]},{"code":"9571-1","display":"Parvovirus B19 DNA [Presence] in Unspecified specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Parvovirus DNA (NAAT)"}]},{"code":"95823-1","display":"SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-related coronavirus E gene NAA+probe Ql (Sal) "}]},{"code":"95824-9","display":"SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe Ql (Sal)"}]},{"code":"95825-6","display":"SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) Ab IA Ql (DBS)"}]},{"code":"95826-4","display":"SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Sal)"}]},{"code":"95941-1","display":"Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel NAA+probe (Resp)"}]},{"code":"95942-9","display":"Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel IA.rapid (Upper resp)"}]},{"code":"95970-0","display":"SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements Sequencing Ql (Bld)"}]},{"code":"95971-8","display":"SARS CoV-2 stimulated gamma interferon [Presence] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS CoV-2 stimulated gamma interferon Ql (Bld)"}]},{"code":"95972-6","display":"SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS CoV-2 stimulated gamma interferon release by T-cells corrected for background Qn (Bld)"}]},{"code":"95973-4","display":"SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS CoV-2 stimulated gamma interferon release by T-cells Qn (Bld)"}]},{"code":"95974-2","display":"SARS CoV-2 stimulated gamma interferon panel - Blood","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS CoV-2 stimulated gamma interferon panel (Bld)"}]},{"code":"96091-4","display":"SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RdRp gene, Saliva"}]},{"code":"96094-8","display":"SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel NAA+probe (Resp)"}]},{"code":"96115-1","display":"Long Common NameLevel of tumor invasion [Type] in Colorectal cancer specimen by Haggitt","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Haggitt level"}]},{"code":"96118-5","display":"SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) Ab Panel IA (DBS)"}]},{"code":"96119-3","display":"SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) Ag IA Ql (Upper resp)"}]},{"code":"96120-1","display":"SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Lower resp)"}]},{"code":"96121-9","display":"SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-related coronavirus E gene NAA+probe Ql (Lower resp)"}]},{"code":"96122-7","display":"SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-related coronavirus E gene NAA+probe Ql (Upper resp)"}]},{"code":"96123-5","display":"SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Upper resp)"}]},{"code":"9627-1","display":"Imipramine+?Desipramine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Imipramine + Desipramine"}]},{"code":"96603-6","display":"SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) S protein RBD neut ab sVNT Ql"}]},{"code":"96741-4","display":"SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) variant Sequencing Nom (Specimen)"}]},{"code":"96742-2","display":"SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) IgG IA [Mass/Vol]"}]},{"code":"96751-3","display":"SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) S gene mutation detected Molgen Nom (Specimen)"}]},{"code":"96752-1","display":"SARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) S gene mutation Molgen Ql (Specimen)"}]},{"code":"96755-4","display":"SARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) variant interpretation Nar (Specimen)"}]},{"code":"96763-8","display":"SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) E gene NAA+probe Ql (Resp)"}]},{"code":"96764-6","display":"SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) E gene NAA+probe (Resp) [ThreshNum]"}]},{"code":"96765-3","display":"SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) S gene NAA+probe Ql (Sal)"}]},{"code":"96797-6","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Oropharyngeal wash)"}]},{"code":"96-8","display":"Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC)","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cefonicid suscep (MIC)"}]},{"code":"96829-7","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Specimen donor)"}]},{"code":"96894-1","display":"SARS coronavirus 2 (COVID-19) whole genome sequencing and identification panel - Specimen by Molecular genetics method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS coronavirus 2 (COVID-19) whole genome sequencing and identification panel Molgen (Specimen)"}]},{"code":"96895-8","display":"SARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) lineage Molgen Nom (Specimen)"}]},{"code":"96896-6","display":"SARS coronavirus 2 (COVID-19) clade [Type] in Specimen by Molecular genetics method","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS coronavirus 2 (COVID-19) clade Molgen Nom (Specimen)"}]},{"code":"96897-4","display":"SARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Oropharyngeal wash)"}]},{"code":"96898-2","display":"SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+probe (Oropharyngeal wash) [ThreshNum] "}]},{"code":"96899-0","display":"SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe (Oropharyngeal wash) [ThreshNum]"}]},{"code":"96900-6","display":"SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) S gene NAA+probe (Oropharyngeal wash) [ThreshNum]"}]},{"code":"96957-6","display":"SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) M gene NAA+probe Ql (Upper resp)"}]},{"code":"96986-5","display":"SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) N gene NAA+non-probe Ql (Nose)"}]},{"code":"9699-0","display":"Paroxetine [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Paroxetine"}]},{"code":"97097-0","display":"SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) Ag IA.rapid Ql (Upper resp)"}]},{"code":"97098-8","display":"SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) Nsp2 gene NAA+probe Ql (Upper resp)"}]},{"code":"97104-4","display":"SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) ORF1ab region NAA+probe Qn (Upper resp)"}]},{"code":"9721-2","display":"Salivary gland Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Salivary gland Ab (titre)"}]},{"code":"9780-8","display":"Spermatozoa [#/volume] in Semen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Sperm count semen"}]},{"code":"9781-6","display":"Acanthamoeba sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Acanthamoeba (culture)"}]},{"code":"9786-5","display":"Microscopic observation [Identifier] in Blood or Marrow by Periodic acid-Schiff stain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"PAS Stain"}]},{"code":"9787-3","display":"Sarcoptes scabiei identified in Skin by Light microscopy","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Scabies skin scraping"}]},{"code":"9790-7","display":"Methyl bromide [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Methyl Bromide"}]},{"code":"98069-8","display":"SARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) Ab IA.rapid Ql (Sal)"}]},{"code":"9811-1","display":"Chromogranin A [Mass/?volume] in Serum or Plasma","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Chromogranin A"}]},{"code":"98131-6","display":"SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) ORF1b region NAA+probe Ql (Resp)"}]},{"code":"98132-4","display":"SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory specimen by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) ORF1a region NAA+probe Ql (Resp)"}]},{"code":"9816-0","display":"Actinomyces sp identified in Unspecified specimen by Organism specific culture","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Actinomyces (culture)"}]},{"code":"9826-9","display":"Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Syphilis Confirmation CSF"}]},{"code":"9838-4","display":"Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Liver/Kidney Ab -Titer"}]},{"code":"98493-0","display":"SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) ORF1b region NAA+probe Ql (Sal)"}]},{"code":"98494-8","display":"SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) ORF1a region NAA+probe Ql (Sal)"}]},{"code":"98732-1","display":"SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) S protein RBD neut ab IA [Titer]"}]},{"code":"98733-9","display":"Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Percent neutralization by SARS-CoV-2 (COVID-19) spike protein receptor binding domain (RBD) neut ab IA [%]"}]},{"code":"98734-7","display":"SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS-CoV-2 (COVID-19) S protein RBD neut ab IA Qn"}]},{"code":"98846-9","display":"SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells corrected for background IA Qn (Bld)"}]},{"code":"98847-7","display":"SARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"SARS coronavirus 2 stimulated gamma interferon release by lymphocytes corrected for background IA Qn (Bld)"}]},{"code":"11481-9","display":"Human papilloma virus identified in Specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"HPV Test Results"}]},{"code":"15212-4","display":"Lipase [Enzymatic activity/volume] in Body fluid","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Lipase (Body fld) [Catalytic activity/Vol]"}]},{"code":"20373-7","display":"Amikacin [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin SlowMyco"}]},{"code":"20376-0","display":"Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clofazimine SlowMyco"}]},{"code":"20377-8","display":"Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ciprofloxacin SlowMyco"}]},{"code":"20381-0","display":"Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethambutol SlowMyco"}]},{"code":"20382-8","display":"Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethionamide SlowMyco"}]},{"code":"20383-6","display":"Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid SlowMyco"}]},{"code":"20385-1","display":"rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"rifAMPin SlowMyco"}]},{"code":"20386-9","display":"Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rifabutin SlowMyco"}]},{"code":"20461-0","display":"Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyrazinamide SlowMyco"}]},{"code":"21976-6","display":"Cancer outcome status","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Cancer outcome status"}]},{"code":"21978-2","display":"Source of follow-up information Cancer","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Source of follow-up information"}]},{"code":"22633-2","display":"Pathology report site of origin Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Site of origin"}]},{"code":"22634-0","display":"Pathology report gross observation Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Gross observation"}]},{"code":"22637-3","display":"Pathology report final diagnosis Narrative","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Final diagnosis"}]},{"code":"23607-5","display":"Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Capreomycin SlowMyco"}]},{"code":"23608-3","display":"cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"cycloSERINE SlowMyco"}]},{"code":"23611-7","display":"Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Para aminosalicylate SlowMyco"}]},{"code":"25174-4","display":"Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 8.0 ug/mL SlowMyco"}]},{"code":"25175-1","display":"Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 16.0 ug/mL SlowMyco"}]},{"code":"25176-9","display":"Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 32.0 ug/mL SlowMyco"}]},{"code":"25177-7","display":"Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 12.0 ug/mL SlowMyco"}]},{"code":"25178-5","display":"Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 30.0 ug/mL SlowMyco"}]},{"code":"25179-3","display":"Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 6.0 ug/mL SlowMyco"}]},{"code":"25180-1","display":"Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ciprofloxacin 2.0 ug/mL SlowMyco"}]},{"code":"25181-9","display":"Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ciprofloxacin 4.0 ug/mL SlowMyco"}]},{"code":"25183-5","display":"Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethionamide 11.0 ug/mL SlowMyco"}]},{"code":"25184-3","display":"rifAMPin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"rifAMPin 14.0 ug/mL SlowMyco"}]},{"code":"25186-8","display":"Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyrazinamide 25.0 ug/mL SlowMyco"}]},{"code":"25187-6","display":"Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethambutol 7.5 ug/mL SlowMyco"}]},{"code":"25188-4","display":"Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ciprofloxacin 8.0 ug/mL SlowMyco"}]},{"code":"25189-2","display":"Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ciprofloxacin 5.0 ug/mL SlowMyco"}]},{"code":"25194-2","display":"Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethambutol 5.0 ug/mL SlowMyco"}]},{"code":"25195-9","display":"Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethambutol 10.0 ug/mL SlowMyco"}]},{"code":"25196-7","display":"Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethionamide 5.0 ug/mL SlowMyco"}]},{"code":"25198-3","display":"Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethionamide 15.0 ug/mL SlowMyco"}]},{"code":"25199-1","display":"Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rifabutin 1.0 ug/mL SlowMyco"}]},{"code":"25200-7","display":"Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rifabutin 2.0 ug/mL SlowMyco"}]},{"code":"25201-5","display":"Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rifabutin 4.0 ug/mL SlowMyco"}]},{"code":"25202-3","display":"rifAMPin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"rifAMPin 1.0 ug/mL SlowMyco"}]},{"code":"25203-1","display":"rifAMPin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"rifAMPin 2.0 ug/mL SlowMyco"}]},{"code":"25204-9","display":"rifAMPin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"rifAMPin 5.0 ug/mL SlowMyco"}]},{"code":"25207-2","display":"cycloSERINE 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"cycloSERINE 10.0 ug/mL SlowMyco"}]},{"code":"25208-0","display":"cycloSERINE 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"cycloSERINE 20.0 ug/mL SlowMyco"}]},{"code":"25209-8","display":"cycloSERINE 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"cycloSERINE 30.0 ug/mL SlowMyco"}]},{"code":"25210-6","display":"Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Capreomycin 10.0 ug/mL SlowMyco"}]},{"code":"25211-4","display":"Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Capreomycin 20.0 ug/mL SlowMyco"}]},{"code":"25212-2","display":"Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Capreomycin 30.0 ug/mL SlowMyco"}]},{"code":"25215-5","display":"Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Para aminosalicylate 2.0 ug/mL SlowMyco"}]},{"code":"25216-3","display":"Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Para aminosalicylate 8.0 ug/mL SlowMyco"}]},{"code":"25217-1","display":"Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid 0.1 ug/mL SlowMyco"}]},{"code":"25218-9","display":"Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid 0.2 ug/mL SlowMyco"}]},{"code":"25219-7","display":"Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid 1.0 ug/mL SlowMyco"}]},{"code":"25229-6","display":"Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyrazinamide 100.0 ug/mL SlowMyco"}]},{"code":"25230-4","display":"Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethambutol 2.5 ug/mL SlowMyco"}]},{"code":"25231-2","display":"Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethionamide 10.0 ug/mL SlowMyco"}]},{"code":"29315-9","display":"Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid 0.4 ug/mL SlowMyco"}]},{"code":"29757-2","display":"Colposcopy study","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Colposcopy study"}]},{"code":"41500-0","display":"Linezolid [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Linezolid SlowMyco"}]},{"code":"41502-6","display":"Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxifloxacin SlowMyco"}]},{"code":"42642-9","display":"Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 2.0 ug/mL SlowMyco"}]},{"code":"42651-0","display":"Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid 5.0 ug/mL SlowMyco"}]},{"code":"42655-1","display":"Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rifabutin 0.5 ug/mL SlowMyco"}]},{"code":"43986-9","display":"Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clofazimine 2.0 ug/mL SlowMyco"}]},{"code":"43988-5","display":"Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clofazimine 0.5 ug/mL SlowMyco"}]},{"code":"43989-3","display":"Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Clofazimine 1.0 ug/mL SlowMyco"}]},{"code":"45215-1","display":"Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid 2.0 ug/mL SlowMyco"}]},{"code":"48169-7","display":"Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 1.5 ug/mL SlowMyco"}]},{"code":"48170-5","display":"Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Capreomycin 3.0 ug/mL SlowMyco"}]},{"code":"48685-2","display":"Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Para aminosalicylate 10.0 ug/mL SlowMyco"}]},{"code":"55194-5","display":"Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ciprofloxacin 1.0 ug/mL SlowMyco"}]},{"code":"55674-6","display":"Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethambutol 2.0 ug/mL SlowMyco"}]},{"code":"55685-2","display":"Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Isoniazid 10.0 ug/mL SlowMyco"}]},{"code":"55711-6","display":"Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyrazinamide 200.0 ug/mL SlowMyco"}]},{"code":"55712-4","display":"rifAMPin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"rifAMPin 40.0 ug/mL SlowMyco"}]},{"code":"56025-0","display":"Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Ethambutol 8.0 ug/mL SlowMyco"}]},{"code":"56026-8","display":"Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Pyrazinamide 300.0 ug/mL SlowMyco"}]},{"code":"60564-2","display":"Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 1.0 ug/mL SlowMyco"}]},{"code":"60565-9","display":"Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Amikacin 4.0 ug/mL SlowMyco"}]},{"code":"61355-4","display":"Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Capreomycin 5.0 ug/mL SlowMyco"}]},{"code":"63565-6","display":"Prothionamide [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Prothionamide SlowMyco"}]},{"code":"76043-9","display":"Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxifloxacin 0.5 ug/mL SlowMyco"}]},{"code":"76044-7","display":"Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxifloxacin 1.0 ug/mL SlowMyco"}]},{"code":"76045-4","display":"Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxifloxacin 2.0 ug/mL SlowMyco"}]},{"code":"8100-0","display":"Specimen preparation [Type]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Specimen preparation"}]},{"code":"85690-6","display":"Rubella virus genotype in Specimen","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Rubella virus genotype (Specimen)"}]},{"code":"88704-2","display":"Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Bedaquiline SlowMyco"}]},{"code":"88706-7","display":"Linezolid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Linezolid 1.0 ug/mL SlowMyco"}]},{"code":"88707-5","display":"Moxifloxacin 0.25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxifloxacin 0.25 ug/mL SlowMyco"}]},{"code":"93497-6","display":"Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Moxifloxacin 3.0 ug/mL SlowMyco"}]},{"code":"48013-7","display":"Genomic reference sequence [ID]","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Genomic reference sequence ID"}]},{"code":"5394-2","display":"Treponema pallidum Ab [Titer] in Serum by Latex agglutination","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"T pallidum Ab Titr Ser LA"}]},{"code":"66746-9","display":"Specimen type","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Specimen type"}]},{"code":"615-5","display":"Viral strain","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Viral strain [Type] in Isolate by Viral subtyping"}]},{"code":"9398-9","display":"Reticulin Ab [Titer] in Serum","designation":[{"language":"en-NZ","use":{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code/designation-use","code":"ConsumerName"},"value":"Reticulin Ab (titre)"}]},{"code":"58453-2","display":"Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay"}]},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014"}]},"expansion":{"identifier":"e6bc8385-db2f-4fd6-b1d7-d400e4e7f6f0","timestamp":"2024-11-11T13:50:00+13:00","total":2303,"offset":0,"parameter":[{"name":"version","valueUri":"http://loinc.org|2.78"},{"name":"version","valueUri":"https://standards.digital.health.nz/ns/loinc-nz-local-code|20240401"},{"name":"version","valueUri":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code|20241014"},{"name":"count","valueInteger":2147483647},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://loinc.org","version":"2.78","code":"1003-3","display":"Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"100383-9","display":"Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"1004-1","display":"Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"1005-8","display":"Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"1007-4","display":"Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"100-8","display":"Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"1008-2","display":"Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"10331-7","display":"Rh [Type] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"10333-3","display":"Appearance of Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"10334-1","display":"Cancer Ag 125 [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"104-0","display":"Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"10501-5","display":"Lutropin [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"10574-2","display":"Fructose [Moles/?volume] in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10579-1","display":"Leukocytes [#/volume] in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10580-9","display":"Liquefaction [Time] in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10602-1","display":"Spermatozoa Abnormal Head/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10603-9","display":"Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10604-7","display":"Spermatozoa Abnormal Tail/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10605-4","display":"Spermatozoa Agglutinated/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10611-2","display":"Spermatozoa Immotile/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10613-8","display":"Spermatozoa Viable/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10620-3","display":"Spermatozoa Nonprogressive/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10622-9","display":"Spermatozoa Normal/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10624-5","display":"Spermatozoa Rapid/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10626-0","display":"Spermatozoa Slow/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"10635-1","display":"Acanthamoeba sp identified in Eye by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"10653-4","display":"Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"10697-1","display":"Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"10715-1","display":"Schistosoma sp identified in Urine sediment by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"10718-5","display":"Strongyloides sp Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"10720-1","display":"Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"10728-4","display":"Trichomonas sp identified in Genital specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"10739-1","display":"Virus identified in Unspecified specimen by Electron microscopy"},{"system":"http://loinc.org","version":"2.78","code":"10753-2","display":"Fat.microscopic observation [Identifier] in Stool by Sudan IV stain"},{"system":"http://loinc.org","version":"2.78","code":"108-1","display":"Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"10835-7","display":"Lipoprotein a [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"10839-9","display":"Troponin I.cardiac [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"10840-7","display":"Atropine [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"10860-5","display":"Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"10886-0","display":"Prostate Specific Ag Free [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"10998-3","display":"Oxycodone [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"11011-4","display":"Hepatitis C virus RNA [Units/?volume] (viral load) in Serum or Plasma by Probe and target amplification method"},{"system":"http://loinc.org","version":"2.78","code":"11018-9","display":"Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain"},{"system":"http://loinc.org","version":"2.78","code":"11060-1","display":"Reducing substances [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"11067-6","display":"Bleeding time"},{"system":"http://loinc.org","version":"2.78","code":"11084-1","display":"Reagin Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"11085-8","display":"Schistosoma sp identified in Stool by Concentration"},{"system":"http://loinc.org","version":"2.78","code":"11135-1","display":"Appearance of Spun Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"11227-6","display":"Pyruvate kinase [Presence] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"112-3","display":"Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"11257-3","display":"Haemophilus influenzae B IgG Ab [Mass/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"11266-4","display":"Streptococcus agalactiae Ag [Presence] in Unspecified specimen"},{"system":"http://loinc.org","version":"2.78","code":"11483-5","display":"Varicella zoster virus DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"11545-1","display":"Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain"},{"system":"http://loinc.org","version":"2.78","code":"11546-9","display":"Microscopic observation [Identifier] in Unspecified specimen by Other stain"},{"system":"http://loinc.org","version":"2.78","code":"11555-0","display":"Base excess in Blood by calculation"},{"system":"http://loinc.org","version":"2.78","code":"11556-8","display":"Oxygen [Partial pressure] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"11557-6","display":"Carbon dioxide [Partial pressure] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"11558-4","display":"pH of Blood"},{"system":"http://loinc.org","version":"2.78","code":"11572-5","display":"Rheumatoid factor [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"11573-3","display":"Rheumatoid factor IgM [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"11579-0","display":"Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L"},{"system":"http://loinc.org","version":"2.78","code":"11580-8","display":"Thyrotropin [Units/?volume] in Serum or Plasma by Detection limit <= 0.005 mIU/?L"},{"system":"http://loinc.org","version":"2.78","code":"116-4","display":"Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"120-6","display":"Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"12176-4","display":"Amino acids [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"12195-4","display":"Creatinine renal clearance/1.73 sq M in 24 hour"},{"system":"http://loinc.org","version":"2.78","code":"12241-6","display":"Osmotic fragility of Red Blood Cells by Diluted RBC"},{"system":"http://loinc.org","version":"2.78","code":"12254-9","display":"Volume of Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"12256-4","display":"Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy"},{"system":"http://loinc.org","version":"2.78","code":"12293-7","display":"Cotinine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"12308-3","display":"Hydrocodone [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"12319-0","display":"Thioridazine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"12327-3","display":"Ketamine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"12389-3","display":"Olanzapine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"12467-7","display":"Amino acids [Identifier] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"124-8","display":"Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"12-5","display":"Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"12708-4","display":"Tin [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"12841-3","display":"Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"12851-2","display":"Protein Fractions [interpretation] in Serum or Plasma by Electrophoresis"},{"system":"http://loinc.org","version":"2.78","code":"128-9","display":"Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"12916-3","display":"Porphobilinogen synthase [Enzymatic activity/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"12998-1","display":"Methylene chloride [Mass/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"13000-5","display":"Mandelate [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"1304-5","display":"D Ab [Titer] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"13046-8","display":"Variant lLymphocytes/100 leukocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"13087-2","display":"Complement alternate pathway AH50 [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"13238-1","display":"Epstein Barr virus Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"13304-1","display":"HLA-DR [Type]"},{"system":"http://loinc.org","version":"2.78","code":"13309-0","display":"Duffy group Ag [Type] on Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"13310-8","display":"Kell group Ag [Type] on Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"13311-6","display":"MNS group Ag [Type] on Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"13316-5","display":"Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"13317-3","display":"Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"13359-5","display":"Character of Semen"},{"system":"http://loinc.org","version":"2.78","code":"133-9","display":"Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"13438-7","display":"Protein Fractions [interpretation] in Urine by Electrophoresis"},{"system":"http://loinc.org","version":"2.78","code":"13488-2","display":"aPTT in Control Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"13513-7","display":"Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain"},{"system":"http://loinc.org","version":"2.78","code":"13514-5","display":"Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative"},{"system":"http://loinc.org","version":"2.78","code":"13532-7","display":"Xanthochromia [Presence] of Cerebral spinal fluid Qualitative"},{"system":"http://loinc.org","version":"2.78","code":"13533-5","display":"Acid hemolysis [Presence] of Blood"},{"system":"http://loinc.org","version":"2.78","code":"13539-2","display":"Phosphate [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"13590-5","display":"Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"137-0","display":"Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"13956-8","display":"Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"13964-2","display":"Methylmalonate [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"13965-9","display":"Homocysteine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"13967-5","display":"Sex hormone binding globulin [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"13969-1","display":"Creatine kinase.MB [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"13996-4","display":"Hydroxyproline/?Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14116-8","display":"IgG synthesis rate [Mass/?time] in Serum and CSF by calculation"},{"system":"http://loinc.org","version":"2.78","code":"14117-6","display":"IgG clearance/Albumin clearance [ratio] in Serum and CSF"},{"system":"http://loinc.org","version":"2.78","code":"141-2","display":"Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"14122-6","display":"Pyruvate [Moles/?volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"14135-8","display":"CD3+?CD8+? (T8 suppressor cells) cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"14136-6","display":"CD34 cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"14196-0","display":"Reticulocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"14207-5","display":"Streptococcal DNAse B [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"14210-9","display":"Giardia lamblia Ag [Presence] in Stool by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"14236-4","display":"Mitochondria Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"14252-1","display":"Smooth muscle Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"14272-9","display":"Liver kidney microsomal Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"14286-9","display":"Carnitine free (C0) [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14314-9","display":"Benzoylecgonine [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"14316-4","display":"Benzodiazepines [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"14332-1","display":"Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"14334-7","display":"Lithium [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14398-2","display":"Creatinine [Mass/?volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"14503-7","display":"Human papilloma virus 16+?18 Ag [Presence] in Cervix"},{"system":"http://loinc.org","version":"2.78","code":"14522-7","display":"Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"145-3","display":"Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"14567-2","display":"11-Deoxycortisol [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14569-8","display":"17-Hydroxyprogesterone [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14573-0","display":"5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14575-5","display":"Blood group antibody investigation [interpretation] in Plasma or RBC"},{"system":"http://loinc.org","version":"2.78","code":"14581-3","display":"Acetaminophen [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14586-2","display":"Aldosterone [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14593-8","display":"Aluminum [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14597-9","display":"Amitriptyline [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14603-5","display":"Androstenedione [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14611-8","display":"Nuclear Ab pattern [interpretation] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"14622-5","display":"Ascorbate [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14628-2","display":"Bile acid [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14629-0","display":"Bilirubin.direct [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14630-8","display":"Bilirubin.indirect [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14631-6","display":"Bilirubin.total [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14635-7","display":"Calcidiol [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14637-3","display":"Calcium [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14638-1","display":"Calculus analysis [interpretation] in Stone"},{"system":"http://loinc.org","version":"2.78","code":"14639-9","display":"Carbamazepine [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14642-3","display":"Carotene [Moles/?volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"14645-6","display":"Chlorpromazine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14646-4","display":"Cholesterol in HDL [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14647-2","display":"Cholesterol [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14650-6","display":"Citrate [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14651-4","display":"Clobazam [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14652-2","display":"Clomipramine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14654-8","display":"Clomipramine+?Norclomipramine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14655-5","display":"Clonazepam [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14656-3","display":"Clozapine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14665-4","display":"Copper [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14666-2","display":"Copper [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14674-6","display":"Corticotropin [Moles/?volume] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14675-3","display":"Cortisol [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14676-1","display":"Cortisol Free [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14678-7","display":"Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen"},{"system":"http://loinc.org","version":"2.78","code":"14679-5","display":"Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen"},{"system":"http://loinc.org","version":"2.78","code":"14682-9","display":"Creatinine [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14683-7","display":"Creatinine [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"14684-5","display":"Creatinine [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14685-2","display":"Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14688-6","display":"Dehydroepiandrosterone sulfate (DHEA-S) [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14691-0","display":"Desipramine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14695-1","display":"Nordoxepin [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14698-5","display":"Digoxin [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14702-5","display":"Disopyramide [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14703-3","display":"Dopamine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14705-8","display":"Doxepin [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14711-6","display":"Epinephrine [Moles/?volume] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14712-4","display":"Epinephrine [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14715-7","display":"Estradiol (E2) [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14719-9","display":"Ethanol [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14720-7","display":"Ethosuximide [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14722-3","display":"Extractable nuclear Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"14726-4","display":"Fluoride [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14731-4","display":"Folate [Moles/volume] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"14732-2","display":"Folate [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14744-7","display":"Glucose [Moles/volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"14745-4","display":"Glucose [Moles/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"14749-6","display":"Glucose [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14754-6","display":"Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO"},{"system":"http://loinc.org","version":"2.78","code":"14761-1","display":"Glucose [Moles/volume] in Serum or Plasma --2 hours post meal"},{"system":"http://loinc.org","version":"2.78","code":"14770-2","display":"Fasting glucose [Moles/volume] in Capillary blood by Glucometer"},{"system":"http://loinc.org","version":"2.78","code":"14771-0","display":"Fasting glucose [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14782-7","display":"Homovanillate [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"14783-5","display":"Homovanillate [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14785-0","display":"Hydroxyproline [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14796-7","display":"Insulin [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14798-3","display":"Iron [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14799-1","display":"Iron [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14800-7","display":"Iron binding capacity [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14801-5","display":"Iron saturation [Molar fraction] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14803-1","display":"Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction"},{"system":"http://loinc.org","version":"2.78","code":"14804-9","display":"Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction"},{"system":"http://loinc.org","version":"2.78","code":"14805-6","display":"Lactate dehydrogenase [Enzymatic activity/?volume] in Serum or Plasma by Pyruvate to lactate reaction"},{"system":"http://loinc.org","version":"2.78","code":"14807-2","display":"Lead [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"14809-8","display":"Lead [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14812-2","display":"Lidocaine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14833-8","display":"Metanephrines [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14835-3","display":"Methanol [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14836-1","display":"Methotrexate [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14852-8","display":"Norepinephrine [Moles/?volume] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14853-6","display":"Norepinephrine [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"14854-4","display":"Norepinephrine [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14856-9","display":"Nortriptyline [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14862-7","display":"Oxalate [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14866-8","display":"Parathyrin.intact [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14874-2","display":"Phenobarbital [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14877-5","display":"Phenytoin [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14879-1","display":"Phosphate [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14881-7","display":"Phosphate [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14883-3","display":"Porphyrins [interpretation] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14885-8","display":"Pregnanediol [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14890-8","display":"Progesterone [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14899-9","display":"Quinidine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14905-4","display":"Retinol [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14909-6","display":"Salicylates [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14913-8","display":"Testosterone [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14914-6","display":"Testosterone Free [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14915-3","display":"Theophylline [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14920-3","display":"Thyroxine (T4) free [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14921-1","display":"Thyroxine (T4) [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14927-8","display":"Triglyceride [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14928-6","display":"Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14930-2","display":"Triiodothyronine (T3) [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14931-0","display":"Trimipramine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14933-6","display":"Urate [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14934-4","display":"Urate [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"14935-1","display":"Urate [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14939-3","display":"Urea nitrogen [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14946-8","display":"Valproate [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14947-6","display":"Vanillylmandelate [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14948-4","display":"Vanillylmandelate/Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"14949-2","display":"Vasopressin [Moles/?volume] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"149-5","display":"Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"14955-9","display":"Zinc [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"14956-7","display":"Microalbumin [Mass/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"14957-5","display":"Microalbumin [Mass/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"14959-1","display":"Microalbumin/Creatinine [Mass Ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"14979-9","display":"aPTT in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"14995-5","display":"Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO"},{"system":"http://loinc.org","version":"2.78","code":"15009-4","display":"5-Hydroxyindoleacetate [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"15032-6","display":"Angiotensin II [Moles/?volume] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15034-2","display":"Bromide [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15038-3","display":"Citrate [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15057-3","display":"Androstanolone [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15058-1","display":"Dopamine [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"15059-9","display":"Dopamine [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"15061-5","display":"Erythropoietin (EPO) [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15066-4","display":"Fatty acids.nonesterified [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15067-2","display":"Follitropin [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15069-8","display":"Fructosamine [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15072-2","display":"Gastrin [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15074-8","display":"Glucose [Moles/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"15076-3","display":"Glucose [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"15081-3","display":"Prolactin [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15083-9","display":"Normetanephrine [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"15087-0","display":"Parathyrin related protein [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15097-9","display":"Vanillylmandelate [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"15099-5","display":"Amiodarone [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15105-0","display":"Flecainide [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15107-6","display":"Imipramine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15108-4","display":"Methadone [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15115-9","display":"Arsenic [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"15117-5","display":"Cadmium [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"15120-9","display":"Ethanol [Moles/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"15148-0","display":"Alkaline phosphatase [Enzymatic activity/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"15176-1","display":"Cryoproteins identified in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15179-5","display":"Fibrin D-dimer [Presence] in Platelet poor plasma"},{"system":"http://loinc.org","version":"2.78","code":"15200-9","display":"Osmolality of Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"15210-8","display":"Thyroglobulin Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"15359-3","display":"dRVVT actual/normal (normalized LA screen)"},{"system":"http://loinc.org","version":"2.78","code":"15363-5","display":"Busulfan [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"153-7","display":"Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"15374-2","display":"Sulfonylurea [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"15376-7","display":"Spermatozoa Abnormal/100 spermatozoa in Semen"},{"system":"http://loinc.org","version":"2.78","code":"15410-4","display":"Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"157-8","display":"Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"16099-4","display":"Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"161-0","display":"Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"16100-0","display":"Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"16128-1","display":"Hepatitis C virus Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"16130-7","display":"Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by NAA with probe detection "},{"system":"http://loinc.org","version":"2.78","code":"16131-5","display":"Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"16195-0","display":"Benzodiazepines [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16201-6","display":"Oxazepam [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16206-5","display":"Temazepam [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16208-1","display":"Buprenorphine [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16221-4","display":"Phenothiazines [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16226-3","display":"Benzoylecgonine [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16227-1","display":"Diazepam [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16228-9","display":"Nordiazepam [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16235-4","display":"Methamphetamine [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16249-5","display":"Oxycodone [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16250-3","display":"Codeine [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16251-1","display":"Morphine [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16254-5","display":"Phencyclidine [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16276-8","display":"Bartonella henselae DNA [Presence] in Blood by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"16284-2","display":"Polio virus Ab [Units/?volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"16337-8","display":"Alkaline phosphatase [Enzymatic activity/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"16348-5","display":"Alpha hydroxyalprazolam [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"16362-6","display":"Ammonia [Moles/?volume] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"16429-3","display":"Barbiturates [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"1648-5","display":"Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal"},{"system":"http://loinc.org","version":"2.78","code":"165-1","display":"Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"16550-6","display":"Carbohydrates [Identifier] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"16-6","display":"Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"16623-1","display":"Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"16676-9","display":"Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"16688-4","display":"Creatine kinase [Enzymatic activity/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"16835-1","display":"Escherichia coli shiga-like toxin identified in Stool by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"16836-9","display":"Escherichia coli verotoxic identified in Stool by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"16853-4","display":"Fat [Mass] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"16859-1","display":"Fibrinogen [Presence] in Platelet poor plasma"},{"system":"http://loinc.org","version":"2.78","code":"16901-1","display":"Gliadin IgA Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"16902-9","display":"Gliadin IgG Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"169-3","display":"Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"16933-4","display":"Hepatitis B virus core Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"16935-9","display":"Hepatitis B virus surface Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"1714-5","display":"Prostatic acid phosphatase [Enzymatic activity/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"17146-2","display":"CD4+?CD8+? cells/?100 cells in Blood"},{"system":"http://loinc.org","version":"2.78","code":"1715-2","display":"Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"17263-5","display":"Methemalbumin [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"173-5","display":"Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"17395-5","display":"Oxymorphone [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"1742-6","display":"Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"1746-7","display":"Albumin [Mass/?volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"1747-5","display":"Albumin [Mass/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"1751-7","display":"Albumin [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"17547-1","display":"Rotavirus Ag [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"1756-6","display":"Albumin in CSF/?Albumin in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"17571-1","display":"Scopolamine [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"17607-3","display":"Volume of Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"1761-6","display":"Aldolase [Enzymatic activity/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"177-6","display":"Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"1777-2","display":"Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"17793-1","display":"Immunoglobulin light chains [Mass/volume] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"17843-4","display":"Cancer Ag 72-4 [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"17857-4","display":"Rheumatoid factor [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"17869-9","display":"Orotate/Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"1795-4","display":"Amylase [Enzymatic activity/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"1798-8","display":"Amylase [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"1799-6","display":"Amylase [Enzymatic activity/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"1-8","display":"Acyclovir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"1805-1","display":"Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"181-8","display":"Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"1824-2","display":"Alpha-1-Antichymotrypsin [Mass/?volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"1825-9","display":"Alpha 1 antitrypsin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"18261-8","display":"Cholesterol in LDL [Mass/?volume] in Serum or Plasma ultracentrifugate"},{"system":"http://loinc.org","version":"2.78","code":"18263-4","display":"Cholesterol in HDL [Mass/?volume] in Serum or Plasma ultracentrifugate"},{"system":"http://loinc.org","version":"2.78","code":"18282-4","display":"Cannabinoids [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"18286-5","display":"Donath Landsteiner Ab [Presence] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"1834-1","display":"Alpha-1-Fetoprotein [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"18358-2","display":"Methylenedioxymethamphetamine [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"18390-5","display":"Opiates [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"18481-2","display":"Streptococcus pyogenes Ag [Presence] in Throat"},{"system":"http://loinc.org","version":"2.78","code":"185-9","display":"Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"1863-0","display":"Anion gap 4 in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"1869-7","display":"Apolipoprotein A-I [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"1884-6","display":"Apolipoprotein B [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"18855-7","display":"5-Fluorocytosine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18857-3","display":"Almecillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18859-9","display":"Amdinocillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18860-7","display":"Amikacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18861-5","display":"Amoxicillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18862-3","display":"Amoxicillin+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18863-1","display":"Amphotericin B [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18864-9","display":"Ampicillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18865-6","display":"Ampicillin+Sulbactam [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18866-4","display":"Azithromycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18867-2","display":"Azlocillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18868-0","display":"Aztreonam [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18869-8","display":"Bacampicillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18870-6","display":"Bacitracin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18871-4","display":"Butirosin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18872-2","display":"Capreomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18873-0","display":"Carbenicillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18874-8","display":"Cefaclor [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18875-5","display":"Cefadroxil [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18876-3","display":"Cefamandole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18877-1","display":"Cefatrizine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18878-9","display":"Cefazolin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18879-7","display":"Cefepime [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18880-5","display":"Cefixime [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18881-3","display":"Cefmetazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18882-1","display":"Cefodizime [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18883-9","display":"Cefonicid [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18884-7","display":"Cefoperazone [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18885-4","display":"Ceforanide [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18886-2","display":"Cefotaxime [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18887-0","display":"Cefotetan [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18888-8","display":"Cefoxitin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18889-6","display":"Cefpirome [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18890-4","display":"Cefpodoxime [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18891-2","display":"Cefprozil [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18892-0","display":"Cefsulodin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18893-8","display":"Ceftazidime [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18894-6","display":"Ceftizoxime [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18895-3","display":"Ceftriaxone [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18896-1","display":"Cefuroxime Parenteral [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18897-9","display":"Cephalexin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18898-7","display":"Cephaloglycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18899-5","display":"Cephaloridine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18900-1","display":"Cephalothin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18901-9","display":"Cephapirin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18902-7","display":"Cephradine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18903-5","display":"Chloramphenicol [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18904-3","display":"Chlortetracycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18905-0","display":"Cinoxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18906-8","display":"Ciprofloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18907-6","display":"Clarithromycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18908-4","display":"Clindamycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18909-2","display":"Clotrimazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"189-1","display":"Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"18910-0","display":"Cloxacillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18911-8","display":"Colistimethate"},{"system":"http://loinc.org","version":"2.78","code":"18912-6","display":"Colistin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18913-4","display":"Cyclacillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18914-2","display":"Cycloserine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18915-9","display":"Demeclocycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18916-7","display":"Dicloxacillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18917-5","display":"Doxycycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18918-3","display":"Enoxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18919-1","display":"Erythromycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18921-7","display":"Ethambutol [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18922-5","display":"Ethionamide [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18923-3","display":"Floxacillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18924-1","display":"Fluconazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18926-6","display":"Framycetin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18927-4","display":"Fusidate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18928-2","display":"Gentamicin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18929-0","display":"Gentamicin.high potency [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18930-8","display":"Gramicidin D [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18931-6","display":"Hetacillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18932-4","display":"Imipenem [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18934-0","display":"Isoniazid [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18935-7","display":"Kanamycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18936-5","display":"Kanamycin.high potency [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18937-3","display":"Ketoconazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18938-1","display":"Lincomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18939-9","display":"Lomefloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18940-7","display":"Loracarbef [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18941-5","display":"Lymecycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18942-3","display":"Meclocycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18943-1","display":"Meropenem [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18944-9","display":"Methacycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18945-6","display":"Methicillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18946-4","display":"Metronidazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18947-2","display":"Mezlocillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18948-0","display":"Minocycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18949-8","display":"Miocamycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18950-6","display":"Moxalactam [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18951-4","display":"Nafcillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18952-2","display":"Nalidixate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18953-0","display":"Neomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18954-8","display":"Netilmicin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18955-5","display":"Nitrofurantoin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18956-3","display":"Norfloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18957-1","display":"Novobiocin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18958-9","display":"Nystatin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18959-7","display":"Ofloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18960-5","display":"Oleandomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18961-3","display":"Oxacillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18962-1","display":"Oxytetracycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18963-9","display":"Pefloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18964-7","display":"Penicillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18965-4","display":"Penicillin G [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18966-2","display":"Penicillin V [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18967-0","display":"Phenethicillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18968-8","display":"Pipemidate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18969-6","display":"Piperacillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18970-4","display":"Piperacillin+Tazobactam [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18971-2","display":"Pivampicillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18972-0","display":"Polymyxin B [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18973-8","display":"Pyrazinamide [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18974-6","display":"Rifampin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18975-3","display":"Ristocetin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18976-1","display":"Rolitetracycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18977-9","display":"Rosoxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18978-7","display":"Roxithromycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18979-5","display":"Sisomicin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18980-3","display":"Spectinomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18981-1","display":"Spiramycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18982-9","display":"Streptomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18983-7","display":"Streptomycin.high potency [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18984-5","display":"Sulfadiazine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18985-2","display":"Sulfamethoxazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18986-0","display":"Sulfisoxazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18987-8","display":"Sulfonamide [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18988-6","display":"Talampicillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18989-4","display":"Teicoplanin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18990-2","display":"Temafloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18991-0","display":"Temocillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18992-8","display":"Terbinafine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18993-6","display":"Tetracycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18994-4","display":"Ticarcillin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18995-1","display":"Ticarcillin+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18996-9","display":"Tobramycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18997-7","display":"Trimethoprim [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18998-5","display":"Trimethoprim+Sulfamethoxazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"18999-3","display":"Troleandomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"19000-9","display":"Vancomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"19001-7","display":"Viomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"19048-8","display":"Nucleated erythrocytes/100 leukocytes [Ratio] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"19057-9","display":"ABO +? Rh group [Type] in Blood from newborn"},{"system":"http://loinc.org","version":"2.78","code":"19072-8","display":"Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"19077-7","display":"Cells identified in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"19080-1","display":"Choriogonadotropin [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"19090-0","display":"Colony count [#/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"19113-0","display":"IgE [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"19141-1","display":"Propoxyphene [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"19149-4","display":"Rifabutin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"19176-7","display":"Alpha-1-Fetoprotein [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"19180-9","display":"Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"1920-8","display":"Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"19261-7","display":"Amphetamines [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19270-8","display":"Barbiturates [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"1928-1","display":"Immunoglobulin light chains [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"19289-8","display":"Cannabinoids [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"19295-5","display":"Opiates [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"1929-9","display":"Immunoglobulin light chains [Mass/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"193-3","display":"Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"19360-7","display":"Cocaine [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"19411-8","display":"Codeine [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"1942-2","display":"Beta galactosidase [Enzymatic activity/?mass] in Tissue"},{"system":"http://loinc.org","version":"2.78","code":"19429-0","display":"Propoxyphene [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"1952-1","display":"Beta-2-Microglobulin [Mass/volume] in Serum or"},{"system":"http://loinc.org","version":"2.78","code":"1953-9","display":"Beta-2-Microglobulin [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"19550-3","display":"Methadone [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19554-5","display":"Methamphetamine [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19561-0","display":"Methylenediamine [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19564-4","display":"Methylenediamine cutoff [Mass/?volume] in Urine for Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"19568-5","display":"Methylenedioxymethamphetamine [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19577-6","display":"Methylphenidate [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19578-4","display":"Methylphenidate [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"1959-6","display":"Bicarbonate [Moles/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"19597-4","display":"Morphine [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19624-6","display":"Nordiazepam [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"1963-8","display":"Bicarbonate [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"19638-6","display":"Oxazepam [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19642-8","display":"Oxycodone [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19659-2","display":"Phencyclidine [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19670-9","display":"Phenothiazines [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"19710-3","display":"Tramadol [Presence] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"197-4","display":"Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"19762-4","display":"General categories [interpretation] of Cervical or vaginal smear or scraping by Cyto stain"},{"system":"http://loinc.org","version":"2.78","code":"19763-2","display":"Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain"},{"system":"http://loinc.org","version":"2.78","code":"19764-0","display":"Statement of adequacy [interpretation] of Cervical or vaginal smear or scraping by Cyto stain"},{"system":"http://loinc.org","version":"2.78","code":"19765-7","display":"Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain"},{"system":"http://loinc.org","version":"2.78","code":"19772-3","display":"Preparation techniques [Type] in Cervical or vaginal smear or scraping by Cyto stain"},{"system":"http://loinc.org","version":"2.78","code":"19773-1","display":"Recommended follow-up [Identifier] in Cervical or vaginal smear or scraping by Cyto stain"},{"system":"http://loinc.org","version":"2.78","code":"1988-5","display":"C reactive protein [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"1992-7","display":"Calcitonin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"1995-0","display":"Calcium.ionized [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2000-8","display":"Calcium [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2004-0","display":"Calcium [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"201-4","display":"Colistimethate by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"20388-5","display":"Nitrofurazone [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"20389-3","display":"Mupirocin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"20390-1","display":"Silver sulfadiazine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"20391-9","display":"Mafenide [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"2039-6","display":"Carcinoembryonic Ag [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"20396-8","display":"Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"20397-6","display":"Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"20402-4","display":"CD16+?CD56+? cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"20404-0","display":"Fibronectin.fetal [Presence] in Vaginal fluid"},{"system":"http://loinc.org","version":"2.78","code":"20447-9","display":"HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"20453-7","display":"Epithelial cells [Presence] in Urine sediment by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"20454-5","display":"Protein [Presence] in Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"20460-2","display":"Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"20483-4","display":"Mitochondria Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"20490-9","display":"Epstein Barr virus capsid IgG Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"20491-7","display":"Epstein Barr virus capsid IgM Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"20495-8","display":"Gliadin IgA Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"20496-6","display":"Gliadin IgG Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"20507-0","display":"Reagin Ab [Presence] in Serum by RPR"},{"system":"http://loinc.org","version":"2.78","code":"20510-4","display":"Lipoprotein fractions [interpretation] in Serum or Plasma by Electrophoresis"},{"system":"http://loinc.org","version":"2.78","code":"20521-1","display":"Carboxy tetrahydrocannabinol [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"205-5","display":"Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"20559-1","display":"Temazepam [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"20563-3","display":"Carboxyhemoglobin/Hemoglobin.total in Blood"},{"system":"http://loinc.org","version":"2.78","code":"20565-8","display":"Carbon dioxide, total [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"20569-0","display":"Creatine kinase.MB/Creatine kinase.total in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"20570-8","display":"Hematocrit [Volume Fraction] of Blood"},{"system":"http://loinc.org","version":"2.78","code":"20575-7","display":"Hepatitis A virus Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"20576-5","display":"Galactose 1 phosphate uridyl transferase [Presence] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"20578-1","display":"Vancomycin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"20626-8","display":"Reducing substances [Units/?volume] in Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"20629-2","display":"Levofloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"2064-4","display":"Ceruloplasmin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"20662-3","display":"Allergens tested for in Serum"},{"system":"http://loinc.org","version":"2.78","code":"2069-3","display":"Chloride [Moles/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"20719-1","display":"Brucella abortus Ab [Titer] in Serum by Tube agglutination"},{"system":"http://loinc.org","version":"2.78","code":"2072-7","display":"Chloride [Moles/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"20728-2","display":"Brucella abortus Ab [Presence] in Serum by Complement fixation"},{"system":"http://loinc.org","version":"2.78","code":"2075-0","display":"Chloride [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2077-6","display":"Chloride [Moles/?volume] in Sweat"},{"system":"http://loinc.org","version":"2.78","code":"2078-4","display":"Chloride [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2079-2","display":"Chloride [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"20-8","display":"Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"209-7","display":"Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"20981-7","display":"Verotoxin identified in Isolate"},{"system":"http://loinc.org","version":"2.78","code":"2098-2","display":"Cholinesterase [Enzymatic activity/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2099-0","display":"Cholinesterase [Enzymatic activity/?volume] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"21027-8","display":"Platelet aggregation [interpretation] in Platelet poor plasma"},{"system":"http://loinc.org","version":"2.78","code":"2106-3","display":"Choriogonadotropin (pregnancy test) [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"21070-8","display":"Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2118-8","display":"Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"21198-7","display":"Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"21233-2","display":"Cryptosporidium sp Ag [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"21259-7","display":"Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination"},{"system":"http://loinc.org","version":"2.78","code":"21363-7","display":"Legionella pneumophila DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"21365-2","display":"Leptin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"21387-6","display":"Methylhippurate [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"213-9","display":"Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"21436-1","display":"Ovary Ab [Presence] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"21566-5","display":"Tolazamide [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"21567-3","display":"Tolbutamide [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2157-6","display":"Creatine kinase [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"21582-2","display":"Tryptase [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"21613-5","display":"Chlamydia trachomatis DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"2164-2","display":"Creatinine renal clearance in 24 hour"},{"system":"http://loinc.org","version":"2.78","code":"217-0","display":"Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"221-2","display":"Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"22150-7","display":"Brucella abortus Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22244-8","display":"Cytomegalovirus IgG Ab [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"22246-3","display":"Cytomegalovirus IgG Ab [Titer] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"22249-7","display":"Cytomegalovirus IgM Ab [Titer] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"22298-4","display":"Epstein Barr virus nuclear IgG Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22312-3","display":"Hepatitis A virus Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22313-1","display":"Hepatitis A virus IgG Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22314-9","display":"Hepatitis A virus IgM Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22320-6","display":"Hepatitis B virus e Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22322-2","display":"Hepatitis B virus surface Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22396-6","display":"Legionella pneumophila Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22425-3","display":"Mycoplasma pneumoniae Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22466-7","display":"Respiratory syncytial virus Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22496-4","display":"Rubella virus Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22497-2","display":"Rubella virus Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"225-3","display":"Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"22568-0","display":"Streptolysin O Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22580-5","display":"Toxoplasma gondii IgG Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22582-1","display":"Toxoplasma gondii IgG Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22584-7","display":"Toxoplasma gondii IgM Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"22664-7","display":"Urea [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"22689-4","display":"Zinc [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"22700-9","display":"Urea [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"22704-1","display":"Carnitine free (C0)/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"22708-2","display":"Homovanillate/Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2271-5","display":"Fat [Mass/time] in 72 hour Stool"},{"system":"http://loinc.org","version":"2.78","code":"22745-4","display":"Ethanol [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"22748-8","display":"Cholesterol in LDL [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"22749-6","display":"Amylase.pancreatic [Enzymatic activity/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2276-4","display":"Ferritin [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"229-5","display":"Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2306-9","display":"Galactose [Presence] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"23159-7","display":"Leishmania sp DNA [Identifier] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"23198-5","display":"Leptospira sp Ab [Titer] in Serum by Agglutination"},{"system":"http://loinc.org","version":"2.78","code":"2324-2","display":"Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2333-3","display":"Gastrin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2335-8","display":"Hemoglobin.gastrointestinal [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"233-7","display":"Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2338-2","display":"Glucagon [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2356-4","display":"Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"23627-3","display":"Clofazimine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23628-1","display":"Sparfloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23629-9","display":"Para aminosalicylate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23636-4","display":"Cefdinir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23637-2","display":"Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"23638-0","display":"Grepafloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23639-8","display":"Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"23640-6","display":"Quinupristin+Dalfopristin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23641-4","display":"Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"23642-2","display":"Trovafloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23643-0","display":"Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"23658-8","display":"Other Antibiotic [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23659-6","display":"Apramycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23709-9","display":"Ceftiofur [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23712-3","display":"Enrofloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23713-1","display":"Ethylene glycol [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"23740-4","display":"Florfenicol [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"23826-1","display":"Bordetella pertussis DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"23831-1","display":"Bordetella pertussis.pertussis toxin IgG Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"2387-9","display":"Glycerol [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"23883-2","display":"Inhibin A [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"23905-3","display":"Mycophenolate [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"23971-5","display":"Epstein Barr virus early IgG Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"23991-3","display":"Dengue virus IgG Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"23992-1","display":"Dengue virus IgM Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"2399-4","display":"Glycosaminoglycans [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"24-0","display":"Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"241-0","display":"Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"24108-3","display":"Cancer Ag 19-9 [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"24109-1","display":"Progesterone [Moles/?volume] in Saliva (oral fluid)"},{"system":"http://loinc.org","version":"2.78","code":"24110-9","display":"Treponema pallidum Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"24111-7","display":"Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"24117-4","display":"Ross river virus IgG Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"24118-2","display":"Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"24120-8","display":"Ross river virus IgM Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"24121-6","display":"Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"24124-0","display":"Casts [Presence] in Urine sediment by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"24125-7","display":"Androgen free Index in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"24312-1","display":"Treponema pallidum Ab [Presence] in Serum by Agglutination"},{"system":"http://loinc.org","version":"2.78","code":"24377-4","display":"Platelet aggregation ADP induced [Presence] in Platelet rich plasma"},{"system":"http://loinc.org","version":"2.78","code":"24378-2","display":"Platelet aggregation epinephrine induced [Presence] in Platelet rich plasma"},{"system":"http://loinc.org","version":"2.78","code":"24379-0","display":"Platelet aggregation collagen induced [Presence] in Platelet rich plasma"},{"system":"http://loinc.org","version":"2.78","code":"24380-8","display":"Platelet aggregation ristocetin induced [Presence] in Platelet rich plasma"},{"system":"http://loinc.org","version":"2.78","code":"24383-2","display":"Intrinsic factor Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"24390-7","display":"Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM"},{"system":"http://loinc.org","version":"2.78","code":"24391-5","display":"Cortisol [Moles/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM"},{"system":"http://loinc.org","version":"2.78","code":"24393-1","display":"Cortisol [Moles/volume] in Serum or Plasma --10 hours post 1 mg dexamethasone PO overnight"},{"system":"http://loinc.org","version":"2.78","code":"24419-4","display":"Pathology report gross observation"},{"system":"http://loinc.org","version":"2.78","code":"24467-3","display":"CD3+?CD4+? (T4 helper) cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"24471-5","display":"Platelet function (closure time) collagen+?Epinephrine induced [Time] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"24472-3","display":"Platelet function (closure time) collagen+?ADP induced [Time] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"245-1","display":"Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"24518-3","display":"Calcium/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"24521-7","display":"Epinephrine [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"24522-5","display":"Epinephrine/Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"24523-3","display":"Norepinephrine/Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"24524-1","display":"Dopamine/Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2458-8","display":"IgA [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2460-4","display":"IgD [Mass/?volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"2464-6","display":"IgG [Mass/?volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"2465-3","display":"IgG [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2466-1","display":"IgG subclass 1 [Mass/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"2467-9","display":"IgG subclass 2 [Mass/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"2468-7","display":"IgG subclass 3 [Mass/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"2469-5","display":"IgG subclass 4 [Mass/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"2470-3","display":"IgG/?Albumin [Mass Ratio] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"2472-9","display":"IgM [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2483-6","display":"Insulin-like growth factor binding protein 3 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2484-4","display":"Insulin-like growth factor-I [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"249-3","display":"Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2495-0","display":"Iodine [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"25095-1","display":"Deoxypyridinoline/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"25142-1","display":"5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak"},{"system":"http://loinc.org","version":"2.78","code":"25143-9","display":"5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough"},{"system":"http://loinc.org","version":"2.78","code":"25145-4","display":"Bacteria [Presence] in Urine sediment by Light microscopy "},{"system":"http://loinc.org","version":"2.78","code":"2514-8","display":"Ketones [Presence] in Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"25168-6","display":"Perhexiline [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25170-2","display":"Mercury [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"2520-5","display":"Lactate [Moles/?volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"2524-7","display":"Lactate [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25302-1","display":"Alanine aminotransferase [Enzymatic activity/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"253-5","display":"5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"25358-3","display":"C peptide [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"25360-9","display":"Cadmium [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"25361-7","display":"Caffeine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25374-0","display":"Chromium [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25375-7","display":"Chymotrypsin [Enzymatic activity/?mass] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"25378-1","display":"Cobalt [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25386-4","display":"Creatinine [Moles/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"25393-0","display":"Desethylamiodarone [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25411-0","display":"Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"25428-4","display":"Glucose [Presence] in Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"25447-4","display":"Insulin Free [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25451-6","display":"Isoniazid [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25452-4","display":"Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"25458-1","display":"Lamotrigine [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25466-4","display":"Manganese [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"25471-4","display":"Mercury [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"25474-8","display":"Metanephrines [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25489-6","display":"Normetanephrine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25501-8","display":"Phosphate [Moles/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"2550-2","display":"Lactate/?Pyruvate [Molar ratio] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"25514-1","display":"Rubella virus IgG Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"25521-6","display":"Selenium [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25524-0","display":"Serotonin [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"25541-4","display":"Topiramate [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25542-2","display":"Toxoplasma gondii IgM Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"25548-9","display":"Urate [Moles/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"25549-7","display":"Urea [Moles/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"25595-0","display":"Econazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"25596-8","display":"Fosfomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"25597-6","display":"Josamycine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"25607-3","display":"Miconazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"25608-1","display":"Nitroxoline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"25637-0","display":"Econazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"25638-8","display":"Eosinophil cationic protein (ECP) [Mass/?volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"25653-7","display":"Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"256-8","display":"Foscarnet [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"25702-2","display":"Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"25721-2","display":"Mianserin [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25722-0","display":"Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"25723-8","display":"Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2572-6","display":"Lipoprotein lipase [Enzymatic activity/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"258-4","display":"Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"25867-3","display":"Echinococcus sp Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"2589-0","display":"Lysozyme [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"25907-7","display":"Elastase.pancreatic [Mass/?mass] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"25909-3","display":"Epinephrine/Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"25931-7","display":"Homovanillate/Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"2596-5","display":"Magnesium [Moles/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"2597-3","display":"Magnesium [Moles/?volume] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"2598-1","display":"Magnesium [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2599-9","display":"Magnesium [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"26004-2","display":"Vanillylmandelate/Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"26009-1","display":"Treponema pallidum Ab [Titer] in Serum by Hemagglutination"},{"system":"http://loinc.org","version":"2.78","code":"2601-3","display":"Magnesium [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"26023-2","display":"Extractable nuclear Ab identified in Serum"},{"system":"http://loinc.org","version":"2.78","code":"26043-0","display":"HLA-B27 [Presence] by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"2606-2","display":"Melanin [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2614-6","display":"Methemoglobin/Hemoglobin.total in Blood"},{"system":"http://loinc.org","version":"2.78","code":"262-6","display":"Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2639-3","display":"Myoglobin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2640-1","display":"Myoglobin [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"26444-0","display":"Basophils [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26446-5","display":"Blasts/100 leukocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26449-9","display":"Eosinophils [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26450-7","display":"Eosinophils/100 leukocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26453-1","display":"Erythrocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26454-9","display":"Erythrocytes [#/volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"26455-6","display":"Erythrocytes [#/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"26464-8","display":"Leukocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26465-5","display":"Leukocytes [#/volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"26466-3","display":"Leukocytes [#/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"26474-7","display":"Lymphocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26475-4","display":"Lymphocytes [#/volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"26476-2","display":"Lymphocytes [#/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"26477-0","display":"Variant lymphocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26478-8","display":"Lymphocytes/100 leukocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26484-6","display":"Monocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26485-3","display":"Monocytes/100 leukocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26489-5","display":"Mononuclear cells [#/volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"26490-3","display":"Mononuclear cells [#/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"26499-4","display":"Neutrophils [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26500-9","display":"Neutrophils [#/volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"26507-4","display":"Band form neutrophils [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26508-2","display":"Band form neutrophils/100 leukocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26511-6","display":"Neutrophils/100 leukocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26515-7","display":"Platelets [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"26523-1","display":"Promyelocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"265-9","display":"Ganciclovir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"26621-3","display":"Legionella sp Ag [Presence] in Unspecified specimen"},{"system":"http://loinc.org","version":"2.78","code":"26705-4","display":"Epstein Barr virus nuclear IgM Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"267-5","display":"Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2676-5","display":"Organic acids [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"26784-9","display":"Diazepam [Mass/?volume] in Serum or Plasma by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"26833-4","display":"Hippurate [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2685-6","display":"Alpha-1-Acid glycoprotein [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"26885-4","display":"Ova and parasites identified in Unspecified specimen by Concentration."},{"system":"http://loinc.org","version":"2.78","code":"2692-2","display":"Osmolality of Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2695-5","display":"Osmolality of Urine"},{"system":"http://loinc.org","version":"2.78","code":"26960-5","display":"Trypsin [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"26969-6","display":"Parietal cell Ab [Presence] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"27071-0","display":"CD45 (Lymphs) cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"27081-9","display":"Itraconazole+?Hydroxyitraconazole [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"27109-8","display":"Paroxetine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"271-7","display":"Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"27198-1","display":"Bilirubin.total [Units/?volume] in Amniotic fluid by Spectrophotometry direct"},{"system":"http://loinc.org","version":"2.78","code":"27200-5","display":"Nuclear Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"2721-9","display":"Pancreatic polypeptide [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"27252-6","display":"Choriogonadotropin.alpha subunit [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"27265-8","display":"Giardia sp Ag [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"2731-8","display":"Parathyrin.intact [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"27320-1","display":"Parietal cell Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"27403-5","display":"Gamma glutamyl transferase [Enzymatic activity/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2742-5","display":"Angiotensin converting enzyme [Enzymatic activity/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2748-2","display":"pH of Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"2752-4","display":"pH of Semen"},{"system":"http://loinc.org","version":"2.78","code":"275-8","display":"Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2758-1","display":"Phenol [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"27811-9","display":"Antithrombin actual/?normal in Platelet poor plasma by Chromogenic method"},{"system":"http://loinc.org","version":"2.78","code":"27812-7","display":"Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"27815-0","display":"Coagulation factor XIII activity actual/?normal in Platelet poor plasma by Chromogenic method"},{"system":"http://loinc.org","version":"2.78","code":"27816-8","display":"von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"27818-4","display":"Protein C actual/?normal in Platelet poor plasma by Chromogenic method"},{"system":"http://loinc.org","version":"2.78","code":"27819-2","display":"Protein C actual/?normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"27820-0","display":"Protein C Ag actual/normal in Platelet poor plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"27821-8","display":"Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"27822-6","display":"Protein S actual/normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"279-0","display":"Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"27977-8","display":"Norepinephrine/Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"27978-6","display":"Metanephrines/?Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"2809-2","display":"Porphobilinogen [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"28-1","display":"Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2811-8","display":"Porphobilinogen [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2812-6","display":"Porphobilinogen deaminase [Enzymatic activity/?volume] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"2821-7","display":"Potassium [Moles/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"2823-3","display":"Potassium [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2828-2","display":"Potassium [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2829-0","display":"Potassium [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"28539-5","display":"MCH [Entitic mass]"},{"system":"http://loinc.org","version":"2.78","code":"28540-3","display":"MCHC [Mass/volume]"},{"system":"http://loinc.org","version":"2.78","code":"28542-9","display":"Platelet mean volume [Entitic volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"2857-1","display":"Prostate specific Ag [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"287-3","display":"Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2880-3","display":"Protein [Mass/volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"2881-1","display":"Protein [Mass/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"2885-2","display":"Protein [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"2888-6","display":"Protein [Mass/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2889-4","display":"Protein [Mass/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"2890-2","display":"Protein/Creatinine [Mass Ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"2903-3","display":"Pyrimidine-5'-Nucleotidase [Enzymatic activity/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"291-5","display":"Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2915-7","display":"Renin [Enzymatic activity/?volume] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"29247-4","display":"Sirolimus [Mass/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"29254-0","display":"Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"29257-3","display":"Mycoplasma pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"29258-1","display":"Linezolid [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"29265-6","display":"Calcium [Moles/volume] corrected for albumin in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"29300-1","display":"Procedure type"},{"system":"http://loinc.org","version":"2.78","code":"2947-0","display":"Sodium [Moles/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"2950-4","display":"Sodium [Moles/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"2951-2","display":"Sodium [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"29520-4","display":"5-Hydroxyindoleacetate/Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"29541-0","display":"HIV 1 RNA [Log #/volume] (viral load) in Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"2954-6","display":"Sodium [Moles/?volume] in Sweat"},{"system":"http://loinc.org","version":"2.78","code":"2955-3","display":"Sodium [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"29558-4","display":"Enterovirus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"295-6","display":"Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"2956-1","display":"Sodium [Moles/time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"29577-4","display":"Fungal susceptibility panel"},{"system":"http://loinc.org","version":"2.78","code":"29591-5","display":"Enterovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"2963-7","display":"Somatotropin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"29652-5","display":"Dothiepin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"29653-3","display":"Dothiepin [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"29659-0","display":"Bordetella pertussis IgG Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"29660-8","display":"Parvovirus B19 IgG Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"29662-4","display":"Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"29747-3","display":"Tocopherols [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"29764-8","display":"Iron [Moles/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"29765-5","display":"Cholesterol [Moles/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"29766-3","display":"Triglyceride [Moles/?volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"29771-3","display":"Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"29877-8","display":"Methylmalonate [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"29891-9","display":"Helicobacter pylori [Presence] in Stomach by urea breath test"},{"system":"http://loinc.org","version":"2.78","code":"29904-0","display":"Toxoplasma gondii DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"29908-1","display":"Parainfluenza virus 1 RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"29909-9","display":"Parainfluenza virus 2 RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"29910-7","display":"Parainfluenza virus 3 RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"29953-7","display":"Nuclear Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"29954-5","display":"Extractable nuclear Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"299-8","display":"Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"29990-9","display":"Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy"},{"system":"http://loinc.org","version":"2.78","code":"30000-4","display":"Microalbumin/?Creatinine [Ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"3002-3","display":"Thiocyanate [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3004-9","display":"Thiocyanate [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"3013-0","display":"Thyroglobulin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"30131-7","display":"Complement total hemolytic CH50 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3016-3","display":"Thyrotropin [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"30173-9","display":"Cortisol Free [Moles/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"30180-4","display":"Basophils/100 leukocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30206-7","display":"Choriogonadotropin.alpha subunit free [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"30246-3","display":"Cytomegalovirus DNA [Presence] in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"30248-9","display":"Transferrin receptor.soluble [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"30298-4","display":"Lamivudine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30299-2","display":"Amprenavir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30300-8","display":"Didanosine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30301-6","display":"Zalcitabine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30302-4","display":"Stavudine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30303-2","display":"Abacavir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30304-0","display":"Adefovir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30305-7","display":"Delavirdine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30306-5","display":"Efavirenz [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30307-3","display":"Indinavir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30308-1","display":"Ritonavir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30309-9","display":"Nelfinavir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30310-7","display":"Saquinavir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30311-5","display":"Nevirapine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"30313-1","display":"Hemoglobin [Mass/?volume] in Arterial blood"},{"system":"http://loinc.org","version":"2.78","code":"30316-4","display":"Alpha subunit free [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"30325-5","display":"Cytomegalovirus IgM Ab [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"30339-6","display":"Epstein Barr virus capsid IgG Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"30340-4","display":"Epstein Barr virus capsid IgM Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"30341-2","display":"Erythrocyte sedimentation rate"},{"system":"http://loinc.org","version":"2.78","code":"3034-6","display":"Transferrin [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"30376-8","display":"Blasts [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"303-8","display":"Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"30385-9","display":"Erythrocyte distribution width [Ratio]"},{"system":"http://loinc.org","version":"2.78","code":"30391-7","display":"Erythrocytes [#/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"30392-5","display":"Nucleated erythrocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30397-4","display":"Hairy cells [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"3040-3","display":"Lipase [Enzymatic activity/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"30405-5","display":"Leukocytes [#/volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"3041-1","display":"Trichloroacetate [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"30412-1","display":"Lymphocytes Abnormal [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30422-0","display":"Lymphoma cells [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30428-7","display":"MCV [Entitic volume]"},{"system":"http://loinc.org","version":"2.78","code":"30433-7","display":"Metamyelocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30446-9","display":"Myelocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30449-3","display":"Neutrophils.hypersegmented [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30450-1","display":"Neutrophils.hypersegmented/100 leukocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30458-4","display":"Plasma cells [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30464-2","display":"Prolymphocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"30480-8","display":"Orotate [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"30522-7","display":"C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method"},{"system":"http://loinc.org","version":"2.78","code":"30524-3","display":"Triglyceride [Moles/volume] in Serum or Plasma --12 hours fasting"},{"system":"http://loinc.org","version":"2.78","code":"3056-9","display":"Trimethylamine [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"307-9","display":"Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"30894-0","display":"Aldosterone/?Renin [Ratio] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"30899-9","display":"Blood volume by Scintigraphy"},{"system":"http://loinc.org","version":"2.78","code":"30903-9","display":"Neutrophil oxidative burst [Presence] in Blood by Flow cytometry (FC)"},{"system":"http://loinc.org","version":"2.78","code":"31022-7","display":"Filaria identified in Unspecified specimen by Concentration"},{"system":"http://loinc.org","version":"2.78","code":"31036-7","display":"Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"31037-5","display":"Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"31038-3","display":"Gatifloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"31039-1","display":"Moxifloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"311-1","display":"Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"31146-4","display":"Reagin Ab [Titer] in Cerebral spinal fluid by VDRL"},{"system":"http://loinc.org","version":"2.78","code":"31152-2","display":"Immunoglobulin light chains [Presence] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"31156-3","display":"Hemoglobin Barts/?Hemoglobin.total in Blood"},{"system":"http://loinc.org","version":"2.78","code":"31204-1","display":"Hepatitis B virus core IgM Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"31208-2","display":"Specimen source identified"},{"system":"http://loinc.org","version":"2.78","code":"3129-4","display":"Menadione [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"31348-6","display":"DNA double strand Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"31418-7","display":"Heterophile Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"315-2","display":"Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3160-9","display":"Volume of Semen"},{"system":"http://loinc.org","version":"2.78","code":"31616-6","display":"Rubella virus IgM Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"31627-3","display":"Smith extractable nuclear Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"3174-0","display":"Antithrombin [Units/?volume] in Platelet poor plasma by Chromogenic method"},{"system":"http://loinc.org","version":"2.78","code":"31798-2","display":"Dengue virus Ag [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"3181-5","display":"Cardiolipin IgG Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"3182-3","display":"Cardiolipin IgM Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"31834-5","display":"Haemophilus influenzae B Ag [Presence] in Unspecified specimen"},{"system":"http://loinc.org","version":"2.78","code":"31843-6","display":"Helicobacter pylori Ag [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"31844-4","display":"Hepatitis B virus e Ag [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"3185-6","display":"Coagulation factor IX inhibitor [Units/?volume] in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"3186-4","display":"Coagulation factor IX activated [Units/?volume] in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"31868-3","display":"Legionella pneumophila 1 Ag [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"31870-9","display":"Legionella pneumophila Ag [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"3187-2","display":"Coagulation factor IX activity actual/?normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"31910-3","display":"Neisseria meningitidis serogroups A+C+w135+Y Ag [Presence] in Unspecified specimen"},{"system":"http://loinc.org","version":"2.78","code":"31913-7","display":"Neisseria meningitidis serogroup B Ag [Presence] in Unspecified specimen"},{"system":"http://loinc.org","version":"2.78","code":"3193-0","display":"Coagulation factor V activity actual/?normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"319-4","display":"Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"31969-9","display":"Streptococcus pneumoniae Ag [Presence] in Unspecified specimen"},{"system":"http://loinc.org","version":"2.78","code":"3198-9","display":"Coagulation factor VII activity actual/?normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"32018-4","display":"Hepatitis A virus IgG Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"32042-4","display":"Thyroperoxidase Ab [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3204-5","display":"Coagulation factor VIII inhibitor [Units/?volume] in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"3209-4","display":"Coagulation factor VIII activity actual/?normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"32095-2","display":"Methanol [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"32098-6","display":"Mexiletine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3210-2","display":"Coagulation factor VIII activity [Units/?volume] in Platelet poor plasma by Chromogenic method"},{"system":"http://loinc.org","version":"2.78","code":"32117-4","display":"Thiopental [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"32140-6","display":"Hemoglobin F [Presence] in Blood by Kleihauer-Betke method"},{"system":"http://loinc.org","version":"2.78","code":"3218-5","display":"Coagulation factor X activity actual/?normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"32210-7","display":"Protein Fractions [interpretation] in 24 hour Urine by Electrophoresis"},{"system":"http://loinc.org","version":"2.78","code":"32217-2","display":"von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasma"},{"system":"http://loinc.org","version":"2.78","code":"32218-0","display":"Cyclic citrullinated peptide Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"3226-8","display":"Coagulation factor XI activity actual/?normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"32286-7","display":"Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"32294-1","display":"Albumin/?Creatinine [Ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"32295-8","display":"Aluminum [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"32-3","display":"Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"32309-7","display":"Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3232-6","display":"Coagulation factor XII activity actual/?normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"32352-7","display":"Alkaline phosphatase.heat stable [Enzymatic activity/volume] in Serum or Plasma by Heat stability"},{"system":"http://loinc.org","version":"2.78","code":"32356-8","display":"Yeast [Presence] in Urine sediment by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"323-6","display":"Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"32364-2","display":"Herpes virus 8 DNA [Presence] in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"32368-3","display":"Ureaplasma sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"32372-5","display":"Fleroxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32373-3","display":"Arbekacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32374-1","display":"Cefotiam [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32375-8","display":"Cefmenoxime [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32376-6","display":"Clinafloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32377-4","display":"Cefetamet [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32378-2","display":"Caspofungin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32379-0","display":"Voriconazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32381-6","display":"Isepamicin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32383-2","display":"Pristinamycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32384-0","display":"Thiacetazone [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"3241-7","display":"Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"3243-3","display":"Thrombin time"},{"system":"http://loinc.org","version":"2.78","code":"3244-1","display":"Clot Lysis [Time] in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"32546-4","display":"Glucose-6-Phosphate dehydrogenase [Enzymatic activity/mass] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"32547-2","display":"Ketones [Moles/?volume] in Serum or Plasma by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"32552-2","display":"Pyruvate kinase [Enzymatic activity/mass] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"32554-8","display":"Thiamine [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"3255-7","display":"Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"32597-7","display":"Natamycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32603-3","display":"Itraconazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"32610-8","display":"Amino acids [Moles/?volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"32631-4","display":"Nitroblue Tetrazolium Test (NBT) [Presence] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"32637-1","display":"Urease [Presence] in Tissue"},{"system":"http://loinc.org","version":"2.78","code":"32654-6","display":"6-Methylmercaptopurine [Entitic substance] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"32660-3","display":"6-Thioguanine [Entitic substance] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"32661-1","display":"Adrenal Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"32672-8","display":"Cold agglutinin [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"32673-6","display":"Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"32674-4","display":"Cryptococcus sp Ag [Titer] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"32677-7","display":"DNA double strand Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"32693-4","display":"Lactate [Moles/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"32709-8","display":"Neutrophils [#/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"3271-4","display":"LMW Heparin [Units/?volume] in Platelet poor plasma by Chromogenic method"},{"system":"http://loinc.org","version":"2.78","code":"32724-7","display":"Trichomonas sp [Presence] in Urine by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"32766-8","display":"Trichomonas vaginalis [Presence] in Unspecified specimen by Wet preparation"},{"system":"http://loinc.org","version":"2.78","code":"327-7","display":"Metronidazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"32786-6","display":"Thyroperoxidase Ab [Titer] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"32789-0","display":"Viscosity of Semen Qualitative"},{"system":"http://loinc.org","version":"2.78","code":"3289-6","display":"Prothrombin activity actual/?normal in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"3299-5","display":"Acetaminophen [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"33006-8","display":"Cytomegalovirus DNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"33007-6","display":"Protoporphyrin.zinc [Mass/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"33037-3","display":"Anion gap in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"33048-0","display":"Eosin-5-Maleimide binding [Presence] in Blood by Flow cytometry (FC)"},{"system":"http://loinc.org","version":"2.78","code":"331-9","display":"Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3319-1","display":"Amikacin [Mass/volume] in Serum or Plasma --peak"},{"system":"http://loinc.org","version":"2.78","code":"33204-9","display":"Troponin T.cardiac [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"33210-6","display":"Transferrin receptor.soluble [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3321-7","display":"Amikacin [Mass/volume] in Serum or Plasma --trough"},{"system":"http://loinc.org","version":"2.78","code":"33271-8","display":"Microscopic observation [Identifier] in Blood by Malaria thin smear"},{"system":"http://loinc.org","version":"2.78","code":"33288-2","display":"Galactose 1 phosphate uridyl transferase [Presence] in DBS"},{"system":"http://loinc.org","version":"2.78","code":"33295-7","display":"JC virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"33313-8","display":"Rheumatoid factor IgA [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"33314-6","display":"Rheumatoid factor IgG [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"3333-2","display":"Amitriptyline [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3335-7","display":"Amitriptyline+?Nortriptyline [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3349-8","display":"Amphetamines [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"335-0","display":"Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"33525-7","display":"Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"},{"system":"http://loinc.org","version":"2.78","code":"33526-5","display":"Reptilase time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"},{"system":"http://loinc.org","version":"2.78","code":"33614-9","display":"Transferrin.carbohydrate deficient.XXX/Transferrin.total in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"33617-2","display":"HLA-DR+? cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"33627-1","display":"Tenofovir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"33628-9","display":"Cidofovir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"33666-9","display":"Erythrocytes.dysmorphic [#/volume] in Urine by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"33673-5","display":"Thrombin time.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of protamine sulfate"},{"system":"http://loinc.org","version":"2.78","code":"33721-2","display":"Bone marrow Pathology biopsy report"},{"system":"http://loinc.org","version":"2.78","code":"33723-8","display":"Specimen length "},{"system":"http://loinc.org","version":"2.78","code":"33725-3","display":"Tumor site"},{"system":"http://loinc.org","version":"2.78","code":"33728-7","display":"Size.maximum dimension in Tumor"},{"system":"http://loinc.org","version":"2.78","code":"33732-9","display":" Histology grade [Identifier] in Cancer specimen"},{"system":"http://loinc.org","version":"2.78","code":"33739-4","display":"Lymphatic.small vessel.invasion [Identifier] in Specimen by CAP cancer protocols"},{"system":"http://loinc.org","version":"2.78","code":"33748-5","display":"Distance from anal verge"},{"system":"http://loinc.org","version":"2.78","code":"33763-4","display":"Natriuretic peptide.B prohormone N-Terminal [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3377-9","display":"Barbiturates [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"33783-2","display":"Atrial natriuretic factor [Moles/?volume] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"33824-4","display":"Iron [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"33872-3","display":"Cystine [Moles/?mass] in Leukocytes"},{"system":"http://loinc.org","version":"2.78","code":"33899-6","display":"Bilirubin.conjugated+?indirect [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3390-2","display":"Benzodiazepines [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"339-2","display":"Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3393-6","display":"Benzoylecgonine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"33941-6","display":"Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"33944-0","display":"Lambda light chains.free [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"33950-7","display":"Magnesium/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"33959-8","display":"Procalcitonin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3397-7","display":"Cocaine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"3-4","display":"Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3414-0","display":"Buprenorphine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34235-2","display":"Amylase/Creatinine [Ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34268-3","display":"Cobalt [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34304-6","display":"Fluoride [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34320-2","display":"Iodine [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34338-4","display":"Mercury [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"343-4","display":"Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"34343-4","display":"Nickel [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34350-9","display":"Oxalate/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34357-4","display":"Porphobilinogen/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34375-6","display":"Streptokinase Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"34382-2","display":"Treponema pallidum Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"34385-5","display":"Urate/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34387-1","display":"Zinc [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"34413-5","display":"Moclobemide [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"34487-9","display":"Influenza virus A RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"3453-8","display":"Cephalexin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"34571-0","display":"aPTT.lupus sensitive (LA screen)"},{"system":"http://loinc.org","version":"2.78","code":"34594-2","display":"Schistosoma sp Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"34615-5","display":"Iron.microscopic observation [Identifier] in Blood by Potassium ferrocyanide stain"},{"system":"http://loinc.org","version":"2.78","code":"34616-3","display":"Amino acids [Identifier] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"34628-8","display":"Methotrexate [Moles/?volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"34645-2","display":"Chlamydophila pneumoniae DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"34701-3","display":"Heparin induced platelet AB [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"34713-8","display":"Clostridioides difficile toxin A+B [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"34717-9","display":"Coxiella burnetii phase 2 IgG Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"3472-8","display":"Chlorpromazine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"347-5","display":"Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3491-8","display":"Clomipramine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"34918-3","display":"Sezary cells [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"34926-6","display":"Promonocytes [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"3493-4","display":"Clomipramine+?Norclomipramine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"34993-6","display":"Smudge cells [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"35026-4","display":"Monocytes [#/volume] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"35039-7","display":"Lymphocytes Plasmacytoid [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"3507-1","display":"Codeine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"35076-9","display":"Monocytes [#/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"35082-7","display":"Lymphocytes Large Granular [#/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"35112-2","display":"Floxacillin [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"351-7","display":"Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3520-4","display":"Cyclosporine [Mass/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"35275-7","display":"Measles virus IgG Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"35276-5","display":"Measles virus IgM Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"35279-9","display":"Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"35280-7","display":"Tissue transglutaminase IgA Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"3531-1","display":"Desipramine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"35352-4","display":"Mycobacterium tuberculosis genotype [Identifier] in Isolate"},{"system":"http://loinc.org","version":"2.78","code":"3548-5","display":"Diazepam [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"35491-0","display":"Leptospira sp DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"3550-1","display":"Diazepam [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"35570-1","display":"Renin [Mass/?volume] in Plasma"},{"system":"http://loinc.org","version":"2.78","code":"355-8","display":"Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35668-3","display":"Gentamicin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"35670-9","display":"Tobramycin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"35698-0","display":"Metformin [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"35745-9","display":"Fat/?Total solids [Mass Ratio] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"35755-8","display":"Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35756-6","display":"Avilamycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35761-6","display":"Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35762-4","display":"Cefditoren [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35765-7","display":"Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35770-7","display":"Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35771-5","display":"Cefotaxime+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35773-1","display":"Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35775-6","display":"Ceftazidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35776-4","display":"Ceftazidime+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35778-0","display":"Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35779-8","display":"Ceftibuten [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35781-4","display":"Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35783-0","display":"Cefuroxime Oral [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35786-3","display":"Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35788-9","display":"Daptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35789-7","display":"Daptomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"3579-0","display":"Doxepin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"35791-3","display":"Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35792-1","display":"Difloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35794-7","display":"Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35795-4","display":"Dirithromycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35798-8","display":"Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35801-0","display":"Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35802-8","display":"Ertapenem [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35804-4","display":"Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35805-1","display":"Bambermycins [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35808-5","display":"Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35812-7","display":"Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35813-5","display":"Garenoxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35815-0","display":"Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35816-8","display":"Gemifloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35821-8","display":"Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35823-4","display":"Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35826-7","display":"Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35827-5","display":"Orbifloxacin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35830-9","display":"Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35831-7","display":"Pirlimycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35834-1","display":"Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35837-4","display":"Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35838-2","display":"Salinomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35844-0","display":"Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35845-7","display":"Telithromycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35847-3","display":"Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35848-1","display":"Tiamulin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35850-7","display":"Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35851-5","display":"Tilmicosin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35853-1","display":"Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35854-9","display":"Trospectinomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35857-2","display":"Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35858-0","display":"Tylosin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35860-6","display":"Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"35861-4","display":"Virginiamycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"35863-0","display":"Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"359-0","display":"Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"363-2","display":"Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"36-4","display":"Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3644-2","display":"Fluoxetine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3663-2","display":"Gentamicin [Mass/volume] in Serum or Plasma --peak"},{"system":"http://loinc.org","version":"2.78","code":"3665-7","display":"Gentamicin [Mass/volume] in Serum or Plasma --trough"},{"system":"http://loinc.org","version":"2.78","code":"367-3","display":"Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"36903-3","display":"Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"3690-5","display":"Imipramine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"36916-5","display":"Kappa light chains.free [Mass/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"36921-5","display":"Herpes simplex virus 1+?2 IgG Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"371-5","display":"Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"375-6","display":"Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3772-1","display":"Methadone [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3773-9","display":"Methadone [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"379-8","display":"Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"38180-6","display":"Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"3827-3","display":"Morphine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"383-0","display":"Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3830-7","display":"Morphine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"38370-3","display":"Voriconazole [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"38379-4","display":"Mycobacterium tuberculosis complex DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"38387-7","display":"C3 nephritic factor [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"38445-3","display":"Calprotectin [Mass/?mass] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"38504-7","display":"Thyroglobulin Ab [Titer] in Serum by Immunoflourescence"},{"system":"http://loinc.org","version":"2.78","code":"3862-0","display":"Nordoxepin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"387-1","display":"Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3872-9","display":"Nortriptyline [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"3879-4","display":"Opiates [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"38917-1","display":"Human metapneumovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"3893-5","display":"Oxycodone [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"390-5","display":"Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"392-1","display":"Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"3924-8","display":"Pentobarbital [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"39354-6","display":"Cholinesterase in Serum or Plasma --dibucaine/Cholinesterase"},{"system":"http://loinc.org","version":"2.78","code":"3936-2","display":"Phencyclidine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"39469-2","display":"Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation"},{"system":"http://loinc.org","version":"2.78","code":"39528-5","display":"Adenovirus DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"39536-8","display":"Influenza virus A Ab [Units/?volume] in Serum by Complement fixation"},{"system":"http://loinc.org","version":"2.78","code":"396-2","display":"Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"39771-1","display":"Porphyrins [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"39774-5","display":"Porphyrins [Moles/?mass] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"39782-8","display":"Delta aminolevulinate/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"39784-4","display":"Porphyrins [Moles/?volume] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"39798-4","display":"Warfarin [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"400-2","display":"Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"4020-4","display":"Quinine [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"4023-8","display":"Salicylates [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4025-3","display":"Salicylates [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"40417-8","display":"Chromium [Moles/?time] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"404-4","display":"Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"40440-0","display":"XXX microorganism serotype [Identifier] in Isolate by Agglutination"},{"system":"http://loinc.org","version":"2.78","code":"40498-8","display":"Yersinia enterocolitica Ab [Titer] in Serum by Agglutination"},{"system":"http://loinc.org","version":"2.78","code":"4057-6","display":"Tobramycin [Mass/volume] in Serum or Plasma --peak"},{"system":"http://loinc.org","version":"2.78","code":"4059-2","display":"Tobramycin [Mass/volume] in Serum or Plasma --trough"},{"system":"http://loinc.org","version":"2.78","code":"40-6","display":"Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"40614-0","display":"Brucella sp Ab [Presence] in Serum by Agglutination"},{"system":"http://loinc.org","version":"2.78","code":"40658-7","display":"Parvovirus B19 IgM Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"40674-4","display":"Toxocara canis IgG Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"40727-0","display":"Hepatitis D virus Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"40745-2","display":"Filaria identified in Blood"},{"system":"http://loinc.org","version":"2.78","code":"40768-4","display":"Cryptococcus sp Ag [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"408-5","display":"Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"4092-3","display":"Vancomycin [Mass/volume] in Serum or Plasma --trough"},{"system":"http://loinc.org","version":"2.78","code":"40958-1","display":"Cryptosporidium parvum identified in Stool"},{"system":"http://loinc.org","version":"2.78","code":"40982-1","display":"Influenza virus B RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"40988-8","display":"Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"41001-9","display":"Human coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"41010-0","display":"Parainfluenza virus 4 RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"41163-7","display":"Treponema pallidum DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"41171-0","display":"Collagen crosslinked C-telopeptide [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"412-7","display":"Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41479-7","display":"BK virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"41499-5","display":"Legionella pneumophila 1 Ag [Presence] in Urine by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"41647-9","display":"Carbon dioxide, total [Moles/?volume] in Arterial blood by calculation"},{"system":"http://loinc.org","version":"2.78","code":"41662-8","display":"Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41665-1","display":"Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41672-7","display":"Cefotetan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41675-0","display":"Cefoxitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41679-2","display":"Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"416-8","display":"Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41681-8","display":"Ceftriaxone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41687-5","display":"Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41689-1","display":"Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41694-1","display":"Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41708-9","display":"Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41710-5","display":"Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41713-9","display":"Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41718-8","display":"Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41721-2","display":"Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41725-3","display":"Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"41727-9","display":"Aztreonam+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41728-7","display":"Biapenem [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41729-5","display":"Cefotetan+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41730-3","display":"Cefoxitin+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41731-1","display":"Cefpodoxime+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41732-9","display":"Ceftriaxone+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41733-7","display":"Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41734-5","display":"Dalbavancin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41735-2","display":"Everninomicin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41736-0","display":"Oritavancin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41737-8","display":"Ramoplanin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41738-6","display":"Rosamicin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41739-4","display":"Sulbactam [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41740-2","display":"Tazobactam [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"41853-3","display":"Orthopoxvirus DNA [Presence] in Specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"41858-2","display":"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"41984-6","display":"Lipoprotein analysis status/?results Set CPHS"},{"system":"http://loinc.org","version":"2.78","code":"41993-7","display":"Atazanavir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"420-0","display":"Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"42180-0","display":"C peptide [Moles/?volume] in Serum or Plasma --fasting"},{"system":"http://loinc.org","version":"2.78","code":"42200-6","display":"DNA double strand Ab [Units/?volume] in Serum by Radioimmunoassay (RIA)"},{"system":"http://loinc.org","version":"2.78","code":"42217-0","display":"Striated muscle IgG Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"42219-6","display":"Chromium [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"42221-2","display":"Manganese [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"42247-7","display":"Hemoglobin pattern [interpretation] in Blood by HPLC Narrative"},{"system":"http://loinc.org","version":"2.78","code":"42330-1","display":"Bordetella pertussis IgG Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"42351-7","display":"Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"42353-3","display":"Cefepime+Clavulanate [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"42355-8","display":"Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"42357-4","display":"Tigecycline [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"424-2","display":"Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"42535-5","display":"Tipranavir [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"42595-9","display":"Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"42807-8","display":"Parasite identified in Isolate"},{"system":"http://loinc.org","version":"2.78","code":"428-3","display":"Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"43092-6","display":"Arbovirus NOS Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"43180-9","display":"Herpes simplex virus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"43198-1","display":"Gamma hydroxybutyrate [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"432-5","display":"Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"43271-6","display":"Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"43272-4","display":"Ceftobiprole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"43279-9","display":"Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"43583-4","display":"Lipoprotein a [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"43590-9","display":"Rabies virus Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"436-6","display":"Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"43913-3","display":"Bordetella pertussis DNA [Presence] in Nasopharynx by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"43979-4","display":"Aspergillus sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"440-8","display":"Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"44357-2","display":"Galactomannan Ag [Units/?volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"444-0","display":"Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"44448-9","display":"Beta 2 glycoprotein 1 IgG Ab [Units/?volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"44534-6","display":"HLA Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"4476-8","display":"Complement C1 esterase inhibitor.functional [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4477-6","display":"Complement C1 esterase inhibitor [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"44798-7","display":"Burkholderia sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"44-8","display":"Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"448-1","display":"Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"4484-2","display":"Complement C2 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4485-9","display":"Complement C3 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"44918-1","display":"Dopamine/Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"44924-9","display":"Normetanephrine/?Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"4498-2","display":"Complement C4 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4505-4","display":"Complement C5 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4507-0","display":"Complement C6 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4508-8","display":"Complement C7 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4509-6","display":"Complement C8 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4510-4","display":"Complement C9 [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4519-5","display":"Complement factor H [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"452-3","display":"Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"45323-3","display":"Mycobacterium tuberculosis tuberculin stimulated gamma interferon [Presence] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"45335-7","display":"Bacteria Identification [Presence] in Isolate by Culture"},{"system":"http://loinc.org","version":"2.78","code":"4542-7","display":"Haptoglobin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"4548-4","display":"Hemoglobin A1c/Hemoglobin.total in Blood"},{"system":"http://loinc.org","version":"2.78","code":"4551-8","display":"Hemoglobin A2/Hemoglobin.total in Blood"},{"system":"http://loinc.org","version":"2.78","code":"456-4","display":"Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"4576-5","display":"Hemoglobin F/Hemoglobin.total in Blood"},{"system":"http://loinc.org","version":"2.78","code":"460-6","display":"Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"46094-9","display":"Plasmodium sp Ag [Presence] in Blood by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"46126-9","display":"Endomysium IgA Ab [Presence] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"46127-7","display":"Haptoglobin [Mass/volume] in Serum or Plasma by Nephelometry"},{"system":"http://loinc.org","version":"2.78","code":"46128-5","display":"Tissue transglutaminase IgA Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"46130-1","display":"Prealbumin [Mass/volume] in Serum or Plasma by Nephelometry"},{"system":"http://loinc.org","version":"2.78","code":"46218-4","display":"5-Fluorocytosine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"46266-3","display":"Myeloperoxidase Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"46267-1","display":"Proteinase 3 Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"46268-9","display":"ABO +? Rh group [Type] in Blood from Blood product unit--after transfusion reaction"},{"system":"http://loinc.org","version":"2.78","code":"46270-5","display":"ABO group [Type] in Blood--after transfusion reaction"},{"system":"http://loinc.org","version":"2.78","code":"46271-3","display":"Blood group antibody screen [Presence] in Serum or Plasma --after transfusion reaction"},{"system":"http://loinc.org","version":"2.78","code":"46272-1","display":"Appearance of Urine--after transfusion reaction"},{"system":"http://loinc.org","version":"2.78","code":"46273-9","display":"Appearance of Serum--after transfusion reaction"},{"system":"http://loinc.org","version":"2.78","code":"46274-7","display":"Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells --after transfusion reaction"},{"system":"http://loinc.org","version":"2.78","code":"46276-2","display":"Rh [Type] in Blood--after transfusion reaction"},{"system":"http://loinc.org","version":"2.78","code":"4633-4","display":"Hemoglobin F/Hemoglobin.total in Blood by Kleihauer-Betke method"},{"system":"http://loinc.org","version":"2.78","code":"4639-1","display":"Unstable Hemoglobin [Presence] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"4644-1","display":"Hemosiderin [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"464-8","display":"Sulfadiazine [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"4679-7","display":"Reticulocytes/100 erythrocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"4685-4","display":"Sulfhemoglobin/Hemoglobin.total in Blood"},{"system":"http://loinc.org","version":"2.78","code":"468-9","display":"Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"4691-2","display":"Viscosity of Plasma"},{"system":"http://loinc.org","version":"2.78","code":"47092-2","display":"Natriuretic peptide B [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"472-1","display":"Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"47255-5","display":"Procollagen type I.N-terminal propeptide [Mass/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"47299-3","display":"DNA double strand Ab [Units/?volume] in Serum by Farr method"},{"system":"http://loinc.org","version":"2.78","code":"47309-0","display":"Haemophilus influenzae B IgG Ab [Ratio] in Serum --2nd specimen/?1st specimen"},{"system":"http://loinc.org","version":"2.78","code":"47393-4","display":"Gliadin peptide IgA Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"47394-2","display":"Gliadin peptide IgG Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"47532-7","display":"Mumps virus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"47545-9","display":"5-Hydroxyindoleacetate/Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"47596-2","display":"Calcium.ionized [Moles/?volume] in Blood by Ion-selective membrane electrode (ISE)"},{"system":"http://loinc.org","version":"2.78","code":"476-2","display":"Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"47828-9","display":"Adiponectin [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"47994-9","display":"Bilirubin.total [Moles/?volume] in Cord blood"},{"system":"http://loinc.org","version":"2.78","code":"480-4","display":"Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"48062-4","display":"Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"48063-2","display":"Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"48111-9","display":"Glutathione.reduced [Moles/?mass] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"48326-3","display":"Glipizide [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"48327-1","display":"Glyburide [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"48329-7","display":"Chlorpropamide [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"48344-6","display":"Activated clotting time.kaolin induced of Platelet poor plasma"},{"system":"http://loinc.org","version":"2.78","code":"48357-8","display":"Testosterone [Moles/?volume] in Saliva (oral fluid)"},{"system":"http://loinc.org","version":"2.78","code":"48359-4","display":"Echinococcus granulosus Ab [Titer] in Serum by Hemagglutination"},{"system":"http://loinc.org","version":"2.78","code":"48377-6","display":"Mullerian inhibiting substance [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"48378-4","display":"Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"48391-7","display":"Carbon dioxide, total [Moles/?volume] in Venous blood by calculation"},{"system":"http://loinc.org","version":"2.78","code":"48398-2","display":"Hepatitis B virus DNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"48419-6","display":"Immune complex.IgG [Mass/?volume] in Serum or Plasma by C1q binding assay"},{"system":"http://loinc.org","version":"2.78","code":"48425-3","display":"Troponin T.cardiac [Mass/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"48432-9","display":"Fructose [Molar amount] in unspecified time Semen"},{"system":"http://loinc.org","version":"2.78","code":"484-6","display":"Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"48508-6","display":"Measles virus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"48509-4","display":"Influenza virus A and B RNA [Identifier] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"48618-3","display":"Cholesterol in VLDL [Mass/?volume] in Serum or Plasma ultracentrifugate"},{"system":"http://loinc.org","version":"2.78","code":"48721-5","display":"Bartonella henselae IgG Ab [Units/?volume] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"48807-2","display":"Bone marrow aspiration report"},{"system":"http://loinc.org","version":"2.78","code":"488-7","display":"Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"48-9","display":"Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"49117-5","display":"Norovirus Ag [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"49233-0","display":"Giardia lamblia+?Cryptosporidium parvum Ag [Presence] in Stool by Rapid, less than 30 minutes"},{"system":"http://loinc.org","version":"2.78","code":"49243-9","display":"Alkaline phosphatase isoenzymes [interpretation] in Serum or Plasma Narrative"},{"system":"http://loinc.org","version":"2.78","code":"49244-7","display":"Alpha 1 antitrypsin phenotype [Interpretation] in Serum or Plasma Narrative"},{"system":"http://loinc.org","version":"2.78","code":"49248-8","display":"Amino acid pattern [interpretation] in Urine Narrative"},{"system":"http://loinc.org","version":"2.78","code":"49252-0","display":"Calculus analysis [interpretation] in Stone Narrative"},{"system":"http://loinc.org","version":"2.78","code":"49268-6","display":"Glycosaminoglycans pattern [interpretation] in Urine Narrative"},{"system":"http://loinc.org","version":"2.78","code":"49279-3","display":"Lactate dehydrogenase isoenzymes [interpretation] in Serum or Plasma Narrative"},{"system":"http://loinc.org","version":"2.78","code":"492-9","display":"Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"49290-0","display":"Porphyrins [interpretation] in Stool Narrative"},{"system":"http://loinc.org","version":"2.78","code":"49291-8","display":"Porphyrins [interpretation] in Urine Narrative"},{"system":"http://loinc.org","version":"2.78","code":"49308-0","display":"Neutrophil cytoplasmic Ab pattern [interpretation] in Serum by Immunofluorescence Narrative"},{"system":"http://loinc.org","version":"2.78","code":"49316-3","display":"Hemoglobin pattern [interpretation] in Blood by Electrophoresis"},{"system":"http://loinc.org","version":"2.78","code":"49323-9","display":"Hemoglobin pattern [interpretation] in Blood by Electrophesis citrate agar"},{"system":"http://loinc.org","version":"2.78","code":"496-0","display":"Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"49671-1","display":"Neisseria meningitidis DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"49755-2","display":"Crystals [Presence] in Urine sediment by Light microscopy "},{"system":"http://loinc.org","version":"2.78","code":"49836-0","display":"Platelet function (closure time) [interpretation] in Blood Narrative"},{"system":"http://loinc.org","version":"2.78","code":"49863-4","display":"Aspergillus sp DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"4996-5","display":"Cytomegalovirus DNA [Presence] in Blood by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"5000-5","display":"Cytomegalovirus DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"500-9","display":"Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"5014-6","display":"Herpes simplex virus DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"50377-1","display":"von Willebrand factor (vWf).collagen binding activity actual/?normal in Platelet poor plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"50378-9","display":"von Willebrand factor (vWf).collagen binding activity/von Willebrand factor Ag [Ratio] in Platelet poor plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"504-1","display":"Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"50410-0","display":"dRVVT/dRVVT W excess phospholipid (screen to confirm ratio)"},{"system":"http://loinc.org","version":"2.78","code":"5043-5","display":"Adrenal Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"5052-6","display":"Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID)"},{"system":"http://loinc.org","version":"2.78","code":"50544-6","display":"Everolimus [Mass/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"50548-7","display":"Respiratory virus DNA+RNA [Identifier] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"50592-5","display":"Ecgonine methyl ester [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"5064-1","display":"Borrelia burgdorferi IgM Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"50761-6","display":"A IgG Ab [Titer] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"50762-4","display":"A IgM Ab [Titer] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"50763-2","display":"B IgM Ab [Titer] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"50764-0","display":"B IgG Ab [Titer] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"508-2","display":"Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"50903-4","display":"Selenium [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"50936-4","display":"Vanadium [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"50968-7","display":"HLA Ab [Type] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"51164-2","display":"CD34 blasts [Units/?volume] in Bone marrow"},{"system":"http://loinc.org","version":"2.78","code":"512-4","display":"Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"5133-4","display":"Streptococcal DNAse B [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"51480-2","display":"Bacteria [#/volume] in Urine by Automated count"},{"system":"http://loinc.org","version":"2.78","code":"51597-3","display":"Glucose [Moles/volume] in Serum or Plasma --1 hour post 75 g glucose PO"},{"system":"http://loinc.org","version":"2.78","code":"516-5","display":"Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"51694-8","display":"Carumonam [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"51698-9","display":"Dapsone [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"51710-2","display":"Leishmania sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"51719-3","display":"Paromomycin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"51724-3","display":"Cefuroxime [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"51774-8","display":"Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"51775-5","display":"Chromatin Ab [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"51776-3","display":"7-Aminoclonazepam [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"51777-1","display":"7-Aminoflunitrazepam [Mass/?volume] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"51781-3","display":"Carbon dioxide, total [Moles/?volume] in Capillary blood by calculation"},{"system":"http://loinc.org","version":"2.78","code":"51844-9","display":"Cortisol [Moles/?volume] in Saliva (oral fluid)"},{"system":"http://loinc.org","version":"2.78","code":"51916-5","display":"Herpes simplex virus 1 IgG Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"5195-3","display":"Hepatitis B virus surface Ag [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"5199-5","display":"Hepatitis C virus Ab [Presence] in Serum by Immunoblot"},{"system":"http://loinc.org","version":"2.78","code":"520-7","display":"Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"52-1","display":"Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"52114-6","display":"Direct antiglobulin test.IgG specific reagent [presence] on Cord red blood cells"},{"system":"http://loinc.org","version":"2.78","code":"5226-6","display":"HTLV I+II Ab [Units/volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"5230-8","display":"Influenza virus B Ab [Titer] in Serum by Complement fixation"},{"system":"http://loinc.org","version":"2.78","code":"524-9","display":"Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"5253-0","display":"Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"5265-4","display":"Pancreatic islet cell Ab [Presence] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"5271-2","display":"Parietal cell Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"528-0","display":"Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"52901-6","display":"Vanadium/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"5290-2","display":"Reagin Ab [Presence] in Cerebral spinal fluid by VDRL"},{"system":"http://loinc.org","version":"2.78","code":"52913-1","display":"Selenium [Moles/?volume] in Red Blood Cells"},{"system":"http://loinc.org","version":"2.78","code":"52915-6","display":"Aluminum [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"52929-7","display":"Mercury/?Creatinine [Molar ratio] in 24 hour Urine"},{"system":"http://loinc.org","version":"2.78","code":"5295-1","display":"Respiratory syncytial virus Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"52961-0","display":"Paraquat [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"52984-2","display":"Cytomegalovirus IgG Ab avidity [Ratio] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"53007-1","display":"PM-SCL extractable nuclear Ab [Presence] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"53020-4","display":"Complement C1q Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"53115-2","display":"Immature granulocytes [#/?volume] in Blood by Automated count"},{"system":"http://loinc.org","version":"2.78","code":"531-4","display":"Zidovudine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"53523-7","display":"Vasoactive intestinal peptide [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"53556-7","display":"Erythrocytes.Plasmodium sp infected/?100 erythrocytes in Blood"},{"system":"http://loinc.org","version":"2.78","code":"53622-7","display":"von Willebrand factor (vWf) cleaving protease actual/?normal in Platelet poor plasma by Chromogenic method"},{"system":"http://loinc.org","version":"2.78","code":"5369-4","display":"Streptokinase Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"5370-2","display":"Streptolysin O Ab [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"53731-6","display":"Posaconazole [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"53812-4","display":"Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"5381-9","display":"Thyroglobulin Ab [Titer] in Serum by Latex agglutination"},{"system":"http://loinc.org","version":"2.78","code":"53819-9","display":"Thiopurine methyltransferase [Enzymatic activity/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"5386-8","display":"Toxocara canis Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"53903-1","display":"Collection method - Specimen"},{"system":"http://loinc.org","version":"2.78","code":"5393-4","display":"Treponema pallidum Ab [Presence] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"53946-0","display":"Escherichia coli shiga-like toxin identified in Unspecified specimen"},{"system":"http://loinc.org","version":"2.78","code":"54067-4","display":"Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"54091-4","display":"Rubella virus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"54187-0","display":"Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"54188-8","display":"Posaconazole [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"54218-3","display":"CD3+?CD4+? (T4 helper) cells/?CD3+?CD8+? (T8 suppressor cells) cells [# Ratio] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"54285-2","display":"Glycerol [Moles/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"54309-0","display":"Lactate/?Pyruvate [Molar ratio] in Cerebral spinal fluid"},{"system":"http://loinc.org","version":"2.78","code":"543-9","display":"Mycobacterium sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"54905-5","display":"Norovirus Genogroup I RNA [Presence] in Stool by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"54906-3","display":"Norovirus Genogroup II RNA [Presence] in Stool by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"54914-7","display":"Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"54941-0","display":"Tungsten [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"55100-2","display":"Respiratory syncytial virus [Presence] in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"55343-8","display":"Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"55580-5","display":"Sulfapyridine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"55581-3","display":"Sulfasalazine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"5568-1","display":"Acetone [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"5570-7","display":"Acetone [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"55805-6","display":"Cyclosporine [Mass/?volume] in Blood by LC/?MS/?MS"},{"system":"http://loinc.org","version":"2.78","code":"5581-4","display":"Antimony [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"5590-5","display":"Barium [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"5598-8","display":"Bismuth [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"560-3","display":"Chlamydia sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"56126-6","display":"Copper [Mass/?mass] in Liver"},{"system":"http://loinc.org","version":"2.78","code":"56145-6","display":"CD55+?CD59 deficient RBC+?Granulocytes [interpretation] in Blood Narrative"},{"system":"http://loinc.org","version":"2.78","code":"56-2","display":"Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"562-9","display":"Clostridioides difficile [Presence] in Stool by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"5646-5","display":"Ethylene glycol [Mass/volume] in Serum, Plasma or Blood"},{"system":"http://loinc.org","version":"2.78","code":"5647-3","display":"Ethylene glycol [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"56536-6","display":"Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"56537-4","display":"Tissue transglutaminase IgG Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"56539-0","display":"Intrinsic factor Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"56540-8","display":"Glutamate decarboxylase 65 Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"56717-2","display":"Histone Ab [Presence] in Serum by Immunoblot"},{"system":"http://loinc.org","version":"2.78","code":"56718-0","display":"Islet cell 512 Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"56721-4","display":"PM-SCL extractable nuclear Ab [Presence] in Serum by Immunoblot"},{"system":"http://loinc.org","version":"2.78","code":"56722-2","display":"Soluble liver Ab [Presence] in Serum by Immunoblot"},{"system":"http://loinc.org","version":"2.78","code":"567-8","display":"Diphtheria identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"5681-2","display":"Manganese [Mass/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"5684-6","display":"Manganese [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"56888-1","display":"HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"56940-0","display":"Inhibin B [Mass/?volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"56972-3","display":"Prolactin [Mass/?volume] in Serum or Plasma --post precipitation"},{"system":"http://loinc.org","version":"2.78","code":"56991-3","display":"Toxoplasma gondii IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"5699-4","display":"Molybdenum [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"57028-3","display":"Iron [Mass/?mass] in Liver"},{"system":"http://loinc.org","version":"2.78","code":"57095-2","display":"Anidulafungin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"5711-7","display":"Pentachlorophenol [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"5722-4","display":"Selenium [Mass/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"5734-9","display":"Silver [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"5735-6","display":"Silver [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"57378-2","display":"Porphyrins/?Creatinine [Molar ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"57416-0","display":"Thyrotropin receptor Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"5745-5","display":"Thallium [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"57502-7","display":"11-Deoxycortisol [Moles/?volume] in Serum or Plasma --1 day post dose metyrapone"},{"system":"http://loinc.org","version":"2.78","code":"5770-3","display":"Bilirubin.total [Presence] in Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"57734-6","display":"Ketones [Presence] in Urine by Automated test strip"},{"system":"http://loinc.org","version":"2.78","code":"57744-5","display":"Striated muscle Ab [Presence] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"57745-2","display":"Adrenal Ab [Presence] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"57746-0","display":"Gamma hydroxybutyrate [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"57761-9","display":"Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"5782-8","display":"Crystals [type] in Urine sediment by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"57838-5","display":"dRVVT W excess phospholipid (LA confirm)"},{"system":"http://loinc.org","version":"2.78","code":"57844-3","display":"Imatinib mesylate [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"57901-1","display":"Clostridioides difficile glutamate dehydrogenase [Presence] in Stool"},{"system":"http://loinc.org","version":"2.78","code":"5794-3","display":"Hemoglobin [Presence] in Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"5799-2","display":"Leukocyte esterase [Presence] in Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"580-1","display":"Fungus identified in Unspecified specimen by Culture"},{"system":"http://loinc.org","version":"2.78","code":"5802-4","display":"Nitrite [Presence] in Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"5803-2","display":"pH of Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"5811-5","display":"Specific gravity of Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"5818-0","display":"Urobilinogen [Presence] in Urine by Test strip"},{"system":"http://loinc.org","version":"2.78","code":"58416-9","display":"MLH1 gene methylation [Presence] in Blood or Tissue by Molecular genetics method"},{"system":"http://loinc.org","version":"2.78","code":"58436-7","display":"Casts [Type] in Urine sediment by Light microscopy "},{"system":"http://loinc.org","version":"2.78","code":"5843-8","display":"Enterovirus identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"5846-1","display":"Herpes simplex virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"5849-5","display":"Herpes simplex virus 2 Ag [Presence] in Unspecified specimen by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"5854-5","display":"Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"5855-2","display":"Herpes simplex virus Ag [Presence] in Unspecified specimen by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"58570-3","display":"Corticotropin [Moles/?volume] in Plasma --1 day post dose metyrapone"},{"system":"http://loinc.org","version":"2.78","code":"5859-4","display":"Herpes simplex virus identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"586-8","display":"Streptococcus agalactiae [Presence] in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"587-6","display":"Helicobacter pylori [Presence] in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"5877-6","display":"Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"58897-0","display":"Methyl ethyl ketone/?Creatinine [Mass Ratio] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"58900-2","display":"HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"5894-1","display":"Prothrombin time (PT) actual/Normal"},{"system":"http://loinc.org","version":"2.78","code":"590-0","display":"Legionella sp identified in Sputum by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"5901-4","display":"Prothrombin time (PT) in control Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"5902-2","display":"Prothrombin time (PT)"},{"system":"http://loinc.org","version":"2.78","code":"59070-3","display":"Paraquat [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"5909-7","display":"Blood smear finding [Identifier] in Blood by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"59176-8","display":"Zopiclone [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"59186-7","display":"Cyanide [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"59261-8","display":"Hemoglobin A1c/Hemoglobin.total in Blood by IFCC protocol"},{"system":"http://loinc.org","version":"2.78","code":"59287-3","display":"Benzylpiperazine [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"59394-7","display":"Glomerular basement membrane Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"594-2","display":"Leptospira sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"59420-0","display":"Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification"},{"system":"http://loinc.org","version":"2.78","code":"5942-8","display":"Reptilase time in control Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"5946-9","display":"aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"},{"system":"http://loinc.org","version":"2.78","code":"59472-1","display":"Calcium.ionized [Mass/?volume] adjusted to pH 7.4 in Arterial blood by Ion-selective membrane electrode (ISE)"},{"system":"http://loinc.org","version":"2.78","code":"5949-3","display":"aPTT.factor substitution in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"},{"system":"http://loinc.org","version":"2.78","code":"5955-0","display":"Thrombin time in control Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"5956-8","display":"Prothrombin time (PT) factor substitution in control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"},{"system":"http://loinc.org","version":"2.78","code":"5959-2","display":"Prothrombin time (PT) factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma"},{"system":"http://loinc.org","version":"2.78","code":"59965-4","display":"Quinine [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"60017-1","display":"Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction"},{"system":"http://loinc.org","version":"2.78","code":"60023-9","display":"Lactate dehydrogenase [Enzymatic activity/?volume] in Cerebral spinal fluid by Pyruvate to lactate reaction"},{"system":"http://loinc.org","version":"2.78","code":"60024-7","display":"Lactate dehydrogenase [Enzymatic activity/?volume] in Cerebral spinal fluid by Lactate to pyruvate reaction"},{"system":"http://loinc.org","version":"2.78","code":"60088-2","display":"Hyoscyamine [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"6014-5","display":"von Willebrand factor (vWf) ristocetin cofactor actual/normal in Platelet poor plasma by Platelet aggregation"},{"system":"http://loinc.org","version":"2.78","code":"60-4","display":"Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"60422-3","display":"Measles virus genotype [Identifier] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"60463-7","display":"Insulin Ab [Moles/?volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"60517-0","display":"Iron/?Transferrin [Ratio] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"61030-3","display":"7-Aminoclonazepam [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"61033-7","display":"7-Aminoflunitrazepam [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"61036-0","display":"Alpha hydroxyalprazolam [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"61152-5","display":"Albumin [Mass/?volume] in Serum or Plasma by Bromocresol purple (BCP) dye binding method"},{"system":"http://loinc.org","version":"2.78","code":"61365-3","display":"Parainfluenza virus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"61406-5","display":"XXX blood group Ab [Titer] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"614-8","display":"Mycobacterium sp identified in Isolate by Mycobacterial subtyping"},{"system":"http://loinc.org","version":"2.78","code":"62238-1","display":"Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (CKD-EPI)"},{"system":"http://loinc.org","version":"2.78","code":"623-9","display":"Bacteria identified in Sputum by Cystic fibrosis respiratory culture"},{"system":"http://loinc.org","version":"2.78","code":"62467-6","display":"Galactomannan Ag [Units/?volume] in Unspecified specimen by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"6298-4","display":"Potassium [Moles/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"6301-6","display":"INR in Platelet poor plasma by Coagulation assay"},{"system":"http://loinc.org","version":"2.78","code":"6303-2","display":"dRVVT (LA screen)"},{"system":"http://loinc.org","version":"2.78","code":"6306-5","display":"Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"6317-2","display":"Bordetella sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"6325-5","display":"Brucella abortus Ab [Titer] in Serum by Complement fixation"},{"system":"http://loinc.org","version":"2.78","code":"63437-8","display":"Brucella abortus Ab [Titer] in Serum by Antihuman globulin"},{"system":"http://loinc.org","version":"2.78","code":"635-3","display":"Bacteria identified in Unspecified specimen by Anaerobe culture"},{"system":"http://loinc.org","version":"2.78","code":"6354-5","display":"Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"6355-2","display":"Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"637-9","display":"Plasmodium sp identified in Blood by Thick film"},{"system":"http://loinc.org","version":"2.78","code":"64013-6","display":"Escherichia coli shiga-like toxin 1 and 2 [Identifier] in Stool by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"64233-0","display":"Benzylpiperazine [Presence] in Urine by Confirmatory method"},{"system":"http://loinc.org","version":"2.78","code":"6450-1","display":"Legionella sp Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"64-6","display":"Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"6463-4","display":"Bacteria identified in Unspecified specimen by Culture"},{"system":"http://loinc.org","version":"2.78","code":"6476-6","display":"Mumps virus IgG Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"6478-2","display":"Mumps virus IgM Ab [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"6486-5","display":"Mycoplasma sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"65340-2","display":"Micafungin [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"6562-3","display":"Treponema pallidum IgM Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"6579-7","display":"Vibrio sp identified in Stool by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"6584-7","display":"Virus identified in Unspecified specimen by Culture"},{"system":"http://loinc.org","version":"2.78","code":"6598-7","display":"Troponin T.cardiac [Mass/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"660-1","display":"Microscopic observation [Identifier] in Unspecified specimen by Dark field examination"},{"system":"http://loinc.org","version":"2.78","code":"6604-3","display":"Influenza virus identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"6609-2","display":"Listeria sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"6630-8","display":"Schistosoma sp Ab [Presence] in Serum by Hemagglutination"},{"system":"http://loinc.org","version":"2.78","code":"664-3","display":"Microscopic observation [Identifier] in Unspecified specimen by Gram stain"},{"system":"http://loinc.org","version":"2.78","code":"6644-9","display":"Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"6652-2","display":"Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"666-8","display":"Microscopic observation [Identifier] in Unspecified specimen by India ink prep"},{"system":"http://loinc.org","version":"2.78","code":"66736-0","display":"Normalized silica clotting time of Platelet poor plasma"},{"system":"http://loinc.org","version":"2.78","code":"667-6","display":"Microscopic observation [Identifier] in Unspecified specimen by KOH preparation"},{"system":"http://loinc.org","version":"2.78","code":"6683-7","display":"Reptilase time"},{"system":"http://loinc.org","version":"2.78","code":"66878-0","display":"Skin Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"6689-4","display":"Glucose [Mass/volume] in Blood -- 2 hours post meal"},{"system":"http://loinc.org","version":"2.78","code":"6-7","display":"Amantadine [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"6709-0","display":"Hippurate [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"675-9","display":"Enterobius vermicularis [Presence] in Unspecified specimen by Pinworm exam"},{"system":"http://loinc.org","version":"2.78","code":"6768-6","display":"Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"678-3","display":"Microscopic observation [Identifier] in Unspecified specimen by Trichrome stain"},{"system":"http://loinc.org","version":"2.78","code":"680-9","display":"Microscopic observation [Identifier] in Unspecified specimen by Wet preparation"},{"system":"http://loinc.org","version":"2.78","code":"6825-4","display":"Crystals [type] in Body fluid by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"6827-0","display":"Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"68324-3","display":"von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"6864-3","display":"Hemoglobin S [Presence] in Blood by Solubility test"},{"system":"http://loinc.org","version":"2.78","code":"68-7","display":"Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"6873-4","display":"Beta hydroxybutyrate [Moles/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"6875-9","display":"Cancer Ag 15-3 [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"68916-6","display":"dRVVT W excess phospholipid actual/normal (normalized LA confirm)"},{"system":"http://loinc.org","version":"2.78","code":"68936-4","display":"Baker's yeast Ab [Units/?volume] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"68969-5","display":"Relative activated clotting time (ACT) of Platelet poor plasma by Kaolin induced method"},{"system":"http://loinc.org","version":"2.78","code":"6913-8","display":"Chlamydophila pneumoniae IgG Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"6916-1","display":"Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"6932-8","display":"Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"6933-6","display":"Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"6948-4","display":"Lamotrigine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"6954-2","display":"Bartonella henselae IgG Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"698-1","display":"Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"6984-9","display":"Beta lactamase.extended spectrum [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"6985-6","display":"Beta lactamase.usual [Susceptibility]"},{"system":"http://loinc.org","version":"2.78","code":"69935-5","display":"Mycoplasma genitalium DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"69937-1","display":"Trichomonas vaginalis DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"69938-9","display":"Astrovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"69949-6","display":"Epstein Barr virus capsid IgG Ab avidity [Presence] in Serum by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"69951-2","display":"Amylase.pancreatic/Creatinine(Ratio) in Urine"},{"system":"http://loinc.org","version":"2.78","code":"70061-7","display":"Human papilloma virus 16 and 18 DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"70147-4","display":"Methadone [Mass/?volume] in Urine by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"7018-5","display":"Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"70205-0","display":"Clonazepam [Moles/?volume] in Serum or Plasma by Screen method"},{"system":"http://loinc.org","version":"2.78","code":"7024-3","display":"Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"70569-9","display":"Plasmodium sp Ag [Identifier] in Blood by Rapid immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"7106-8","display":"Aspergillus sp IgE Ab [Units/?volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"716-1","display":"Heinz bodies [Presence] in Blood by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"71792-6","display":"Procollagen type III.N-terminal propeptide [Mass/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"71793-4","display":"Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination"},{"system":"http://loinc.org","version":"2.78","code":"718-7","display":"Hemoglobin [Mass/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"72111-8","display":"Sapovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"72160-5","display":"Holo-transcobalamin II [Moles/?volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"72493-0","display":"Cytomegalovirus DNA [Units/volume] (viral load) in Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"725-2","display":"Hemoglobin [Presence] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"72624-0","display":"Rivaroxaban [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"72625-7","display":"Dabigatran [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"72-9","display":"Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"73654-6","display":"Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method"},{"system":"http://loinc.org","version":"2.78","code":"73655-3","display":"Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method"},{"system":"http://loinc.org","version":"2.78","code":"73723-9","display":"Riboflavin [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"74096-9","display":"Tacrolimus [Mass/?volume] in Blood by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"74097-7","display":"Tacrolimus [Mass/?volume] in Blood by LC/?MS/?MS"},{"system":"http://loinc.org","version":"2.78","code":"74442-5","display":"Pyridoxal phosphate [Moles/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"75050-5","display":"Coenzyme Q10 [Moles/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"75515-7","display":"Lupus anticoagulant aPTT and dRVVT screening panel W Reflex"},{"system":"http://loinc.org","version":"2.78","code":"76-0","display":"Cefazolin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"76346-6","display":"Microorganism identified in Isolate by MS.MALDI-TOF"},{"extension":[{"url":"http://ontoserver.csiro.au/profiles/expansion","extension":[{"url":"inactive","valueBoolean":true}]}],"system":"http://loinc.org","inactive":true,"version":"2.78","code":"7799-0","display":"Fibrin D-dimer [Units/volume] in Platelet poor plasma"},{"system":"http://loinc.org","version":"2.78","code":"7808-9","display":"Aspergillus sp Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"7852-7","display":"Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"7853-5","display":"Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"7883-2","display":"Epstein Barr virus nuclear IgG Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"7905-3","display":"Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Neutralization test"},{"system":"http://loinc.org","version":"2.78","code":"7906-1","display":"Hepatitis D virus RNA [Presence] in Serum by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"7918-6","display":"HIV 1+2 Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"7948-3","display":"Legionella pneumophila 1 Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"7959-0","display":"Leptospira sp Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"7968-1","display":"Mumps virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"7993-9","display":"Rhinovirus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"7994-7","display":"Rickettsia sp Ab [Units/?volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8012-7","display":"Rotavirus dsRNA [Presence] in Stool by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"8013-5","display":"Rubella virus Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8014-3","display":"Rubella virus IgG Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8015-0","display":"Rubella virus IgM Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"80-2","display":"Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"8039-0","display":"Toxoplasma gondii IgG Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8040-8","display":"Toxoplasma gondii IgM Ab [Units/volume] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"80515-0","display":"Kappa light chains.free [Mass/volume] in Serum by Nephelometry"},{"system":"http://loinc.org","version":"2.78","code":"80516-8","display":"Lambda light chains.free [Mass/volume] in Serum by Nephelometry"},{"system":"http://loinc.org","version":"2.78","code":"80517-6","display":"Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum by Nephelometry"},{"system":"http://loinc.org","version":"2.78","code":"8061-4","display":"Nuclear Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8076-2","display":"Jo-1 extractable nuclear Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8091-1","display":"Ribonucleoprotein extractable nuclear Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8092-9","display":"SCL-70 extractable nuclear Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8093-7","display":"Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8094-5","display":"Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8095-2","display":"Smooth muscle Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"8098-6","display":"Thyroglobulin Ab [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"8099-4","display":"Thyroperoxidase Ab [Units/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"8116-6","display":"CD19 cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"81169-5","display":"Residual tumor [Interpretation] Cancer Narrative --postoperative"},{"system":"http://loinc.org","version":"2.78","code":"8122-4","display":"CD3 cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"81317-0","display":"Additional pathological findings [Identifier] in Specimen"},{"system":"http://loinc.org","version":"2.78","code":"8150-5","display":"Amphetamines [Mass/?volume] in Urine"},{"system":"http://loinc.org","version":"2.78","code":"8161-2","display":"Bismuth [Mass/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"81691-8","display":"DNA mismatch repair protein Mlh1 [Presence] in Cancer specimen by Immune stain"},{"system":"http://loinc.org","version":"2.78","code":"81692-6","display":"DNA mismatch repair protein Msh2 [Presence] in Cancer specimen by Immune stain"},{"system":"http://loinc.org","version":"2.78","code":"81693-4","display":"DNA mismatch repair protein Msh6 [Presence] in Cancer specimen by Immune stain"},{"system":"http://loinc.org","version":"2.78","code":"81694-2","display":"Mismatch repair endonuclease PMS2 [Presence] in Cancer specimen by Immune stain"},{"system":"http://loinc.org","version":"2.78","code":"8275-0","display":"Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"8-3","display":"Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"83121-4","display":"Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"83126-3","display":"Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"84-4","display":"Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"84882-0","display":"Histologic type in Colorectal cancer specimen by WHO classification"},{"system":"http://loinc.org","version":"2.78","code":"84883-8","display":"Deepest extent of tumor invasion [Type] in Colorectal cancer specimen"},{"system":"http://loinc.org","version":"2.78","code":"85291-3","display":"Surgical margin tumor involvement.deep [Presence] in Colorectal cancer specimen by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"85299-6","display":"BRAF V600E mutant protein [Presence] in Cancer specimen by Immune stain"},{"system":"http://loinc.org","version":"2.78","code":"882-1","display":"ABO and Rh group [Type] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"88-5","display":"Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"888-8","display":"Blood group antibodies identified in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"890-4","display":"Blood group antibody screen [Presence] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"897-9","display":"Blood group antibody screen [Presence] in Serum or Plasma by Elution"},{"system":"http://loinc.org","version":"2.78","code":"89873-4","display":"Unique identifier [Identifier] of Initial sample"},{"system":"http://loinc.org","version":"2.78","code":"92-7","display":"Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"92837-4","display":"Perineural invasion [Presence] in Cancer specimen"},{"system":"http://loinc.org","version":"2.78","code":"933-2","display":"Blood product type"},{"system":"http://loinc.org","version":"2.78","code":"9335-1","display":"Appearance of Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"94306-8","display":"SARS-CoV-2 (COVID-19) RNA panel - Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94307-6","display":"SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N1"},{"system":"http://loinc.org","version":"2.78","code":"94308-4","display":"SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N2"},{"system":"http://loinc.org","version":"2.78","code":"94309-2","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94310-0","display":"SARS-like Coronavirus N gene [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94311-8","display":"SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N1"},{"system":"http://loinc.org","version":"2.78","code":"94312-6","display":"SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Unspecified specimen by Nucleic acid amplification using CDC primer-probe set N2"},{"system":"http://loinc.org","version":"2.78","code":"94313-4","display":"SARS-like Coronavirus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94314-2","display":"SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94315-9","display":"SARS-related coronavirus E gene [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94316-7","display":"SARS-CoV-2 (COVID-19) N gene [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94499-1","display":"Respiratory viral pathogens DNA and RNA panel - Respiratory specimen Qualitative by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94500-6","display":"SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94501-4","display":"Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94502-2","display":"SARS coronavirus+SARS-like coronavirus+SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94503-0","display":"SARS coronavirus 2 IgG and IgM panel - Serum or Plasma Qualitative by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94504-8","display":"SARS coronavirus 2 IgG and IgM panel - Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94505-5","display":"SARS coronavirus 2 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94506-3","display":"SARS coronavirus 2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94507-1","display":"SARS coronavirus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94508-9","display":"SARS coronavirus 2 IgM Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94509-7","display":"SARS coronavirus 2 E gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94510-5","display":"SARS coronavirus 2 N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94511-3","display":"SARS coronavirus 2 ORF1ab region [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94531-1","display":"SARS Coronavirus 2 RNA panel - Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94532-9","display":"SARS coronavirus+SARS-like coronavirus+SARS coronavirus 2+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94533-7","display":"SARS coronavirus 2 N gene [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94534-5","display":"SARS coronavirus 2 RdRp gene [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94547-7","display":"SARS coronavirus 2 IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94558-4","display":"SARS coronavirus 2 Ag [Presence] in Respiratory specimen by Rapid immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94559-2","display":"SARS coronavirus 2 ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94562-6","display":"SARS coronavirus 2 IgA Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94563-4","display":"SARS coronavirus 2 IgG Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94564-2","display":"SARS coronavirus 2 IgM Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94565-9","display":"SARS coronavirus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94639-2","display":"SARS coronavirus 2 ORF1ab region [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94640-0","display":"SARS coronavirus 2 S gene [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94641-8","display":"SARS coronavirus 2 S gene [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94642-6","display":"SARS coronavirus 2 S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94643-4","display":"SARS coronavirus 2 S gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94644-2","display":"SARS coronavirus 2 ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94645-9","display":"SARS coronavirus 2 RdRp gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94646-7","display":"SARS coronavirus 2 RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94647-5","display":"SARS-related coronavirus RNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94660-8","display":"SARS coronavirus 2 RNA [Presence] in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94661-6","display":"SARS coronavirus 2 Ab [Interpretation] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"94720-0","display":"SARS coronavirus 2 IgA Ab [Units/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94745-7","display":"SARS coronavirus 2 RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94746-5","display":"SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94756-4","display":"SARS coronavirus 2 N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1"},{"system":"http://loinc.org","version":"2.78","code":"94757-2","display":"SARS coronavirus 2 N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N2"},{"system":"http://loinc.org","version":"2.78","code":"94758-0","display":"SARS coronavirus 2 E gene [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94759-8","display":"SARS coronavirus 2 RNA [Presence] in Nasopharynx by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94760-6","display":"SARS-CoV-2 (COVID19) N gene [Presence] in Nasopharynx by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94761-4","display":"SARS coronavirus 2 IgG Ab [Presence] in DBS by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94762-2","display":"SARS coronavirus 2 Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94763-0","display":"SARS coronavirus 2 [Presence] in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"94764-8","display":"SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing"},{"system":"http://loinc.org","version":"2.78","code":"94765-5","display":"SARS coronavirus 2 E gene [Presence] in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94766-3","display":"SARS coronavirus 2 N gene [Presence] in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94767-1","display":"SARS coronavirus 2 S gene [Presence] in Serum or Plasma by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94768-9","display":"SARS coronavirus 2 IgA Ab [Presence] in Serum or Plasma by Rapid immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94769-7","display":"SARS coronavirus 2 Ab [Units/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"94819-0","display":"SARS coronavirus 2 RNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"94822-4","display":"SARS coronavirus 2 RNA [Presence] in Saliva (oral fluid) by Sequencing"},{"system":"http://loinc.org","version":"2.78","code":"94845-5","display":"SARS coronavirus 2 RNA [Presence] in Saliva (oral fluid) by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95125-1","display":"SARS-CoV-2 (COVID19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"95209-3","display":"SARS-CoV+SARS-CoV-2 (COVID19) Ag [Presence] in Respiratory specimen by Rapid immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"95380-2","display":"Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95383-6","display":"Symptom resolution status"},{"system":"http://loinc.org","version":"2.78","code":"95406-5","display":"SARS-CoV-2 (COVID19) RNA [Presence] in Nose by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95409-9","display":"SARS-CoV-2 (COVID19) N gene [Presence] in Nose by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95410-7","display":"SARS-CoV-2 (COVID19) neutralizing antibody [Titer] in Serum by pVNT"},{"system":"http://loinc.org","version":"2.78","code":"95411-5","display":"SARS-CoV-2 (COVID19) neutralizing antibody [Presence] in Serum by pVNT"},{"system":"http://loinc.org","version":"2.78","code":"95416-4","display":"SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"95422-2","display":"Long Common NameInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95423-0","display":"Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95424-8","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing"},{"system":"http://loinc.org","version":"2.78","code":"95425-5","display":"Long Common NameSARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95427-1","display":"SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"95428-9","display":"SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"95429-7","display":"SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"95521-1","display":"Long Common NameSARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95522-9","display":"SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95542-7","display":"SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"9558-8","display":"CD20 cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"9559-6","display":"CD5 cells [#/?volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"95608-6","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95609-4","display":"SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing"},{"system":"http://loinc.org","version":"2.78","code":"9571-1","display":"Parvovirus B19 DNA [Presence] in Unspecified specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95823-1","display":"SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95824-9","display":"SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95825-6","display":"SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"95826-4","display":"SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95941-1","display":"Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"95942-9","display":"Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"95970-0","display":"SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing"},{"system":"http://loinc.org","version":"2.78","code":"95971-8","display":"SARS CoV-2 stimulated gamma interferon [Presence] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"95972-6","display":"SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood"},{"system":"http://loinc.org","version":"2.78","code":"95973-4","display":"SARS CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood"},{"system":"http://loinc.org","version":"2.78","code":"95974-2","display":"SARS CoV-2 stimulated gamma interferon panel - Blood"},{"system":"http://loinc.org","version":"2.78","code":"96091-4","display":"SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96094-8","display":"SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96115-1","display":"Long Common NameLevel of tumor invasion [Type] in Colorectal cancer specimen by Haggitt"},{"system":"http://loinc.org","version":"2.78","code":"96118-5","display":"SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"96119-3","display":"SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"96120-1","display":"SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96121-9","display":"SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96122-7","display":"SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96123-5","display":"SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"9627-1","display":"Imipramine+?Desipramine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"96603-6","display":"SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by sVNT"},{"system":"http://loinc.org","version":"2.78","code":"96741-4","display":"SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing"},{"system":"http://loinc.org","version":"2.78","code":"96742-2","display":"SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"96751-3","display":"SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method"},{"system":"http://loinc.org","version":"2.78","code":"96752-1","display":"SARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method"},{"system":"http://loinc.org","version":"2.78","code":"96755-4","display":"SARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative"},{"system":"http://loinc.org","version":"2.78","code":"96763-8","display":"SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96764-6","display":"SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96765-3","display":"SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96797-6","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96-8","display":"Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC)"},{"system":"http://loinc.org","version":"2.78","code":"96829-7","display":"SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96894-1","display":"SARS coronavirus 2 (COVID-19) whole genome sequencing and identification panel - Specimen by Molecular genetics method"},{"system":"http://loinc.org","version":"2.78","code":"96895-8","display":"SARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method"},{"system":"http://loinc.org","version":"2.78","code":"96896-6","display":"SARS coronavirus 2 (COVID-19) clade [Type] in Specimen by Molecular genetics method"},{"system":"http://loinc.org","version":"2.78","code":"96897-4","display":"SARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96898-2","display":"SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96899-0","display":"SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96900-6","display":"SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96957-6","display":"SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"96986-5","display":"SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection"},{"system":"http://loinc.org","version":"2.78","code":"9699-0","display":"Paroxetine [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"97097-0","display":"SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"97098-8","display":"SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"97104-4","display":"SARS-CoV-2 (COVID-19) ORF1ab region [Units/volume] (viral load) in Upper respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"9721-2","display":"Salivary gland Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"9780-8","display":"Spermatozoa [#/volume] in Semen"},{"system":"http://loinc.org","version":"2.78","code":"9781-6","display":"Acanthamoeba sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"9786-5","display":"Microscopic observation [Identifier] in Blood or Marrow by Periodic acid-Schiff stain"},{"system":"http://loinc.org","version":"2.78","code":"9787-3","display":"Sarcoptes scabiei identified in Skin by Light microscopy"},{"system":"http://loinc.org","version":"2.78","code":"9790-7","display":"Methyl bromide [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"98069-8","display":"SARS-CoV-2 (COVID-19) Ab [Presence] in Saliva (oral fluid) by Rapid immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"9811-1","display":"Chromogranin A [Mass/?volume] in Serum or Plasma"},{"system":"http://loinc.org","version":"2.78","code":"98131-6","display":"SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"98132-4","display":"SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory specimen by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"9816-0","display":"Actinomyces sp identified in Unspecified specimen by Organism specific culture"},{"system":"http://loinc.org","version":"2.78","code":"9826-9","display":"Treponema pallidum Ab [Presence] in Cerebral spinal fluid by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"9838-4","display":"Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence"},{"system":"http://loinc.org","version":"2.78","code":"98493-0","display":"SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Saliva (oral fluid) by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"98494-8","display":"SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Saliva (oral fluid) by NAA with probe detection"},{"system":"http://loinc.org","version":"2.78","code":"98732-1","display":"SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Titer] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"98733-9","display":"Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"98734-7","display":"SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Units/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"98846-9","display":"SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells [Units/volume] corrected for background in Blood by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"98847-7","display":"SARS coronavirus 2 stimulated gamma interferon release by lymphocytes [Units/volume] corrected for background in Blood by Immunoassay"},{"system":"http://loinc.org","version":"2.78","code":"11481-9","display":"Human papilloma virus identified in Specimen"},{"system":"http://loinc.org","version":"2.78","code":"15212-4","display":"Lipase [Enzymatic activity/volume] in Body fluid"},{"system":"http://loinc.org","version":"2.78","code":"20373-7","display":"Amikacin [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"20376-0","display":"Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"20377-8","display":"Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"20381-0","display":"Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"20382-8","display":"Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"20383-6","display":"Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"20385-1","display":"rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"20386-9","display":"Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"20461-0","display":"Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"21976-6","display":"Cancer outcome status"},{"system":"http://loinc.org","version":"2.78","code":"21978-2","display":"Source of follow-up information Cancer"},{"system":"http://loinc.org","version":"2.78","code":"22633-2","display":"Pathology report site of origin Narrative"},{"system":"http://loinc.org","version":"2.78","code":"22634-0","display":"Pathology report gross observation Narrative"},{"system":"http://loinc.org","version":"2.78","code":"22637-3","display":"Pathology report final diagnosis Narrative"},{"system":"http://loinc.org","version":"2.78","code":"23607-5","display":"Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"23608-3","display":"cycloSERINE [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"23611-7","display":"Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25174-4","display":"Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25175-1","display":"Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25176-9","display":"Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25177-7","display":"Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25178-5","display":"Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25179-3","display":"Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25180-1","display":"Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25181-9","display":"Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25183-5","display":"Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25184-3","display":"rifAMPin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25186-8","display":"Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25187-6","display":"Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25188-4","display":"Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25189-2","display":"Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25194-2","display":"Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25195-9","display":"Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25196-7","display":"Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25198-3","display":"Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25199-1","display":"Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25200-7","display":"Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25201-5","display":"Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25202-3","display":"rifAMPin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25203-1","display":"rifAMPin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25204-9","display":"rifAMPin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25207-2","display":"cycloSERINE 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25208-0","display":"cycloSERINE 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25209-8","display":"cycloSERINE 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25210-6","display":"Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25211-4","display":"Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25212-2","display":"Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25215-5","display":"Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25216-3","display":"Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25217-1","display":"Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25218-9","display":"Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25219-7","display":"Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25229-6","display":"Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25230-4","display":"Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"25231-2","display":"Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"29315-9","display":"Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"29757-2","display":"Colposcopy study"},{"system":"http://loinc.org","version":"2.78","code":"41500-0","display":"Linezolid [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"41502-6","display":"Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"42642-9","display":"Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"42651-0","display":"Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"42655-1","display":"Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"43986-9","display":"Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"43988-5","display":"Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"43989-3","display":"Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"45215-1","display":"Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"48169-7","display":"Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"48170-5","display":"Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"48685-2","display":"Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"55194-5","display":"Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"55674-6","display":"Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"55685-2","display":"Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"55711-6","display":"Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"55712-4","display":"rifAMPin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"56025-0","display":"Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"56026-8","display":"Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"60564-2","display":"Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"60565-9","display":"Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"61355-4","display":"Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"63565-6","display":"Prothionamide [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"76043-9","display":"Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"76044-7","display":"Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"76045-4","display":"Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"8100-0","display":"Specimen preparation [Type]"},{"system":"http://loinc.org","version":"2.78","code":"85690-6","display":"Rubella virus genotype in Specimen"},{"system":"http://loinc.org","version":"2.78","code":"88704-2","display":"Bedaquiline [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"88706-7","display":"Linezolid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"88707-5","display":"Moxifloxacin 0.25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"93497-6","display":"Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria"},{"system":"http://loinc.org","version":"2.78","code":"48013-7","display":"Genomic reference sequence [ID]"},{"system":"http://loinc.org","version":"2.78","code":"5394-2","display":"Treponema pallidum Ab [Titer] in Serum by Latex agglutination"},{"system":"http://loinc.org","version":"2.78","code":"66746-9","display":"Specimen type"},{"system":"http://loinc.org","version":"2.78","code":"615-5","display":"Viral strain"},{"system":"http://loinc.org","version":"2.78","code":"9398-9","display":"Reticulin Ab [Titer] in Serum"},{"system":"http://loinc.org","version":"2.78","code":"58453-2","display":"Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5400","display":"1st Antenatal Screen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0150","display":"5HIAA"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0149","display":"5HIAA - 24h"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5404","display":"AHG (direct)"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0098","display":"Albumin"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0123","display":"Albumin 24h urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0124","display":"Albumin urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0195","display":"Alk phosphatase isoenzymes"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5434","display":"Anti neutrophil cytoplasmic Ab"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0278","display":"Antiglobulin test"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0313","display":"Antinuclear Ab"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5445","display":"Apolipoproteins"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5412","display":"APTT (+ Polybrene)"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5435","display":"Autoantibodies"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0113","display":"B-J protein urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0112","display":"B-J protein urine 24h"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5415","display":"Bacteria urine"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5419","display":"Bacteria urine (microscopy)"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5447","display":"Bile Pigments"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0136","display":"Blood gases"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5448","display":"Blood gases + Electrolytes"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5290","display":"Body fluid (microscopy)"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5465","display":"BRAF Method of testing"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0392","display":"C. trachomatis Ag"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5444","display":"C3 Breakdown/cleavage products"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5456","display":"Calcium Group"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5420","display":"Casts urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5341","display":"Casts urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0013","display":"Catecholamines urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0007","display":"Catecholamines urine 24h"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0202","display":"CBC"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0080","display":"Cholesterol (LDL)"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0084","display":"Cholesterol Total/HDL ratio"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5410","display":"CK Isoenzymes Group"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5424","display":"CMV NAAT/Viral Load"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0383","display":"CMV Serology"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0271","display":"Coagulation Profile"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5437","display":"Complement"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5436","display":"Complement Special Assays"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5546","display":"Completeness of excision"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0001","display":"Cortisol"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5472","display":"COVID-19 order"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5421","display":"Crystals [Presence] in Urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5342","display":"Crystals urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5416","display":"CSF Biochemistry"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5301","display":"CSF Micro/Culture"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5459","display":"Degree of Dysplasia [Presence]"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5512","display":"Drop off time - specimen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5451","display":"Drug Screen (urine)"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0391","display":"EBV Serology"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ0260","display":"Echis time/prothrombin time"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5446","display":"Electrolytes"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5430","display":"Electrolytes urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5458","display":"Electrolytes urine 24h"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5439","display":"ENA Identification"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5438","display":"ENA screen"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5150","display":"ESBL bacteria (culture)"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5516","display":"Extent of invasion"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0051","display":"Faecal Occult blood"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0265","display":"Fibrinogen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5417","display":"Filiaria - blood film examination for microfilaria"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0288","display":"G6PD"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0060","display":"Gestational diabetes screen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5440","display":"Gliadin antibodies"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0058","display":"Glucose tolerance test"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"RNZ0504","display":"Gynaecological cytology"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0504","display":"Gynaecological cytology"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0291","display":"Haemoglobinopathy screen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0057","display":"HbA1c"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0298","display":"HbF (Kleihauer)"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5405","display":"Heparin induced thrombocytopaenia (HIT) Screen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5426","display":"Hepatitis A  Serology"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5427","display":"Hepatitis B Serology"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5428","display":"Hepatitis B Viral Load"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5429","display":"Hepatitis C Ab"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0422","display":"HIV 1 & 2"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5552","display":"HPV Detection Status"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5554","display":"HPV Type"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5413","display":"HSV Ag"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0408","display":"HSV DNA (NAAT)"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0404","display":"HSV Serology"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5560","display":"IFOB Test Group"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0107","display":"IgG subclasses"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ0510","display":"Immune function status"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0432","display":"Immunoglobulins"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0428","display":"Intrinsic factor Ab"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5518","display":"Invasion into adjacent structure and/or organ"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5457","display":"Iron Studies"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5464","display":"Kikuchi level"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0093","display":"Lamotrigine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0201","display":"LDH"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5295","display":"LDH Body fluid"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5308","display":"Leptospira Ab"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0434","display":"Liver profile"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5526","display":"Loss of expression for MMR protein"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5476","display":"Lower left lobe lung swab"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5478","display":"Lower right lobe lung swab"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5406","display":"Lupus anticoagulant screen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5441","display":"Lymphocyte Immunophenotyping"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5321","display":"Malaria blood"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5450","display":"Metanephrine/Normetanephrine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5449","display":"Metanephrine/Normetanephrine urine 24h"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5541","display":"MeV DSId"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5539","display":"MeV named strain"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5160","display":"Micro-organism (phage typing)"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5136","display":"Microscopy (other method)"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5494","display":"Nasopharyngeal swab"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5522","display":"Number of tumour buds"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5498","display":"Oropharyngeal and anterior nares swab"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5496","display":"Oropharyngeal swab"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5462","display":"Peripheral margin status"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5422","display":"Platelet aggregation interpretation"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5407","display":"Platelet Aggregation Studies"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5408","display":"Platelet Function Screen (PFA)"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5538","display":"POCT hs-TnI (Siemens VTLi)"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5515","display":"Polyp profile"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5460","display":"Poor / undifferentiated tumour [presence]"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0117","display":"Protein urine"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5423","display":"PSA"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5534","display":"Rapid Antigen Test performed by patient reported by GP"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0276","display":"Reticulocytes"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0324","display":"Rheumatoid factor"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0359","display":"Rubella antibody"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5544","display":"RuV DSId"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5542","display":"RuV named strain"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5479","display":"Saliva specimen"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5470","display":"Sample Day [SARS-CoV-2 Instrument independent]"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5466","display":"SARS-CoV-2 [Instrument independent]"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5474","display":"SARS-CoV-2 Antibody"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5484","display":"SARS-CoV-2 IgA"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5508","display":"SARS-CoV-2 IgA Anti N"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5506","display":"SARS-CoV-2 IgA Anti S"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5480","display":"SARS-CoV-2 IgG"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5514","display":"SARS-CoV-2 IgG Ab Nucleosome and spike"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5504","display":"SARS-CoV-2 IgG Anti N"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5502","display":"SARS-CoV-2 IgG Anti S"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5482","display":"SARS-CoV-2 IgM"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5510","display":"SARS-CoV-2 IgM Anti N"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5537","display":"SARS-CoV-2 LAMP"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5530","display":"SARS-CoV-2 Rapid Antigen self reported"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5527","display":"SARS-CoV-2 Rapid or PoCT Molecular"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5536","display":"SARS-CoV-2 sequencing order"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5490","display":"SARS-CoV-2 Total Anti N"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5488","display":"SARS-CoV-2 Total Anti S"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5326","display":"Semen (post vasectomy)"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5325","display":"Seminal Fluid Fertility"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5452","display":"Serum free light chains"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5453","display":"SHBG/Testos/FAI group"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5486","display":"Sputum specimen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0331","display":"Streptococcal Antibodies"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5401","display":"Subsequent Antenatal Screen"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5468","display":"Surveillance [Instrument independent]"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0004","display":"Synacthen stimulation test"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5551","display":"TB MIRU Cluster Id"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5547","display":"TB MIRU-12 Profile"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5549","display":"TB MIRU-24 Profile"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0247","display":"Thrombin time"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5409","display":"Thrombophilia Screen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5442","display":"Thyroglobulin Ab"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5454","display":"Thyroid Function Test"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0319","display":"Tissue Autoantibodies"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5455","display":"Tobramycin Level"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5431","display":"Toxoplasma Serology"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5432","display":"Treponemal Serology"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0146","display":"TSH"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5443","display":"TTG Ab"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5520","display":"Tumour budding assessment indicator"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5524","display":"Tumour budding score"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5500","display":"Unspecified specimen"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5338","display":"Urine (dipstick)"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5418","display":"Urine Micro and Culture"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5340","display":"Urine Microscopy"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5556","display":"Vaping status"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5433","display":"Varicella serology"},{"system":"https://standards.digital.health.nz/ns/loinc-nz-local-code","version":"20240401","code":"XNZ5461","display":"Venous invasion"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ0075","display":"Vitamin B12 and Folate"},{"system":"https://nzhts.digital.health.nz/fhir/CodeSysrtem/loinc_nz_local_order_code","version":"20241014","code":"XNZ5411","display":"Von Willebrand"}]}}